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ABSTRACT 
 
Discovery of Candidate Genes for Stallion Fertility from the Horse Y Chromosome. 
(August 2009) 
Nandina Paria, B.S., University of Calcutta; 
M.S., University of Calcutta 
Chair of Advisory Committee: Dr. Terje Raudsepp 
 
The genetic component of mammalian male fertility is complex and involves 
thousands of genes. The majority of these genes are distributed on autosomes and the X 
chromosome, while a small number are located on the Y chromosome. Human and 
mouse studies demonstrate that the most critical Y-linked male fertility genes are present 
in multiple copies, show testis-specific expression and are different between species. 
In the equine industry, where stallions are selected according to pedigrees and 
athletic abilities but not for reproductive performance, reduced fertility of many breeding 
stallions is a recognized problem. Therefore, the aim of the present research was to 
acquire comprehensive information about the organization of the horse Y chromosome 
(ECAY), identify Y-linked genes and investigate potential candidate genes regulating 
stallion fertility. 
To achieve theses goals, a direct cDNA (complementary DNA) selection 
procedure was used to isolate Y-linked genes from horse testes and 29 Y-specific genes 
were identified. All 29 genes were mapped to ECAY and their sequences were used to 
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further expand the existing map. Copy number analysis identified 15 multicopy genes of 
which 9 were novel transcripts. Gene expression analysis on a panel of selected body 
tissues showed that some ECAY genes are expressed exclusively in testes while others 
show ubiquitous or intermediate expression. Quantitative Real-Time PCR using primers 
for 9 testis-specific multicopy genes revealed 5 genes with statistically significant 
differential expression in testis of normal fertile stallions and stallions with impaired 
fertility. Gene copy number analysis showed that the average copy number of 4 such 
genes was decreased in subfertile/infertile stallions compared to normal animals.  
Taken together, this research generated the first comprehensive physical gene 
map for the horse Y chromosome and identified a number of candidate genes for stallion 
fertility. The findings essentially expand our knowledge about Y chromosome genes in 
horses, open a new avenue for investigating the potential role of ECAY genes in stallion 
fertility which contribute to the development of molecular tools for the assessment of 
fertility in stallions. 
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CHAPTER I 
 
GENERAL INTRODUCTION 
 
OVERVIEW OF THE GENETICS OF MALE FERTILITY IN MAMMALS 
Male fertility in mammals is a complex trait and is governed by a combination of 
multiple environmental and genetic factors. Though only limited information is available 
about the latter, it has been proposed that almost 20% of the genes in mammalian 
genomes (~5,000 genes) are involved in different aspects of male fertility - sex 
determination, sexual differentiation and testicular development, spermatogenesis, sperm 
function and sperm-oocyte interactions preceding fertilization (Hargreave 2000; Matzuk 
and Lamb 2002; Carrell 2007; Krausz and Giachini 2007). Male fertility is the result of a 
well orchestrated and spatio-temporally regulated interaction of these genes, though our 
current knowledge about the role of specific genes at different stages of male 
development is limited. This also implies that very little is known about the underlying 
molecular causes of male infertility. To date only a few hundreds male fertility genes 
have been identified using mainly transgenic, knockout, or mutant rodent models 
(Matzuk and Lamb 2002; Carrell 2008; Matzuk and Lamb 2008). In the following 
sections a brief overview of current knowledge about the genetic regulation of the most 
critical steps in male fertility is presented. 
 
____________ 
This dissertation follows the style of Cytogenetic and Genome Research. 
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Male sex determination  
Male sex determination in mammals is a complex process that involves a cascade 
of molecular events and interactions among many genes. In eutherian mammals the 
onset of maleness is governed by a single gene - SRY (Sex-determining Region on Y) 
that encodes a high mobility group (HMG) family transcription factor protein. In mouse 
Sry transcripts are expressed for a brief period during early stages of gonadal 
development (between 10.5-12.5 days postcoitum) and the ability of SRY to induce testis 
development is limited to a time window of only 6 hours after the normal onset of its 
expression in XY gonads. This is an indication that SRY mainly initiates testis 
development rather than maintains testis differentiation (Hiramatsu et al. 2009; Sekido 
and Lovell-Badge 2009). Several hypotheses have been proposed regarding SRY 
function in sex determination. For example, SRY might antagonize a repressor of male 
development or might initiate transcription of one or more genes that have important 
roles in male development (Wilhelm et al. 2007a). However, in order to understand SRY 
functional pathway(s), knowledge of SRY target genes is required. With recent progress 
in deciphering the genetic component of mammalian sex determination, several other 
genes with important roles in sex determination and male development have been 
discovered. Among these are SRY-box 9 (SOX9), steroidogenic factor (SF1, now known 
as nuclear receptor subfamily 5, group A, member 1, NR5A1), GATA-binding protein 4 
(GATA4), fibroblast growth factor 9 (FGF9), wingless-type MMTV integration site family, 
member 4 (WNT4), R-Spondin1 (RSPO1) and many more. Rodent studies provide 
compelling evidence that the only downstream target of SRY is SOX9 which in turn 
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activates the rest of the male pathway genes, drives Sertoli cell formation and hence, 
testis differentiation (Sekido et al. 2004; Wilhelm et al. 2005; Sekido and Lovell-Badge 
2008). Murine Sry binds to multiple elements within a Sox9 gonad-specific enhancer and 
upregulates Sox9. Although Sry initiates maleness in the embryo, Sox9 maintains the 
later part of male development. While Sry expression is transient, Sox9 expression is 
maintained in Sertoli cells throughout life (Sekido and Lovell-Badge 2009). 
Furthermore, SRY upregulates SOX9 expression rather than initiates it. It is proposed that 
SOX9 transcriptional regulation consists of at least three phases: i) SRY-independent and 
probably SF1-dependent initiation, ii) SRY-dependent upregulation, and iii) SRY-
independent maintenance (Sekido et al. 2004). This also explains how gain-of-function 
mutations of SOX9 in humans and mice can initiate male development in female (XX) 
embryos in the absense of SRY (Polanco and Koopman 2007; Wilhelm et al. 2007b). 
Another key-role gene in the self-reinforcing pathway of male sex determination is SF1 
which initiates SOX9 transcription and thereafter, cooperatively with SRY, upregulates 
SOX9 expression. A positive feed-back loop between SF1 and SOX9 is also needed to 
maintain SF1 transcription. After SRY expression has ceased, SOX9 binds to its enhancer 
along with SF1 to maintain SOX9 expression in the absence of SRY. Therefore, 
mammalian sex determination involves the synergistic action of SRY and SF1 on a 
specific SOX9 enhancer to upregulate and maintain SOX9 expression (Sekido and 
Lovell-Badge 2008). Additionally, SOX9 binds to its own enhancer and self-regulates its 
expression. These early events in male sex determination involve mainly three critical 
genes – SRY, SF1, SOX9 and focus on the initiation and maintenance of SOX9 
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expression. SOX9, in turn, is probably the pivotal and distinguishing factor that 
influences the expression of genes that define Sertoli cell phenotype and function, such 
as anti-Mullerian hormone (AMH) and prostaglandin D2 synthase (PTGDS). A positive 
feed-forward loop between SOX9 and FGF9 activates the FGF9-FGFR2 signalling 
pathway which antagonizes the activity of RSPO1-WNT4 and suppresses ovarian 
development (Kim et al. 2006; Wilhelm 2007). FGF9, in turn, is indispensable to 
maintain SOX9 expression in Sertoli precursor cells. DAX1 acts as an anti-testis gene by 
antagonizing the function of SRY in mammalian sex determination pathways (Swain et 
al. 1998). While SOX9 activates genes critical for male development, it also represses 
the activity of genes typical to bipotential cell precursors and follicle cells. Once SOX9 
activity has reached a critical threshold, it represses SRY activity, as well as the activity 
of typical female pathway genes such as WNT4, RSPO1, DAX1 and FOXL2 (Nef et al. 
2003; Sekido and Lovell-Badge 2008).  In summary, male sex determination in 
mammals is a complex process which is sensitive to gene dosages, involves synergistic 
interactions of many genes forming a network of  positive and negative feedback or feed 
forward loops and keeps a fine balance between male and female developmental 
pathways (Sekido and Lovell-Badge 2008). However, it should be noted that most 
current knowledge about male sex determination is based on mouse models and might 
not reflect the situation in other mammalian species. A schematic representation of SRY-
SOX9 interplay in mammalian sex determination pathways is shown in Fig. 1.  
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Male sexual differentiation 
Once the sex of the embryo is determined as male, the bipotential gonad 
differentiates along the male pathway into a testis which, in turn, dictates the 
development of male secondary sex organs and the differentiation of Wolffian ducts into 
the male genital tract, viz., epididymis, vas deferens and seminal vesicles (Matzuk and 
Lamb 2008). All these events, especially the processes that lead to the proper 
Figure 1: Schematic representation of SOX9-SRY interactions at the onset of 
mammalian sex determination (Wilhelm 2007, Wilhelm et al. 2007b, Sekido and 
Lovell-Badge 2008).  
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development, growth, and descent of testes, are critical for spermatogenesis and male 
fertility. 
The complex events of male sexual differentiation are sensitive to environmental 
influences (e.g., toxins, temperature) and are regulated by many genes coding for various 
growth and transcription factors, hormones and signaling molecules (Matzuk and Lamb 
2008). As already mentioned, testis differentiation is induced by the expression of SRY 
and SOX9 in a subset of somatic cells, known as Sertoli cell precursors that develop into 
Sertoli cells. Sertoli cells, in turn, orchestrate the differentiation of all other cell types in 
males by secreting appropriate levels of signaling molecules (Wilhelm et al. 2007b). 
This leads to the formation of testis cords (the precursors of adult spermatogenic 
tubules), differentiation of Leydig cells, vascular cells and other interstitial cells such as 
fibroblasts, mast cells, macrophages and lymphocytes. Leydig cells are important for 
secreting the hormones that play vital roles in establishing and maintaining the 
secondary male sex characteristics (Wilhelm et al. 2007b). Increased proliferation and 
migration of peritubular myoid cells, Leydig cells and endothelial cells from adjacent 
mesonephros are responsible for the increase of testis size (Schmahl et al. 2000).  
An important event in male differentiation is proper descent of the testes. 
Impaired testicular descent, cryptorchidism, exposes the undescended testis for a 
prolonged time to increased temperature resulting in compromised spermatogenesis and 
reduced fertility or infertility. Cryptorchdism as a possible cause of impaired 
spermatogenesis was first described over 80 years ago (Crew 1922) and is one of the 
best-characterized risk factors for reduced male fertility (Foresta et al. 2008). The 
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condition is a more common problem (2-12%) in humans, pigs, dogs, cats and horses 
compared to cattle and sheep (<1%) (Amann and Veeramachaneni 2007). Despite this, 
very little is known about the genetic causes of cryptorchidism. The Mouse Genome 
Informatics (MGI: http://www.informatics.jax.org/1) database describes about 44 genes 
and markers that are associated with the murine cryptorchid phenotype. Eighteen of 
these genes are also believed to be involved in unilateral or bilateral cryptorchidism in 
humans (Matzuk and Lamb 2008), though causative mutations have been found in only a 
few genes and a few individuals. For example, a single nucleotide mutation in insulin-
like factor 3 (INSL3) is associated with some, but not all, cases of human cryptorchidism 
(Feng et al. 2004; Agoulnik and Feng 2007). INSL3 is required for gradual expansion of 
the gubernaculum which, in turn, provides an anchor for normal abdominal translocation 
of the testis. Other critical candidate genes for cyptorchidism are INSL3 receptor (LGR8, 
now known as RXFP2), homeo box A10 (HOXA10) and estrogen receptor 1 (ESR1) 
(Matzuk and Lamb 2008). Over-expression of the aromatase gene (CYP19A1) can cause 
cryptorchidism by raising intra-testicular estradiol levels, introducing hormonal 
imbalance in the system (Klonisch et al. 2004). Additionally, environmental factors that 
interfere with the endocrine regulation of testicular descent might also contribute to the 
etiology of cryptorchidism (Foresta et al. 2008) and complicate the search for genetic 
causes. 
Compared to the well studied physiology and biochemical pathways of signaling 
molecules leading to the differentiation of primordial germ cells, not much is known 
about the genetic basis of male sexual development and differentiation in mammals. 
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There is a non-exhaustive list of about 90 candidate genes that might be associated with 
various stages of male differentiation, while single nucleotide polymorphisms (SNPs) or 
mutations have been described for only seven genes, viz., ATF3, CFTR, ESR1, ESR2, 
FGFR2, INSL3, SF1 (Matzuk and Lamb 2008). Similarly to male sex determination, 
most of the genetic studies on male sexual differentiation are based on rodent models 
and only a few have searched for candidate genes and mutations in humans or domestic 
animals (Matzuk and Lamb 2002; Wilhelm et al. 2007b; Barthold 2008; Foresta et al. 
2008). 
 
Spermatogenesis 
Mammalian spermatogenesis entails a sequence of events that are initiated in the 
testis, proceed in the epididymis, and culminate with sperm capacitation in the female 
reproductive tract. For successful sperm, these events are followed by acrosomal 
exocytosis, penetration of the oocyte zona pellucida, and fertilization (Luk et al. 2006; 
Varner and Johnson 2007; Marengo 2008). Spermatogenesis involves mitotic and 
meiotic cell divisions and both nuclear and cytoplasmic reorganizations, thus, many 
proteins are transiently or temporally expressed in a particular stage of the 
spermatogenic cycle (Cheng and Mruk 2002). This implies that spermatogenesis is under 
spatio-temporal control of many genes. A variety of approaches have identified over 
1000 genes that are specifically expressed in male germline and become active in testis 
exemplifying the complexity of the process. This also indicates that mutations in 
thousands of different genes could cause male infertility (Cooke and Saunders 2002; 
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Nayernia et al. 2003; Chenoweth 2005; Carrell 2007). Targeting specific genes that 
regulate particular processes during spermatogenesis, however, has had limited success, 
and has been carried out mainly in model species like mice and rats (Matzuk and Lamb 
2002; Nayernia et al. 2003). In contrast, very little is known about the genes controlling 
spermatogenesis and male fertility in other mammalian species, including humans and 
horses. To illustrate the complex genetics underlying spermatogenesis, a summary of 
events at different phases of this process is described below.   
 
i) Mitotic and meiotic germ cell divisions 
Male germ cell proliferation begins in embryogenesis and with the exception of a 
short prenatal-prepubertal period, spermatogonial stem cells proliferate throughout life. 
Spermatogenesis, the development of mature sperm from spermatogonia, starts at 
puberty under the influence of the hormone testosterone. Spermatogonial cells 
differentiate into diploid primary spermatocytes which then undergo meiosis. Meiosis is 
a type of cell division unique to germ cells and is needed for the production of haploid 
gametes for sexual reproduction. Synapsis of homologous chromosomes during the 
prophase of the first meiotic division is necessary for proper segregation of homologous 
chromosomes into haploid spermatids, while meiotic recombination increases genetic 
variation by exchanging alleles between paternal and maternal homologs. 
Recombination and faultless segregation of homologous chromosomes are, thus, among 
the most critical events during spermatogenesis and any mistake results in aberrant 
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sperm. The most extreme consequence of meiotic errors is the production of semen 
without sperm (azoospermia) causing complete infertility.  
Mitotic and meiotic cell divisions are controlled by hundreds of genes. Recent 
studies of transcriptional regulatory network of the mitotic cell cycle in normal human 
fibroblasts identified 480 periodically expressed genes (Bar-Joseph et al. 2008) and it 
could be expected that meiosis is regulated by even more genes. Among the 
approximately 115 genes associated with various types of sperm defects (O'Bryan and de 
Kretser 2006; Matzuk and Lamb 2008), several are critical for meiotic recombination 
and chromosome movements during meiosis. To mention a few, male mice lacking both 
copies of synaptonemal complex protein 3 (SYCP3) produce no sperm (Hughes 2008), 
mutation in chromosomal passenger protein aurora kinase C gene (AURKC) which is 
needed for normal centromere function, leads to the production of large-headed 
polyploid multi-flagellar spermatozoa causing infertility in human males (Dieterich et al. 
2009) and mutations in recombination genes such as SPO11, DMC1, MSH4 and MSH5 
cause complete arrest of germ cells at zygonema of meiosis I prophase and result in 
azoospermia both in men and mice (Gonsalves et al. 2004). Normally, aberrant germ 
cells are arrested at cell cycle checkpoints and subjected to DNA repair or, if damaged 
beyond repair, eliminated by programmed cell death also known as apoptosis (Gonsalves 
et al. 2004). Consequently, mutations in genes controlling cell cycle checkpoints, DNA 
repair mechanisms or apoptosis contribute to the production of various types of defective 
sperm (Matzuk and Lamb 2008).  
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 ii) Spermiogenesis 
The final phase of sperm development within testis is spermiogenesis. During 
this stage the haploid round spermatids undergo dramatic transformation and are finally 
released during the process called spermiation into the lumen of seminiferous tubules as 
spermatozoa (Beardsley and O'Donnell 2003; Varner and Johnson 2007). Terminal 
differentiation of spermatids involves four major events: i) acrosome biogenesis, ii) 
formation of sperm tail or flagellum, iii) chromatin condensation, and iv) removal of 
most of the sperm cytoplasm. These complex processes are critical for the development 
of fully functional sperm and at this time the sperm are most vulnerable to both 
structural and genetic defects (Varner and Johnson 2007). 
The acrosome is a large secretory vesicle located in the sperm’s head between the 
nucleus and the plasma membrane and is essential for penetration of the sperm through 
the oocyte’s zona pellucida and fertilization (Mayorga et al. 2007; Varner and Johnson 
2007; Zhao et al. 2007; Zhao et al. 2008). The absence of the acrosome, also known as 
globozoospermia, is a genetic disorder of male infertility and is characterized by the 
presence of 100% round-headed sperm lacking an acrosome (Dam et al. 2007). Studies 
in humans and mice agree that defects in acrosome biogenesis have a genetic basis, 
though very little is known about candidate genes and mutations. MGI 
(http://www.informatics.jax.org/1) describes about 40 murine genes and phenotypes with 
an abnormal or missing acrosome of which some though not all might be associated with 
similar conditions in humans or other mammals. For example, homozygous deletion of 
the casein kinase 2 (Csnk2a2) causes globozoospermia in mouse (Rocha and Affara 
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2000; Truong et al. 2003) but in spite of expectations, no mutations in CSNK2A2 have 
been detected in globozoospermic human patients (Pirrello et al. 2005).  
The development of the sperm tail is another key-process which directly affects 
sperm motility and involves formation of axoneme, outer dense fibres, fibrous sheath 
and mitochondrial sheath (Varner and Johnson 2007; Matzuk and Lamb 2008). Mouse 
models showing impaired sperm motility, also known as asthenozoospermia, provide 
some clues concerning potential gene defects in humans. Among proposed candidate 
genes for human asthenozoospermia, several encode known flagellar proteins such as 
axoneme associated proteins SPAG6 and SPAG16, A kinase (PRKA) anchor protein 4 
(AKAP4) and genes encoding proteins in axonemal dynein cluster (DNAI1, DNAH5 and 
DNAH11 (O'Bryan and de Kretser 2006; Matzuk and Lamb 2008). Sperm motility can 
be affected also by deletions and mutations in mitochondrial genes such as MTCYB and 
MTATP6 (Feng et al. 2008), genes governing sperm transit from epididymis, such as 
homeobox 5 (Rhox5) (Shanker et al. 2008), sperm without mobility 2 (SWM2) (Lessard 
et al. 2007) and genes regulating intracellular calcium channels and potassium currents 
in sperm, such as the CATSPER gene family (Matzuk and Lamb 2008). 
 
iii) Epididymal transit and sperm maturation  
Though sperm chromatin condensation starts during spermiogenesis, most of it 
takes place during sperm maturation in the epididymis. This process involves extensive 
cellular remodeling and results in packing the haploid genome of sperm into a compact 
transcriptionally silent structure where most histones are replaced with protamines 
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(Braun 2001; Varner and Johnson 2007). After maturation, sperm chromatin packing 
level exceeds that of a diploid somatic cell by about six fold (Braun 2001). Sperm 
chromatin remodeling has several unique features and requires expression of many male-
specific genes of which the most important and unique are protamines (Braun 2001). 
Sperm maturation is a systematic and gradual process. First, somatic histones are partly 
replaced by testis-specific histones which then are replaced by transitional nuclear 
proteins (TNP1, TNP2) and finally by protamines PRM1, PRM2 and PRM3 (van Roijen 
et al. 1998; Braun 2001). In contrast to sperm from other species, mature human sperm 
still contain a significant amount of histones, including testis-specific histone 2B 
(TH2B) (van Roijen et al. 1998). Expression and knockout studies in mouse underline 
the essential role of sperm chromatin genes and proteins in male fertility. These studies 
show that appropriate expression levels of Prm1 and Prm2 are required for male fertility 
and deletions of Tnp1 and Tnp2 cause subfertility, whereas mice with double knockouts 
for protamines and transitional nuclear proteins are completely infertile (O'Bryan and de 
Kretser 2006; Ravel et al. 2007). Mouse models also show that male fertility depends on 
the right balance between the sperm chromatin genes. For example, deletion of Tnp1 
triggers compensatory rise of the expression levels of Prm2 and Tnp2 and results in 
abnormal rod-shaped chromatin condensation, spermatozoa with blunted head tips and 
poor motility (Yu et al. 2000; O'Bryan and de Kretser 2006; Ravel et al. 2007). A 
heterozygous SNP in PRM1 gene might be associated with male infertility also in 
humans (Iguchi et al. 2006). 
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iv) Capacitation, acrosome reaction and fertilization  
The final and biologically most significant events in a sperm’s life take place in 
the female genital tract and involve sperm capacitation, sperm-oocyte recognition, 
sperm-zona binding, acrosomal exocytosis (also known as acrosomal reaction) and 
culminate with fertilization. Capacitation hyperactivates sperm by giving it elevated 
motility to successfully penetrate egg’s zona pellucida (ZP). It also destabilizes sperm's 
plasma membrane and prepares it for the acrosomal exocytosis. The latter happens when 
sperm contact the egg and the ZP proteins bind to the sperm plasma membrane 
(Mayorga et al. 2007; Varner and Johnson 2007; Zhao et al. 2007; Zhao et al. 2008). 
Acrosomal exocytosis facilitates the passage of the sperm through the zona and is 
absolutely necessary for fertilization (Mayorga et al. 2007; Varner and Johnson 2007). 
All these events are interrelated, regulated by complex biochemical pathways involving 
interactions of multiple proteins and protein complexes (De Blas et al. 2005; Mayorga et 
al. 2007; Varner and Johnson 2007). The best known of these is SNARE – a protein 
complex that controls membrane fusion and exocytosis, both in neuronal synapses and 
the sperm acrosome (De Blas et al. 2005; Kitamura et al. 2005). During recent years, the 
physiology and biochemistry of sperm capacitation and sperm-zona interactions have 
been extensively studied in mice, rats, humans and several domestic animals, including 
the horses (Varner et al. 2000; Bosard et al. 2005; De Blas et al. 2005; Neild et al. 2005; 
Obermann et al. 2005; Conner et al. 2007; Mayorga et al. 2007; Varner and Johnson 
2007). These studies have revealed a number of previously unknown critical proteins 
such as complexins I and II that facilitate acrosome membrane fusions in the mouse 
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(Zhao et al. 2007; Zhao et al. 2008), or membrane-permeant protein RAB3A which is 
needed to trigger acrosome exocytosis in humans (Lopez et al. 2007). Contrary to this, 
very little is known about the genetic regulation of these processes. Discovery of a few 
candidate genes and causative mutations has been successful mainly in the mouse and rat 
because of the possibility to study changes in gene expression at different developmental 
stages, induce targeted mutations and generate knockout models or transgenic animals. 
For example, approximately 30 murine genotypes are known to be associated with 
impaired acrosomal exocytosis and 8 genotypes which cause errors in other aspects of 
sperm-oocyte interactions (MGI: http://www.informatics.jax.org/1). As expected, among 
the genes causing impaired acrosomal exocytosis (IAE) are those involved in cation 
channels and calcium oscillations (Fukami et al. 2001; Jin et al. 2005), tetraspanins that 
regulate membrane fusions (Tanigawa et al. 2008) and acrosome expressed proteins (Lee 
et al. 2008), but also neurotransmitter receptors because the biochemical events in 
acrosomal exocytosis closely resemble those taking place in neuronal synapses (Sato et 
al. 2000; Meizel and Son 2005). Precise molecular functions of these and several other 
candidate genes are yet to be discovered and mouse models suggest that the events from 
sperm capacitation to fertilization are controlled by synergistic interactions of many 
genes (Nayernia et al. 2003). In summary, genetic regulation of male developmental 
pathway from sex determination to fertilization in mammals is complex and involves 
interactions of many genes. Recent discoveries that spermatogenesis is regulated also by 
epigenetic factors and that aberrant DNA methylation in control regions of imprinted 
genes expressed in sperm might be associated with human oligozoosperma (Filipponi 
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and Feil 2009) indicate that the regulatory machinery governing male fertility is 
probably more complicated than currently appreciated.  
 
Chromosomal distribution of male fertility genes in mammalian genomes 
Mammalian male fertility is influenced by thousands of genes which are 
distributed throughout the genome. In order to target the likely candidate genes more 
efficiently, it is important to know whether this distribution is uniform between and 
within chromosomes or if certain genomic regions are more enriched for male fertility 
genes than others. Furthermore, the position of a gene in the genome might have 
important consequences for its function (Betran et al. 2004). With the advancement of 
gene mapping and sequencing technology, medium- to high-resolution gene maps and/or 
whole genome (WG) sequence data are available for more than 50 mammalian species 
including human, chimpanzee, model species such as mouse and rat, and a number of 
domestic animals, viz., cattle, sheep, pig, horse, dog, cat, and rabbit 
(http://www.ncbi.nlm.nih.gov/2, http://www.ensembl.org/index.html3, http://genome.ucs 
c.edu/4). However, to date, identification and mapping of candidate genes for male 
fertility has been successful mainly in mouse and to a limited extent in humans. The 
available data from these two species indicate that the majority of male fertility genes 
are located on autosomes and the X chromosome, while a small proportion is strictly 
male specific and reside on the Y chromosome (Charlesworth 1991; Charlesworth and 
Charlesworth 2000; Charlesworth 2002; Charlesworth and Charlesworth 2005; Gvozdev 
et al. 2005; Graves et al. 2006). A comprehensive review on mammalian fertility genes 
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was published recently by Matzuk and Lamb (2008) and describes over 460 autosomal 
and X-linked murine genes of which 208 are specifically associated with male fertility. 
Additionally, the authors list over 200 human genes that are associated with different 
human male infertility phenotypes. The review provides information about the genes, 
mutations (if known), corresponding reproduction phenotypes, fertility status (e.g., 
subfertile, infertile) and chromosomal location. For example, there are about 40 genes 
responsible for spermatid differentiation. Of these Adamts2 and Ube2b are located on 
mouse (Mus musculus, MMU) chromosome 11, Ddx25 on MMU9 and Six5 on MMU7. 
Human orthologs of these genes are located on human (Homo sapiens, HSA) autosomes 
HSA5, HSA11 and HSA19, respectively. Over 1000 genes are reported to be associated 
with spermatogenesis. To name a few, estrogen receptor 1 (ESR1) is located on MMU10 
and HSA6, c-kit oncogene (KIT) on MMU5 and HSA4, and kit ligand (KITLG) on 
MMU5 and HSA12, respectively (Galan et al. 2005; Galan et al. 2006). Overall, the 
distribution of male fertility genes among autosomes is relatively uniform with slightly 
higher numbers of genes located on gene rich chromosomes such as MMU11 and 
HSA17 (Matzuk and Lamb 2008).  
Several studies have underlined a special connection between the X chromosome 
and male fertility genes (Betran et al. 2004; Emerson et al. 2004; Wang 2004; Ellis and 
Affara 2006). First, several autosomal genes and gene families with testis-biased 
expression have been retrotransposed from X-linked genes (Emerson et al. 2004). For 
example, human CSTF2T is the retrotransposed autosomal gene originating from its X-
linked progenitor CSTF64. CSTF2T shows testis-specific expression and has been 
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mapped to HSA10q22-23 – a region involved in  reciprocal translocation in 
oligozoospermic males (Wang 2004). A mutation in an X-derived autosomal retrogene 
mUtp14b causes juvenile spermatogonial depletion (jsd) phenotype in mouse 
(Rohozinski and Bishop 2004). Second, X chromosome has a tendency to recruit genes 
involved in male reproduction from other genomic locations and is therefore 
disproportionately enriched with testis-specific genes but also with genes involved in 
brain function, signifying the role of brain in male reproductive success (Zechner et al. 
2001; Emerson et al. 2004; Wang 2004; Ellis and Affara 2006). Alternatively, 
accumulation of testis and brain genes on the mammalian X chromosomes might be 
because the same protein complexes, thus the same genes, regulate interactions between 
the sperm and the egg and between neurons in the brain (De Blas et al. 2005; Kitamura 
et al. 2005). It is likely that due to hemizygous condition in males, the X chromosome 
genes are under unique evolutionary pressure and hence, the X chromosome serves as a 
preferred location for spermatogenesis genes (Torgerson and Singh 2006). Some of the 
X-linked spermatogenesis genes, such as the Rhox (Reproductive Homeobox genes on X 
chromosome) gene family, have been so far discovered only in mice. These genes are 
present on the X chromosome in clusters, predominantly expressed in Sertoli cells of 
adult testis and are involved in spermatogenesis (MacLean et al. 2005; Daggag et al. 
2008). It has been common knowledge that X-linked spermatogenesis genes are 
expressed before sex chromosome meiotic silencing (Reinke 2004). Therefore, the 
recent discovery that 33 mouse X-linked multicopy gene families, representing 
approximately 273 spermatogenesis genes, are expressed predominantly in post-meiotic 
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cells (Mueller et al. 2008) is of outstanding importance and might fundamentally change 
our understanding about the function of reproduction related genes during male meiosis. 
The mammalian Y chromosome is typically the smallest element in the 
karyotype, and forms only about 2% of an average mammalian genome. Surprisingly, 
despite the minute size and small proportion of euchromatin compared to 
heterochromatic regions, the Y chromosome is highly enriched with male fertility genes. 
However, to grasp a better understanding of how genes present on the Y chromosome 
acquired male fertility related functions, it is necessary to appreciate the evolution of this 
unique chromosome. A detailed knowledge about Y chromosome studies in human and 
mouse and the role of Y chromosome genes in male fertility in these two species will 
underline the importance of the Y chromosome in mammalian male fertility. The 
following sections will present a comprehensive overview about the evolution, structure 
and function of the mammalian Y chromosome. 
 
MAMMALIAN Y CHROMOSOME AND ITS ROLE IN MALE FERTILITY 
 
The origin and evolution of the Y chromosome 
An hypothesis accounting for mammalian sex-chromosome evolution was first 
proposed by Susumo Ohno in 1967 suggesting that sex chromosomes in mammals 
evolved from a pair of ancestral autosomes about 300 million years ago (Ohno 1967). In 
course of evolution, one of the homologs in this ancestral chromosome pair acquired 
mutations that possibly had advantage in males. These mutations might have given rise 
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to a male sex determining locus, TDF (testis-determining factor, later known as Sex 
determining Region on Y, SRY) on one homolog which then became proto-Y 
chromosome, designating the other homolog as the proto-X chromosome. The proto Y 
started accumulating male advantage genes around the TDF, suppressing recombination 
with its homolog to keep a male-specific gene package together, and thus, creating a 
male-specific region on the Y chromosome (MSY). Suppression of recombination 
between X and Y initiated differentiation of these two chromosomes about 240-320 
million years ago, shortly after the divergence of mammalian and avian lineages (Lahn 
and Page 1999). Thereafter the Y chromosome rapidly started to accumulate mutations 
and deletions which were not eliminated efficiently by selection pressure due to gradual 
loss of recombination with the X chromosome (Charlesworth 1991). As a consequence, 
in course of millions of years of evolution the male specific and hemizygous Y 
chromosome lost the majority of the ancestral set of genes and acquired an extensive 
amount of heterochromatic material. It retained only the genes that had selective 
advantage for critical male-specific functions and were possibly detrimental to females 
(Graves 1995, 2004, 2006; Delbridge and Graves 2007). The present mammalian Y 
chromosome is typically one of the smallest elements in the genome, has lost about 1250 
of its original ~1300 genes and is a degraded version of the X chromosome. The 
outstanding evolutionary history of the Y chromosome thereby explains its unique 
specialization for genetic regulation of male reproduction. 
Due to the presence of extremely high amounts of repeats, the Y chromosome 
was regarded, until as late as mid-1980s, as a genetic wasteland with the sole function of 
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male sex determination (Polani 1981; Sinclair et al. 1990; Quintana-Murci and Fellous 
2001) and largely ignored by human, mouse and other mammalian genome mapping 
projects. However, it soon became evident that the Y chromosome has retained more 
genes than only SRY and that a few of them regulate spermatogenesis and male fertility 
(Chandley and Cooke 1994; Lahn and Page 1997, 2000; Saxena et al. 2000; Makrinou et 
al. 2001; Dorus et al. 2003; Giachini et al. 2005; Lardone et al. 2007a). These pioneering 
studies opened a new avenue for Y chromosome research in mammals and eventually 
led to sequencing of the Y chromosome in humans. 
 
Y chromosome studies in mammals 
 
Human (Homo sapiens, HSA) 
The human Y chromosome (HSAY), is approximately 60 Mb in size and largely 
(~60%) heterochromatic. The 23 Mb of euchromatic portion covers approximately 8 Mb 
on the short arm (Yp) and 14.5 Mb on the long arm (Yq) of HSAY. The 40 Mb of 
heterochromatin comprises the bulk of the distal part of HSAYq and approximately 1 
Mb at the centromere. Besides large numbers of heterochromatic repeats, another 
signature feature of HSAY is the presence of sequences with multiple copies also known 
as ampliconic sequences. The ampliconic region on HSAYq is comprised of eight 
massive palindromes and is one of the most peculiar structural features of the 
chromosome (Skaletsky et al. 2003). 
 22 
Complete sequencing of the male-specific region of the human Y chromosome 
(MSY) revealed the presence of 156 transcriptional units which include 78 functional 
genes that collectively encode at least 27 distinct proteins. Several MSY genes are 
members of multicopy gene families of which 10 are expressed specifically in testis 
(Skaletsky et al. 2003). The HSAY gene list is still not complete because only recently 
eight more genes, all with open reading frames (ORFs), were discovered from a small 
euchromatic island within the pericentromeric heterochromatin (Kirsch et al. 2005). 
According to evolutionary origin and copy numbers the human Y chromosome genes are 
divided into four categories: X-degenerate, ampliconic, X-transposed and 
pseudoautosomal genes (Lahn and Page 1997; Skaletsky et al. 2003). 
X-degenerate genes share ancestral homology with the X chromosome and the 
present-day HSAY has retained 16 genes with a gametologue on the X chromosome, for 
example UTY-UTX or USP9Y-USP9X. X-degenerate genes are usually single copy and 
are expressed in most of the body tissues including testis, i.e., their expression is 
ubiquitous. They are usually involved in housekeeping activities but might have gained 
also other functions. The most remarkable example of X-degenerate genes is the male 
sex determination gene SRY which shares ancestral homology with X-linked SOX3 but 
has gained entirely new and unique functions on the Y chromosome (Skaletsky et al. 
2003; Sekido and Lovell-Badge 2008; Hiramatsu et al. 2009). 
Ampliconic genes, as inferred from the name, are present in multiple copies. 
They can be Y-borne (present only on Y) or have moved to the Y chromosome from 
other genomic locations. It is believed that amplification of these sequences on the Y 
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chromosome has occurred mainly through gene conversion and duplications (Skaletsky 
et al. 2003). Demarcation between X-degenerate and ampliconic genes is not always 
distinct. Some X-degenerate genes such as TSPY (X-linked homolog is TSPX) or RBMY 
(X-linked homolog is RBMX) can also be present in multiple copies (Skaletsky et al. 
2003; Delbridge et al. 2004). The majority of ampliconic genes, however, show testis-
limited expression and might be involved in spermatogenesis and other male 
reproductive functions (Prosser et al. 1996; Lahn and Page 1997; Mitchell 2000; Toure 
et al. 2004a; Toure et al. 2004b; Delbridge and Graves 2007). It has been hypothesized 
that these genes have acquired multiple copies due to significant role in male fertility, so 
that a potentially harmful mutation in one copy will be compensated by multiple other 
normally functioning copies (Graves 2006). Such compensatory mechanism is necessary 
to grant normal function of genes on the hemizygous and non-recombining Y 
chromosome. A total of 9 ampliconic gene families with approximately 60 
transcriptional units are present on HSAY. 
X transposed genes, TGIF2LY and PCDH11Y, have moved to HSAY from 
HSAXq21 (Skaletsky et al. 2003) and are characteristic to human Y chromosome only. 
No X transposed genes have yet been found in other mammals including the closest 
relative of human, the chimpanzee (Hughes et al. 2005; Kuroki et al. 2006). 
Pseudoautosomal genes are present in the pseudoautosomal region (PAR) which 
is a short region of homology between the mammalian X and Y chromosomes. The 
pseudoautosomal genes behave like autosomal genes by pairing and recombining during 
meiosis (Burgoyne 1982) and are thus inherited in autosomal rather than sex-linked 
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pattern (Mangs and Morris 2007). Human sex chromosomes are exceptional among 
mammals by having two pseudoautosomal regions - PAR1 and PAR2 (Goodfellow et al. 
1986; Rouyer et al. 1986; Freije et al. 1992). PAR1 corresponds to other eutherian PARs 
while PAR2 is human specific. PAR1 is approximately 2.6 Mb, located at the terminal 
region of the short arms of the X and Y chromosomes (Goodfellow et al. 1986; Rouyer 
et al. 1986; Rappold 1993; Graves 1998), whereas PAR2 is a fairly short region 
spanning only 320 kb at the tips of the long arms of the sex chromosomes (Freije et al. 
1992). PAR1 consists of at least 24 genes that  have been characterized so far (Mangs 
and Morris 2007) while PAR2 contains only 4 genes, viz., SPRY3, SYBL1, IL9R and 
CXYorf1 of which none has been associated with likely fertility functions (Kvaloy et al. 
1994; Li and Hamer 1995). 
 
Mouse (Mus musculus, MMU) 
Besides human, mouse is the only other mammalian species with detailed 
information about the organization, gene content and gene expression profiles for the Y 
chromosome, MMUY (Mazeyrat et al. 1998; Affara and Mitchell 2000). Murine Y 
chromosome studies strongly confirm the findings in humans and show that MMUY 
contains transcriptionally active genes, a number of which are critically involved in male 
fertility and reproduction (McElreavey et al. 2002; Toure et al. 2004a; Toure et al. 
2004b; Ellis et al. 2007; Grzmil et al. 2007). Currently, 53 genes and gene families are 
assigned to MMUY (http://www.ncbi.nlm.nih.gov/mapview/5). Like in humans, mouse 
Y chromosome genes are either X-degenerate, belong to multicopy gene families or are 
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pseudoautosomal. Notably, MMUY multicopy gene families are murine-specific, share 
no homology with human ampliconic genes but, interestingly, carry out similar male 
fertility related functions (Ellis et al. 2007). MMUY mutations have directly been 
associated with different male infertility phenotypes (Cooke and Saunders 2002). In 
contrast to human, mouse pseudoautosomal region (PAR) is only ~ 700 kb in size, 
harbors only two genes (STS, MID1) and shares no homology with human PAR1 (Perry 
et al. 2001).  
These outstanding findings in human and mouse have encouraged Y 
chromosome studies also in other mammalian species and will be discussed in the 
following paragraphs. 
 
Chimpanzee (Pan troglodytes, PTR) 
Beside human, chimpanzee is the only species where the sequence information of 
Y chromosome is available. The sequencing of PTRY involves 12.7 Mb of MSY and 
271 kb of PAR. Sequencing of the X-degenerate portion (~9.5 Mb) of the chimpanzee 
MSY has identified 19 protein-coding and 13 transcribed genes (Hughes et al. 2005; 
Kuroki et al. 2006). 59 pseudogenes were identified in the analyzed region of PTRY. 
Notably, all genes annotated as pseudogenes in humans are also pseudogenes in 
chimpanzee with one exception CD24L4 which is a pseudogene in human is absent in 
chimpanzee (Kuroki et al. 2006). Despite the similarities, there are also pronounced 
differences between the two species - four PTRY genes viz., CYorf15a, CYorf15b, 
TBL1Y, TMSB4Y and USP9Y, have disruptions and mutations causing alteration or loss 
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of function (Hughes et al. 2005; Perry et al. 2007). In contrast to human where X-
degenerate sequences are distributed along both arm of the Y chromosome and they are 
interrupted at several points by large blocks of ampliconic, heterochromatic and other 
sequences, the X-degenerate sequences in chimpanzee are present in a single, nearly 
contiguous block on the long arm of the PTRY. Moreover, there are also differences in 
the repeat elements. For example, PTRY harbors active L1 elements and endogenous 
retroviruses whereas HSAY is more enriched with Alu elements. Two novel endogenous 
retoviruses, CERV1 and CERV2 are present in 21 copies on PTRY but completely 
absent from human genome (Hughes et al. 2005). Despite these differences, overall, 
HSAY and PTRY have a sequence divergence of 1.78% whereas for rest of the genome 
the sequence divergence between human and chimpanzee is 1.23% (Kuroki et al. 2006). 
 
Cattle (Bos taurus, BTA) 
The first radiation hybrid (RH) map of the bovine Y chromosome (BTAY) was 
generated in 2002 (Liu et al. 2002) using a 7000 rad panel of 92 cattle x hamster hybrid 
clones. The map consisted of 49 microsatellites, 3 genes and 10 Sequence Tagged Sites 
(STSs). Microsatellite and STS markers were developed from a bovine Y-specific 
library, constructed by chromosome microdissection and microcloning. Two years later 
three more genes, SRY, ANT3 (currently known as SLC25A6) and CSF2RA were mapped 
on BTAY by RH and FISH (Liu and de Leon 2004). The latter two genes and another 
gene, STS, were assigned to the bovine PAR (Moore et al. 2001). Recently the bovine 
pseudoautosomal boundary (PAB) was identified in the SHROOM2-GPR143 interval. 
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The cattle PAR is longer than the human PAR but fewer genes have been indentified in 
cattle PAR so far compared to human PAR and the PAB extends more towards the 
centromeric region of the BTAY (Van Laere et al. 2008). Polymorphism analysis of 38 
BTAY microsatellites showed that 24 have two or more alleles in cattle populations, 
whereas 7 microsatellites showed the presence of multiple copies in the same individual 
– a typical feature of Y-linked multicopy sequences (Liu et al. 2003).  
 
Pig (Sus scrofa, SSC) 
The only available porcine Y chromosome map (Quilter et al. 2002) comprises of 
10 Y-specific genes. The gene order was determined by RH analysis and later confirmed 
by dual-color FISH. Both RH mapping and FISH confirmed that the genes on SSCY are 
clustered in two groups on the porcine MSY: a distal group with 6 genes (AMELY, 
EIF2s3Y, ZFY, USP9Y, DBY and UTY) and a proximal group with 4 genes (TSPY, 
SMCY, UBE1Y and SRY). As in humans, mice and cats, the order of USP9Y-DBY-UTY 
has been evolutionarily conserved also in pigs. Since the relative order of X-Y 
gametologues on porcine sex chromosomes is conserved, it was proposed that the 
porcine X-Y homologous genes closely resemble the ancestral eutherian sex 
chromosome gene order (Quilter et al. 2002).  
 
Cat (Felis catus, FCA) 
The basic RH map of cat Y chromosome was first published in 1999 (Murphy et 
al. 1999a). The map comprises of 8 genes and provides a preliminary comparison with 
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the existing human and mouse Y chromosome maps. Three loci, USP9Y-DBY-UTY, 
showed evolutionarily conserved physical order across all three species (Murphy et al. 
1999b). As mentioned in the previous section, conserved linkage between these three 
genes was observed also in pigs (Quilter et al. 2002). It is noteworthy that the region 
containing USP9Y-DBY-UTY on FCAY corresponds to the AZFa region in humans and 
to Sxrb interval in mouse where deletions are associated with spermatogenic arrest 
(Mazeyrat et al. 1998; Luddi et al. 2009). The most recent FCAY RH map contains 12 
single copy X-degenerate genes (Murphy et al. 2006). Additionally, 6 multicopy Y-
linked genes were identified using cDNA selection procedure where flow sorted Y 
chromosome DNA was hybridized to testis cDNA (Murphy et al. 2006). Expression 
profiles of all feline Y-linked genes have been studied on a panel of selected body 
tissues and full length cDNA sequences have been generated for 10 X-degenerate FCAY 
genes (Pearks Wilkerson et al. 2008). After human and mouse, FCAY is to date one of 
the best studied mammalian Y chromosomes. 
 
Dog (Canis familiaris, CFA) 
One of the first studies involving the dog Y chromosome described cloning and 
mapping of  two pseudoautosomal genes, CSF2RA and ANT3 (currently known as 
SLC25A6) on the dog sex chromosomes (Toder et al. 1997) and showed that canine PAR 
is larger than human PAR1 and extends further proximal on the short arm of the X 
chromosome. Later 10 male specific markers including the SRY gene were assigned to 
the canine Y chromosome using FISH and RH mapping approaches (Olivier et al. 1999; 
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Guyon et al. 2003b). Recent systematic gene discovery in the cat Y chromosome 
(Murphy et al. 2006) revealed that an X-degenerate gene CUL4BY and a Y-linked gene 
of autosomal origin TETY2, are both present in multiple copies also on the dog Y 
chromosome. Notably, these two genes have been found to be Y-linked so far only in 
carnivores (dog and cat) (Murphy et al. 2006). Additionally, 14 SNPs have been 
identified from CFAY sequences and used for population studies in dogs to generate the 
first dog Y chromosome phylogeny (Natanaelsson et al. 2006). 
 
Rat (Rattus norvegicus, RNO)  
Compared to the extensive Y chromosome research in mouse, the studies of the 
rat Y chromosome have been quite modest. Nevertheless, a few interesting differences 
have been discovered between the Y chromosomes of the two closely related species. As 
in most other mammals, the rat Tspy is a functional gene whereas mouse Tspy has 
become a nonfunctional pseudogene (Mazeyrat and Mitchell 1998). Studies show that 
rat Tspy is a low copy number gene with at least two copies on RNOYp – one copy 
being complete and functional, another truncated and probably nonfunctional (Dechend 
et al. 1998). Similarly to other species, rat Tspy demonstrates testis-specific expression 
(Mazeyrat and Mitchell 1998). Another RNOY gene that has attracted attention is SRY. 
While SRY in mouse and human is a single copy gene, in rat it is present in multiple 
copies. At least six full length copies of Sry have been identified on RNOY. These 
copies have a consereved coding region and conserved amino acid sequence (Turner et 
al. 2007). Expression analysis using RT-PCR showed that multiple copies of rat Sry are 
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expressed in adult testis and adrenal glands, though the possible function of the sex 
determining gene in adult testis is as yet poorly understood. 
 
Rabbit (Oryctolagus cuniculus, OCU)  
Y chromosome studies in rabbit have been limited mainly to the SRY gene. The 
2,388 bp of rabbit SRY, including the open reading frame has been sequenced and two 
repetitive sequences in the 5′ region have been identified (Geraldes et al. 2005). 
Additionally, a 7 bp insertion  polymorphism was recently discovered  in the 3′ 
untranslated region and it was shown that the rabbit SRY gene is duplicated and evolves 
under concerted evolution (Geraldes and Ferrand 2006). SRY functional studies show 
that SRY-SOX9 expression regulates gonadal morphogenesis in rabbit the same way as in 
human and other mammals but is different from mouse (Diaz-Hernandez et al. 2008). 
 
Summary of Y chromosome studies in mammals 
The data hitherto available on Y chromosomes of different mammals suggest that 
the chromosome carries functional genes but the gene content is not strongly conserved 
across species (Ehrmann et al. 1998; Liu et al. 2002; Ma et al. 1993; Mazeyrat et al. 
1998; Mitchell et al. 1991; Murphy et al. 1999b; Quilter et al. 2002). There is a small 
core set of X-degenerate genes which is shared between mammals, while most of 
multicopy genes are restricted to one species or a group of related species. Thus, through 
species-specific loss and acquisition of genes, mammalian Y chromosomes have 
acquired unique repertoires of genes and it is not uncommon that Y-linked orthologs 
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exhibit differences in copy numbers and expression patterns (Delbridge et al. 1999; 
Graves 1995). For example, TSPY, is a testis-specific multicopy gene in human and 
primates, rat, cat, cattle, goat, sheep and horse (Arnemann et al. 1987; Dechend et al. 
1998; Manz et al. 1993; Mazeyrat et al. 1998; Murphy et al. 2006; Raudsepp et al. 2004; 
Vogel et al. 1997a; Vogel et al. 1997b) but a nonfunctional single copy gene in mouse 
(Mazeyrat et al. 1998; Schubert et al. 2000a; Schubert et al. 2000b). These unique 
properties of the Y chromosome set limitations to the use of comparative genomics in Y 
chromosome research and necessitate species-specific approaches. Therefore, in order to 
develop a proper understanding of the expression and function of Y-linked genes, it is 
important to identify and analyze these genes separately within each species.  
Mammalian Y chromosomes, though variable in organization and gene content 
among species, share some important common features of which the most distinctive is 
the presence of multicopy sequences. It is proposed that due to the lack of recombination 
over most of its length, amplification of genes may be an important compensatory 
mechanism that protects functionally essential sequences from being lost through 
mutational degradation (Skaletsky et al. 2003). Since most of multicopy genes typically 
show testis-specific expression it is likely that they have roles in regulating male 
fertility. Therefore, the identification and functional analysis of Y-linked multicopy 
sequences might be a key to discover important male fertility genes in mammals. 
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Male fertility and mammalian Y chromosome genes 
In 1931, eminent evolutionary biologist and geneticist Sir Ronald Fisher 
suggested that genes involved in benefit to the male (including spermatogenesis genes) 
would accumulate on the Y chromosome (Affara and Mitchell 2000). The validity of 
these ideas was proved approximately 45 years later by the discoveries that human and 
mouse Y chromosome microdeletions and mutations are associated with diverse 
spectrum of defective spermatogenic phenotypes (Cooke and Saunders 2002; Mazeyrat 
et al. 1998; Tiepolo and Zuffardi 1976). Different portions of human and mouse MSY 
show the presence of intervals containing one or more genes that control male germ cell 
differentiation and hence, are capable of causing infertility. These intervals have been 
mapped, cloned and examined in detail for functional genes. For example, deletion of 
the distal portion of HSAYq11, a region known as azoospermia factors (AZFa, AZFb, 
AZFc) containing clusters of spermatogenesis genes causing azoospermia in humans 
(Tiepolo and Zuffardi 1976; Vogt et al. 1996). It has been shown that the deleted region 
of AZFc in infertile men, always includes DAZ (deleted in azoospermia) genes and the 
frequencies of Y chromosome microdeletions and chromosomal abnormalities are 
associated with azoospermic and oligozoospermic conditions in males (Vicdan et al. 
2004). Additionally, it has been shown that distinct regions in HSAYq11 overlapping 
with the genomic AZFb and AZFc intervals are probably involved in the pre-meiotic X 
and Y chromosome pairing process (Vogt et al. 2008). Murine Y chromosome interval 
∆Sxrb contains Spy spermatogenetic factor genes, the expression of which is important 
for proper development of germ cells. Deletion of this portion of ∆Sxrb impairs fertility 
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in mouse. Studies indicate that AZFa in human and Spy in mouse are both critical for 
male fertility and may be encoded by homologous genes (Mazeyrat et al. 1998). 
Although Y chromosome microdeletions account for the most important genetic 
causes of spermatogenic failure in humans, a significant proportion of patients with 
impaired spermatogenesis are not known to have Y deletions. Studies in human and 
mouse show that male infertility can be caused also by other specific changes in a 
number of Y-linked genes. A few of them will be discussed briefly in the following 
sections. 
RBMY is a member of RBM (RNA-binding motif) family and encodes a protein 
that localizes to the nucleus of all spermatogenic cell types (Elliott et al. 1996; Elliott et 
al. 1997; Elliott et al. 1998). RBMY is required for normal male fertility, but because 
RBMY is a multicopy gene, it is not easy to understand the effect of RBMY deletions on 
fertility (Kostiner et al. 1998). However, there is an indirect evidence of RBMY in 
relation to male fertility, based primarily on the correlation between the AZFb interval 
and expression of the gene encoding the RBMY protein in germ cells. Human RBMY is 
located in the AZFb interval and deletion of this region abolishes RBMY protein 
production in germ cells of affected males (Affara 2001). Since human RBMY protein 
recognizes RNA through a novel mode of protein interaction which could be important 
for the initiation of spermatogenesis (Skrisovska et al. 2007), the lack of RBMY protein 
might seriously affect the production of germ cells. Mouse studies, on the other hand, 
show that severe Rbmy deficiency causes increase in the number of abnormal sperm 
(Szot et al. 2003). Twelve potential target mRNAs that are bound to the RBMY protein 
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have been identified in mouse testis. Murine RBMY protein can bind also to its own 
transcript and may, thus, affect alternate splicing and regulate its own expression. These 
are new findings and it is necessary to further explore the role of RBMY in 
spermatogenesis (Zeng et al. 2008).  
DAZ (Deleted in AZoospermia) gene cluster was transposed to the Y 
chromosome during primate evolution but has remained at its original autosomal 
location in other mammalian species (Saxena et al. 1996; Saxena et al. 2000; Skaletsky 
et al. 2003). The gene cluster is named “deleted in azoospermia” (DAZ) because deletion 
in this region completely removes all DAZ genes in an individual and causes 
azoospermia. DAZ has a diverse spectrum of transcripts reflecting the transcriptional 
activity of all members of the gene family (Yen et al. 1997). Functional homologs of 
human DAZ genes have been found also in mouse Y chromosome and are called Dazl 
(DAZ-Like). Mice with no functional Dazl genes are sterile, whereas heterozygous mice 
with one intact copy of Dazl are subfertile due to the reduced number of germ cells. This 
indicates that the number of DAZ or Dazl copies might be important for germ cell 
production (Kostiner et al. 1998). This is supported by human studies showing that three 
different patterns of DAZ gene deletions are associated with severe oligozoospermia and 
infertility (A et al. 2006). In patients with spermatogenic arrest DAZ gene transcripts are 
localized in primary spermatocytes and DAZ gene activity seems to correspond to the 
proliferative activity of stem cells of germinal epithelium (Szczerba et al. 2006). 
TSPY (testis-specific protein, Y encoded) genes are part of DYZ5 - a clustered 
array of repeats, located on the proximal short arm of the human Y chromosome. 
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Evolutionary conservation of TSPY sequence and expression pattern among primates 
suggests that TSPY might play an important role in testicular function and male fertility 
(Manz et al. 1993). Similarly to primates, TSPY genes are arranged in clusters on the Y 
chromosome of several other mammals and show sequence conservation across species 
(Mazeyrat and Mitchell 1998; Skaletsky et al. 2003). It is proposed that TSPY is 
involved in early stages of spermatogenesis to help the proliferation of spermatocytes 
(Schnieders et al. 1996; Vogel and Schmidtke 1998). Extensive amplification of TSPY 
on the Y chromosome of most studied mammals indicates that there might be a 
requirement for a critical dose of TSPY during spermatogenesis (Delbridge et al. 2004). 
Notably, infertile men have more TSPY gene copies compared to normal fertile men 
insisting that copy number difference might be the main factor that determines the effect 
of TSPY on spermatogenesis and male fertility in humans (Vodicka et al. 2007). 
UBE1Y is a Y-linked gene in mouse and several other mammals (Mitchell et al. 
1991; Quilter et al. 2002; Murphy et al. 2006) but has been lost from the Y 
chromosomes in humans, chimpanzees and old world monkeys (Mitchell et al. 1998). 
The fact that UBE1Y encodes for ubiquitin activating enzyme E1 which promotes cell 
proliferation and mitosis (Odorisio et al. 1996) makes it a strong candidate gene for 
spermatogenesis (Levy et al. 2000). This is supported by mouse studies showing that 
Ube1y is expressed exclusively in spermatogonial cells and is part of a gene cluster in 
the ∆Sxrb deletion interval known to be critical for the proliferation of mitotic germ cells 
during spermatogenesis (Levy et al. 2000). 
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USP9Y (Ubiquitin-specific protease 9 Y) is located in the AZFa region of human 
Y chromosome and possesses ubquitin protease activity (deubiquitination) by which it 
might stabilize specific target proteins that are important for male germ cell development 
(Lee et al. 2003). Data about the role of USP9Y in male fertility are controversial. There 
are studies showing that a point mutation in USP9Y causes partial arrest of 
spermatogenesis at the post meiotic spermatocyte stage resulting in severe 
spermatogenic failure and infertility (Sun et al. 1999). However, recently a complete 
deletion of USP9Y was found in a normospermic man, his brother and father without any 
deleterious effect on fertility (Luddi et al. 2009). This indicates that USP9Y, previously 
considered a candidate gene for male infertility and azoospermia, does not play a key 
role in male reproduction. It is likely that USP9Y acts rather as a fine tuner to increase 
efficiency of spermatogenesis than being a direct provider of essential functions (Krausz 
et al. 2006). 
SRY, the sex determining region on Y, is indisputably the “signature” gene of the 
Y chromosome and has been studied, compared to other Y-linked genes, in more detail. 
Besides human and mouse, the coding sequence of this small, one exon gene is 
characterized in bovids (Cheng et al. 2001), horse (Hasegawa et al. 1999), rat (Turner et 
al. 2007), pig (Parma et al. 1999), sheep (Payen et al. 1996), goat (Pannetier et al. 2006) 
and rabbit (Geraldes and Ferrand 2006; Geraldes et al. 2005). SRY conserved regulatory 
regions have been identified in 10 different mammals (Margarit et al. 1998) and studied 
in detail in pigs (Boyer et al. 2006; Pilon et al. 2003). Information about SRY expression 
is available for human (Skaletsky et al. 2003), mouse (Mazeyrat et al. 1998), rat 
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(Mazeyrat and Mitchell 1998) horse (Hasegawa et al. 1999), pigs (Boyer et al. 2006; 
Pilon et al. 2003) and carnivores (Murphy et al. 2006). These studies indicate that SRY, 
despite of being the “master” sex determination factor in all eutherians, exhibits 
variation in coding and regulatory sequences, as well as in expression profile across 
species. Furthermore, SRY shows variation also in copy numbers being a single-copy 
gene in human and mouse and having multiple copies in cat, rat and rabbit (Nagamine 
1994; Bullejos et al. 1999; Skaletsky et al. 2003; Geraldes et al. 2005; Turner et al. 2007; 
Pearks Wilkerson et al. 2008). The most intriguing feature of SRY, however, is that in 
most of the species studied it is highly expressed in adult testis indicating that male sex 
determination is not the only function of SRY and it might be involved in processes 
taking place also in adult testis. 
In addition to Y chromosome microdeletions and gene mutations, some infertile 
phenotypes can be caused by transcriptional alterations of AZF genes. For example, 
infertile males with complete Sertoli cell only syndrome (SCOS) show no expression of 
RBMY, DAZ and TSPY whereas DDX3Y (alias DBY) is expressed at very low levels 
(Lardone et al. 2007b).  
In summary, studies in human, mouse and other mammals provide convincing 
evidence that Y chromosome sequences are critically involved at various stages of 
spermatogenesis and play essential roles in regulating male fertility. The critical role of 
the Y chromosome in male fertility is further underscored by the facts that about 10-15% 
of idiopathic male infertility in humans is caused by Y chromosome mutations and that 
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the currently available genetic diagnostic tests for human male infertility are exclusively 
based on Y chromosome markers (Peterlin et al. 2004). 
 
MALE FERTILITY IN HORSES 
Stallion reproduction and fertility is of vital significance to the horse industry. 
There are over 9.2 million horses in the United States and it is estimated that almost one-
fourth of horses are used for breeding purposes. Stud fees for stallions can range from a 
few thousand to half a million dollars (www.horsecouncil.org6). Thus, fixed expenses, 
lost potential profits and reduced revenue from impaired fertility of stallions has an 
enormous economic impact on the horse industry. Because of the structure of horse 
breeding where one stallion covers many mares, economic losses due to reduced fertility 
of stallions can be even more dramatic. In contrast to many other livestock species where 
animals are selected for fertility, stallions are selected mainly on the basis of their 
ancestry, athletic performance and overall appearance, but not for their reproductive 
potential (Colenbrander et al. 2003). Furthermore, not all stallions are subjected to a 
detailed breeding soundness examination prior to standing at stud (Colenbrander et al. 
2003) and fertility problems become apparent only later when desired foaling rate is not 
achieved. Due to this, poor fertility of breeding stallions is a serious problem worldwide. 
For example, it has been estimated that 36%-43% of prospective breeding stallions fail 
breeding soundness evaluation (Blanchard and Varner 1997; Woods et al. 2000). These 
examinations traditionally include analysis of semen parameters such as sperm count, 
sperm motility and sperm morphology (Graham 1996; Madill 2002; Colenbrander et al. 
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2003; Love et al. 2003), examination of external genitalia and a general physical 
evaluation. Additionally, the sperm chromatin structure assay and the acrosomal 
responsiveness assay can be carried out to evaluate sperm functionality in more detail 
(Love and Kenney 1998; Varner et al. 2000). More indirect measures, like per-cycle 
pregnancy rate are also used to estimate stallion fertility (Colenbrander et al. 2003; Love 
et al. 2003) but these factors are influenced by management practice of both mares and 
stallions (Rousset et al. 1987; Love et al. 2003) due to which precise definition of 
fertility in stallions remains obscure. 
Of the two main factors governing stallion fertility and reproduction, 
environment has been extensively studied and optimized (Roser 2001; Madill 2002; 
Merkies and Buhr 2004) while very little is known about the role of genetics. As yet, 
only a handful of reproduction and fertility related genes have been analyzed in horses 
(Ing et al. 2004; Leeb et al. 2005; Hamann et al. 2007) and even fewer have been studied 
for their function, interactions and mutations that could lead to aberrant conditions and 
impaired fertility. The remarkable progress in equine genome mapping (Chowdhary et 
al. 2003; Penedo et al. 2005; Swinburne et al. 2006; Raudsepp et al. 2008a) which 
ultimately led to the sequencing of the whole genome (Wade et al. 2007) provides a 
unique opportunity to initiate organized genome-wide search for reproduction related 
genes in horses. However, because the equine genome is sequenced from a female 
individual, the whole genome sequence will not furnish any information on the genes 
and transcripts residing on the Y chromosome, several of which are critical for male 
reproductive development and fertility. Hence, obtaining information on the structure, 
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gene content and functional profile of the Y chromosome will be essential to identify the 
Y-linked components of stallion fertility. 
 
PRESENT STATUS OF THE HORSE Y CHROMOSOME RESEARCH 
The overall information on the structure and organization of the horse Y 
chromosome (ECAY) is limited – a situation common to other livestock and companion 
animal species. Cytogenetic studies indicate that the sub-metacentric equine Y 
chromosome (ECAY) is one of the smallest elements in the genome (Power 1988), 
consists of a large heterochromatic region which covers the entire short and majority of 
the long arm, while the tiny euchromatic region is located at the distal end of ECAYq. 
The chromosome was first microdissected in 1999 (Raudsepp and Chowdhary 1999) to 
make a chromosome-specific paint that was used for comparative mapping on metaphase 
spreads of different equids. The first formal map for the Y chromosome was generated 
by assigning STS-Y, SRY and ZFY to the Y chromosome by somatic cell hybrid analysis 
(Shiue et al. 2000). Later SRY and ZFY were localized by FISH to the long arm of the 
chromosome (Hirota et al. 2001). The first detailed physical map of horse Y 
chromosome containing 7 contigs was constructed in 2004 (Raudsepp et al. 2004b). The 
map comprises of 73 overlapping Bacterial Artificial Chromosome (BAC) clones and 
shows the linear order of 100 Sequence Tagged Sites (STSs) and 9 genes. The BACs 
spanning the minimum tiling path (MTP) of each of the contig indicate a cumulative 
coverage of ~4 Mb which corresponds to almost 20-25% of the ~15 Mb euchromatic 
region of ECAY (Raudsepp et al. 2004b). Notably, contig II in this map is composed of 
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genes, markers and BAC clones that are all present in multiple copies - a hallmark of 
mammalian Y chromosomes. 
Recently a detailed map was constructed for the horse pseudoautosomal region 
(PAR) and physically assigned to the terminal end of the long arm of the Y chromosome 
(Raudsepp and Chowdhary 2008). The map has 129 physically ordered markers (110 
STSs and 19 genes) contained in 71 BAC clones that are arranged into 2 contigs 
spanning the region. Horse, cattle (Van Laere et al. 2008) and dog (Young et al. 2008)  
are to date the only domestic animals with precisely defined pseudoautosomal boundary 
(PAB). Interestingly, a ~200 kb region was discovered in the middle of the equine PAR 
that is also present in the male specific region of the Y (MSY). Duplication of this kind 
is a novel observation in mammals and it is not clear whether this can affect sex 
chromosome pairing and segregation in male meiosis. Overall, following 
human/chimpanzee and mouse, horse is the only species where PAR is described in such 
details. The initial map of MSY and high-resolution map of PAR serve as an important 
foundation for further expansion of Y chromosome studies in horses. 
 
RATIONALE OF THE PRESENT STUDY 
The significant economic impact of stallion reproductive performance to the 
equine industry and our limited knowledge about the genetic factors governing male 
fertility, underline the urgent need to initiate systematic studies of male fertility genes in 
horses. Given the outstanding role of Y chromosome in human and mouse 
spermatogenesis, the specific focus of this research is the horse Y chromosome. The 
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rationale is that if we obtain thorough knowledge about the organization and functional 
profile of the Y chromosome, this will help us to identify key-role Y-linked male fertility 
genes in horses. The central focus of the work is, thus, isolation, identification and 
expression analysis of Y chromosome genes and ESTs (Expressed Sequence Tags). This 
information will be used to improve the existing ECAY map and develop a 
comprehensive, high-resolution map for the horse Y chromosome. Analysis of 
differential expression of Y-linked genes between normal stallions and stallions with 
fertility problems will help identify the key-role male fertility genes in horses. 
The specific goals of the project are 1) to develop a comprehensive physical map 
and gene catalogue of the horse Y chromosome and 2) identify Y-linked candidate genes 
responsible for stallion fertility. To achieve these goals, first new Y chromosome 
genes/ESTs will be isolated from horse testis. Human and mouse studies have shown 
that 99% of Y-linked genes are expressed in testis (Skaletsky et al. 2003). Therefore, 
testis should be the most informative tissue for Y chromosome gene discovery also in 
horse. A direct cDNA selection procedure (Lovett et al. 1991; Del Mastro and Lovett 
1997) will be used for new gene discovery from horse testis by hybridizing testis cDNA 
with Y-specific BAC clones and with flow sorted ECAY. This will enable the specific 
retrieval of only Y-linked testis transcripts. The Y chromosome BAC clones will also be 
used for chromosome walking and isolation of new clones to fill the gaps on the current 
map and to expand the map over the entire MSY. Expression patterns and copy numbers 
of the newly identified genes/ESTs will be analyzed to identify candidate genes for 
stallion fertility. 
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The long term goal of this project is to obtain complete sequence information for 
the horse Y chromosome. Generation of a comprehensive ECAY map in this project will 
serve as a good foundation for this goal. Detailed analysis of ECAY gene content will 
serve also as a basis for studying the evolution of ECAY compared to other mammalian 
Y chromosomes. Functional analysis of candidate genes for stallion fertility will help to 
understand the genes and gene networks regulating male fertility and develop diagnostic 
tests for early discovery of potentially infertile phenotypes in horses. 
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CHAPTER II 
 
DISCOVERY OF Y-SPECIFIC GENES FROM HORSE TESTIS AND 
GENERATION OF A DETAILED MAP FOR THE HORSE Y CHROMOSOME 
 
 
INTRODUCTION 
In order to understand the role of the Y chromosome in the biology of a species it 
is necessary to acquire detailed information about the Y chromosome organization and 
most importantly, identify all Y-linked genes and study their structure, expression 
profiles and possible functions. 
The first systematic search for genes from the non-recombining region of the Y 
chromosome (NRY), later known also as the male-specific region of Y (MSY, 
(Skaletsky et al. 2003), was carried out in humans (Lahn and Page 1997). This study 
used testis, a single complex organ, as the source of Y-linked transcripts and identified 
12 novel genes or gene families. According to expression profiles, evolutionary history 
and possible function, these human Y-linked genes were classified into two categories: i) 
genes that were expressed in many tissues including testis, had an ancestral homolog on 
the X chromosome and carried out house-keeping functions, and ii) genes that were 
expressed exclusively in testes, belonged to Y-specific gene families and were possibly 
involved in male fertility-related functions. The authors concluded that in contrast to 
other chromosomes there is a clear functional coherence of the gene content of the Y 
chromosome. 
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This first gene discovery from MSY was carried out using the direct cDNA 
selection procedure (Lovett et al. 1991) from human testis where testis cDNA served as 
a driver and a flow-sorted human Y chromosome cosmid library as a selector. Later, the 
same procedure allowed isolation of 12 Y-specific genes in the domestic cat (Felis catus, 
FCA, (Murphy et al. 2006; Pearks Wilkerson et al. 2008). Notably, six FCAY genes 
were novel, three were derived from putative autosomal progenitors and another three 
were X-degenerate. 
In horses the very first basic gene map of ECAY was built using a somatic cell 
hybrid (SCH) panel and showed synteny between STS-Y, SRY and ZFY (Shiue et al. 
2000). A year later SRY and ZFY were assigned to ECAY by fluorescence in situ 
hybridization (Hirota et al. 2001). Currently partial genomic and/or cDNA sequences are 
available for nine ECAY genes, viz., AMELY, TSPY, DDX3Y (alias DBY), USP9Y, UTY, 
TBL1Y, KDM5D (alias JARID1D, SMCY), SRY and ZFY (Agulnik et al. 1997; Raudsepp 
et al. 2004b), though no systematic efforts have been made to generate a comprehensive 
gene catalogue for the horse Y chromosome. In this study the cDNA selection procedure 
which has been successfully applied for Y chromosome gene discovery in humans and 
cats, will be adopted, and used it to identify Y-specific ESTs from horse testis. Flow-
sorted equine Y chromosome and pools of BAC clones from the ECAY contig map 
(Raudsepp et al. 2004b) will serve as two different types of selectors to capture horse 
testis cDNA sequences. Y-specific ESTs will be assigned to the existing ECAY contig 
map by STS content analysis. The cDNA sequences will also be used to identify new 
BAC clones for the expansion of the contig map. 
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OBJECTIVES 
1. Isolate and identify Y-specific genes/ESTs from horse testis by cDNA selection 
procedure. 
2. Isolate BAC clones containing the Y-specific genes/ESTs and map the BACs to 
the ECAY contig map by STS content analysis. 
3. Use STS content analysis and chromosome walking to expand the existing 
ECAY contig map and bridge gaps where possible. 
As a result, Y-specific expressed sequences and genes will be identified and used 
to construct a comprehensive, physically ordered gene map for the horse Y chromosome. 
The map will serve as a template for complete sequencing of equine MSY. ECAY-
specific transcripts will be analyzed for expression profiles to discover potential 
candidate genes for stallion fertility. Details of the experimental design and the outcomes 
of the experiments are presented in the following sections. 
 
MATERIALS AND METHODS 
 
Extraction of messenger RNA (mRNA) from horse testis 
Messenger RNA (mRNA) was isolated from normal adult horse testis using Fast 
Track 2.0 mRNA isolation kit (Invitrogen) following the manufacturer’s instruction with 
minor modifications. Briefly, about 1 g of testis tissue was homogenized using lysis 
buffer and incubated for 1 hour at 45oC to facilitate complete lysis of cells. Next, 950 µl 
of 5M NaCl was added to the solution and DNA was sheared using a 22 gauge needle 
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and a 20 ml syringe. After adding Oligo dT cellulose the solution was incubated for 1 
hour to ensure the binding of oligo dT cellulose to poly A tail of mRNA. The solution 
was then centrifuged at 3000 x g for 5 min at room temperature to pellet the cellulose. 
Supernatant was discarded and the cellulose was resuspended in 20 ml binding buffer. 
The centrifugation step was repeated twice and the final pellet was resuspended in low 
salt buffer to help remove the unbound materials from the cellulose. This washing step 
was repeated for three times and finally the cellulose was resuspended in 800 µl of low 
salt buffer and transferred into spin columns supplied with the kit. The columns were 
centrifuged at 5000 x g for 10 sec at room temperature to bind the cellulose with the spin 
column membrane. The flow through was discarded, 500 µl of low salt buffer was added 
to the column and centrifuged at 5000 x g for 10 sec at room temperature. The process 
was repeated for three more times to wash the cellulose. The column was placed into a 
fresh tube and 200 µl of pre-warmed (65oC) elution buffer was used to elute the RNA 
from the column. Elution was repeated twice. The eluted RNA solution was mixed with 
60 µl of sodium acetate and 1ml of 100% ethyl alcohol and stored overnight at -80oC. 
The solution was then thawed and centrifuged for 30 min at 4oC at maximum speed 
(13000 x g). The supernatant was removed and the pellet was centrifuged again to 
remove all remaining droplets. The final mRNA pellet was dissolved in 30 µl of elution 
buffer. DNase treatment was carried out using Turbo DNase Kit (Ambion) following 
manufacturer’s instructions. Quantity and quality of the isolated mRNA was evaluated 
using NanoDrop Spectrophotometer and Agilent Bioanalyzer (Agilent, CA) with the 
RNA 6000 Nano chip kit (Agilent, CA). 
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cDNA synthesis 
Testis cDNA was synthesized using a combination of random primers and oligo 
dT primers with Superscript II reverse transcriptase provided by Superscript Choice 
System for cDNA Synthesis (Invitrogen) following manufacturer’s instructions. Briefly, 
4 µg of testis mRNA was used for cDNA synthesis with random hexamer and oligo dT 
primers. The first and second strands of cDNA were synthesized in two steps followed 
by phenol chloroform extraction and cDNA precipitation with ammonium acetate and 
absolute alcohol. The cDNA was ligated with adapter primers, PCR amplified and 
designated as primary cDNA. 
 
cDNA selection  
Isolation of Y-specific ESTs from horse testis was carried out by direct cDNA 
selection following the protocol of Del Mastro and Lovett (1997). The PCR amplified 
primary cDNA was first pre-annealed with horse Cot-1 DNA (Cot1:cDNA ratio ranged 
from 2:1 to 15:1) for 4 hours to block repetitive sequences. In some experiments 
blocking DNA contained also cDNA sequences from UBE1Y - the most abundant ECAY 
transcript in testis - to allow better hybridization of unique and less abundant sequences 
(see discussion for explanations). Horse Y chromosome specific probes were generated 
from two sources: i) flow sorted and GenomiPhi (Amersham Biosciences) amplified 
ECAY (7000 copies provided by Cambridge Resource Centre for Comparative 
Genomics) and ii) 183 BAC clones from the ECAY contig map (Raudsepp et al. 2004b; 
Raudsepp et al. 2008b). The BAC clones were divided into 6 pools with ~30 clones in 
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each. Flow sorted ECAY and BAC pools were labeled with biotin by nick translation 
(see FISH below) and hybridized individually with pre-annealed testis cDNA for 50 
hours. Testis cDNA and biotinylated Y chromosome hybrids were captured with 
streptavidin coated paramagnetic beads (Dynabeads® M-280 Streptavidin, Invitrogen) 
and Y-specific testis cDNA was eluted. This primary selected cDNA was PCR amplified 
using adapter primers and used for a second round of hybridization to obtain secondary 
selected cDNA.  
 
cDNA cloning, sequencing and sequence analysis  
The secondary selected cDNA was PCR-amplified and cloned en masse into 
TOPO-TA cloning vector (Invitrogen) following manufacturer’s recommendations. The 
vector was transformed into One Shot Top10 E. coli DH5α chemically competent cells 
(Invitrogen), plated on LB agar plates containing ampicillin (50 µg/ml) and incubated 
overnight at 37ºC. Plasmid clones were picked and grown overnight at 37ºC in 2 ml, 96-
well culture plates containing LB media and ampicillin (50 µg/ml). Plasmid DNA was 
isolated with an alkaline lysis based kit (REAL-prep96; Qiagen) following 
manufacturer’s instructions. A random set of clone DNA was digested with EcoRI 
(Invitrogen) to confirm the presence of different inserts. All cDNA clones were 
sequenced using BigDye (Applied Biosystems) terminator chemistry, universal primers 
(T7 and T3) and ~300-500 ng of plasmid DNA as template. The sequencing reactions 
were resolved on an ABI-3730 capillary sequencer (Applied Biosystems). After the 
sequences were quality trimmed and checked for vector contamination, they were 
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assembled into contigs using Sequencher V 4.7 software (GeneCodes Co). The contigs 
were checked for the presence of repetitive elements with RepeatMasker 
(http://www.repeatmasker.org8) and analyzed using Discontiguous MegaBLAST 
(http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi9) to identify putative orthologs from 
human, mouse and other mammalian genomes. The cutoff threshold was 1e-8. The 
sequences were also aligned with horse whole genome (WG) sequence assembly 
EquCab2 (http://www.ensembl.org/Equus_caballus/index.html10). Because a female 
horse has been sequenced, no alignment of WG sequences with the partial cDNA 
sequences indicated the likelihood that the selected cDNA sequences were Y-specific. 
 
cDNA analysis by PCR 
 
After analysis with Discontiguous MegaBLAST the sequences with similarity to 
mammalian X- or Y-linked orthologs, sequences with weak similarity to autosomal 
genes and sequences with no significant similarity to any mammalian sequences were 
considered for further analysis. Where possible, the partial cDNA sequences were 
aligned with human and mouse Y chromosome genes 
(http://www.ensembl.org/index.html3) to identify likely exon/intron boundaries. Intron-
spanning or exonic primers (Table 1) were designed with Primer 3 software 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi11).  
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Table 1: Detailed information about ECAY genes and ESTs. 
 
Gene 
symbol 
Gene name Primers 5′ to 3′ Annealing 
temperature, 
°C 
Genomic
product 
size, bp 
GenBank 
accession 
No 
*AMELY Amelogenin, Y-linked F: CCAACCCAACACCACCAGCCAA 
ACCTCCCT 
R: AGCATAGGGGGCAAGGGCTGCA  
AGGGGAAT 
65 160 AB032194 
CUL4BY Cullin 4 B Y F: TGTGGGGTTCGTGTGAAATA 
R: CAAGGATCGCTGGGTCTTAC 
58 172 EU687546 
 
CYorf15 Chromosome Y open reading frame 
15 
F:CAACCATGCATTGAAAGAGG 
R:TGCACTCCGATTCTTGTTGA  
58 152 EU687545 
 
DDX3Y 
(DBY) 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 3, Y-linked 
F:CTCGAGATCCAAAACTGCTG 
R:TGATAAAAACAGTTCAGGGTGGA 
58 68 EU687547 
 
EIF1AY Translation initiation factor 1A Y F:GATCGTGGCCTTCTGACATT 
R:TTATTTTTGGGCATGGTGGT 
58 187 ET052957 
 
*EIF2s3Y Eukaryotic translation initiation 
factor 2, subunit 3 gamma, Y- linked 
F:GAGCCATCTGTGTGATCGTC 
R:TATTCCTGGCCCTAAGCACA 
58 223  
EIF3CY 
(EIF3s8Y) 
Eukaryotic translation initiation 
factor 3, subunit C on Y 
F:CCCAAGCAGGGTACCTATGG 
R:GGACAGAAGTGACGCAATCA 
58 134 (M), 
230 (M/F) 
EU687548 
 
ETSTY1 Equus Testis-specific transcript Y1 F:GACGGACGACCTTGTGTTTT 
R:CTAGTGGCGAGTCCTTTTGG  
58 234 EU687549 
 
ETSTY2 Equus Testis-specific transcript Y2 F:ATCATCGTGGAAAGCCTCAC 
R:AGTGCTGAAGAGGCTGTGGT  
58 223 EU687550 
 
ETSTY3 Equus Testis-specific transcript Y3 F:TTACATTTGTTGCGCCATGT 
R:GCCCAAAGAAGTAACCGACA  
58 134 EU687551 
 
ETSTY4 Equus Testis-specific transcript Y4 F:TAAGGCTTCCCTCCTCCAAT 
R:CCAGTGACCCGACATACTGA 
58 175 EU687552 
 
ETSTY5 Equus Testis-specific transcript Y5 F:CAAAACCAAGAGGAGGACCA 
R:CTCCAGAGGCAGGTACTTCG 
58 210 EU687553 
 
ETSTY6 Equus Testis-specific transcript Y6 F:ACATGGCGCAACAAATGTAA 
R:TAGCTGTTTGCTGCAGTGCT 
58 245 EU687554 
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Table 1 continued 
 
Gene 
symbol 
Gene name Primers 
5′ to 3′ 
Annealing 
temperature, 
°C 
Genomic
product 
size, bp 
GenBank 
accession 
no 
ETY1 Equus transcript Y1 F:TCCAGAGCAACAACAGCAAC 
R:CATCAGTCTGCCCAAACCTT 
58 127 EU687555 
 
ETY2 Equus transcript Y2 F:TAAGGCTTCCCTCCTCCAAT 
R:CCAGTGACCCGACATACTGA 
58 850 EU687556 
 
ETY3 Equus transcript Y3 F:TTTTGGCTTGTGTCTTTCTCTG 
R:ATAGGGCCAGACTTTCACAGC 
58 150 EU687557 
 
ETY4 Equus transcript Y4 F:TGGGGATATTGGCTTAGCTG 
R:CTGGGAGCACGTCTGTATCA 
58 180 EU687558 
 
*KAL1Y Kallmann Syndrome 1 on Y F:AGGCACAGTCTTAGGGCAAA 
R: TTTTGGCATTCCCTTCTCTG 
58 231  
KDM5D 
(SMCY) 
Jumonji, AT rich interactive domain 
1D 
F: AACAGCGAGCCAATGTTTTT 
R: GCAAAATTCTGGGAAATCCA 
58 400 EU687564 
 
*MAP3K
7IP3Y 
 
Mitogen-activated protein kinase 
kinase kinase 7 interacting protein 3 
on Y 
F: GTGGAATCCCTATTGCTAAAGTTAC 
R: CCAGAGAGCTGTGACCAAG 
58 138  
MT-ND1Y Mitochondrially encoded NADH 
dehydrogenase 1 on Y 
F:CCCTCCGCTTTCCTAGACC 
R:CAACGATGGCTTGAAAGGAT 
58 100 EU687559 
 
NLGN4Y Neuroligin 4 isoform Y F:GGGGATCCATCTTTGTGTTG 
R:GTCACACAGCAGGCTCTGAC 
58 156 EU687560 
 
RBMY RNA-binding motif Y F:TTCGGCCTTCTCTTTCACAT 
R:ACTCAAGCAGCCGAAATGAT 
58 180 EU687561 
 
RFX5Y Regulatory factor X 5 on Y F:ACCCTTAGGGGGAAAAATCC 
R:TTTCGTCCCTCAAGTTCCTG 
58 201 EU687562 
 
RPS3AY Ribosomal Protein S3A F:CCGGAAGAAGATGATGGAAA 
R:CAAACTTGGGCTTCTTCAGC 
58 179 (M), 
790 (M/F) 
EU687563 
 
SRY Sex determining region Y F:TGCATTCATGGTGTGGTCTC 
R:ATGGCAATTTTTCGGCTTC 
58 200 EU687565 
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Table 1 continued 
 
Gene 
symbol 
Gene name Primers 
5′ to 3′ 
Annealing 
temperature, 
°C 
Genomic
product 
size, bp 
GenBank 
accession 
no 
*STS-Y Steroid sulfatase (microsomal), 
isozyme S on Y 
F:TGTGTGTTTCTGTCATGGGGATTACA
TC 
R:CAGACAATGTTTCCCAGTGACAATTG
ATTA 
58 210 
(M/F) 
AF133205 
TMSB4Y Thymosin (beta) 4 Y F:ACCCACCCAGCCTCTTACTT 
R:GCCTAAGCTGCCAATATCCA 
58 246 EU687566 
 
TSPY Testis-specific Protein Y F: GAAGTCAGGCACACCAGTGA 
R: TAAGGCTGCAGTTGTCATGC 
58 280 EU687567 
 
UBE1Y Ubiquitin activating enzyme Y F:TGGCCAACTCACGGCTGATCCAA 
R:CTTCTCCACTCACCCTACTTGGG 
58 210 EU687568 
 
USP9Y Ubiquitin-specific protease 9 Y F:GGTTATGAAATGGTCTCTGC 
R:CGAGTCTGTCCATCAGGAGTC 
58 228 EU687569 
 
*UTY Ubiquitously transcribed 
tetratricopeptide repeat gene, Y-
linked 
F: CAGCTGTTTTCGGTGATGAG 
R: GCCTCCTTCTCTTCGGTTG 
54 110  
YIR2 Inverted repeat 2 Y F:AGGGTTGGGCTAAGTCACCT 
R:ACCTTGGATCCAGACTCACG 
58 170 EU687570 
 
ZFY Zinc finger Y F:TGAGCTATGCTGACAAAAGGTG 
R:TCTTTCCCTTGTCTTGCTTGA 
58 186 EU687571 
 
ZNF33bY Zinc Finger protein 33b on Y F:CCACAGCAAATACAGGAGCA 
R:GTCTGACTCCTCCCCCTTTC 
58 800 (M) 
3000 
(M/F) 
EU687572 
 
 
* genes identified only from BAC end sequences and not recovered from cDNA selection 
 
  
54 
These primers were used for PCR amplification from genomic DNA of 5 normal 
male and 5 normal female horses to confirm their male specificity. All PCR reactions 
were carried out in 10 µl volume containing 1X buffer (Sigma Aldrich), 0.3 pmol of 
each primer, 0.2 mM dNTPs, 1.5 mM MgCl2 and 0.25 units JumpStart REDTaq DNA 
polymerase (Sigma Aldrich) and the products were resolved on 2.0 % agarose gels. 
 
cDNA mapping 
Male-specific cDNA sequences, as identified in the previous step, were mapped 
to the ECAY contig map by STS content analysis. Primers designed from cDNA 
sequences were used to PCR amplify from the DNA of the 183 Y-specific BAC clones 
that form the current ECAY contig map (Raudsepp et al. 2004b; Raudsepp and 
Chowdhary 2008). Additionally, primers from all anonymous  sequences that are present 
both in males and females, were used for STS content mapping on the 12 BAC clones 
which form the minimum tiling path (MTP) of the horse pseudoautosomal region . 
 
Presence of Open Reading Frames (ORFs) 
The sequences were analyzed for the presence of putative open reading frames 
(ORFs) using Sequencher V 4.7 (GeneCodes Co) and NCBI ORF finder 
(http://www.ncbi.nlm.nih.gov/projects/gorf/12) software packages. 
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Screening of male equine BAC libraries by PCR  
Primers from those cDNA sequences that were not present on ECAY contig map 
were used to screen the CHORI-241 male horse BAC library 
(http://bacpac.chori.org/equine241.htm13) by PCR. If BACs corresponding to some 
cDNA sequences could not be found from the CHORI-241 BAC library, TAMU 
(http://hbz7.tamu.edu/homelinks/bac_est/bac.htm14) and INRA (Milenkovic et al. 2002) 
male horse BAC libraries were screened. Library screening, growing BAC cultures and 
BAC DNA isolation was carried out as described earlier (Raudsepp and Chowdhary 
2008). Briefly, cDNA primers were used to screen BAC library superpools, plate pools 
and pools of rows and columns to identify individual BAC clones containing specific 
cDNA sequences. New BACs were cultured in 2YT media containing 30µl/ml 
chloramphenicol and plated on LB agar plates which also contained 30µl/ml 
chloramphenicol. Single colonies were picked and verified once again for identity by 
PCR with cDNA specific primers,   inoculated into 100ml of 2YT (with 30µl/ml 
chloramphenicol) and grown overnight at 37oC. BAC DNA was isolated by alkaline 
lysis method (Birnboim and Doly 1979; Birnboim 1983) using Qiagen Midiprep kit 
(Qiagen) according to the manufacturer’s instructions. End sequences of the new BAC 
clones were used for the development of STS markers, STS content mapping and 
chromosome walking. 
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BAC end sequencing  
Ends of newly isolated CHORI-241 library BAC clones were sequenced in 10 µl 
reactions using the standard T7 (5′-GCCGCTAATACGACTCACTATAGGGAGAG-3′) 
and SP6 (5′-CCGTCGACATTTAGGTGACACTATAG-3′) primers and BigDye 
chemistry. For TAMU and INRA BAC clones, short T7 (5′- 
TAATACGACTCACTAAGGG-3′) and M13 (5′-CAGGAAACAGCTATGACC-3′) 
universal primers were used. Reaction products were purified through Sephadex G-50 
Spin-columns (BioMax) and resolved on an ABI-3730 capillary sequencer (PE Applied 
Biosystems). All BAC end sequences were analyzed for the contents of repeats using 
RepeatMasker and for the contents of known genes using discontiguous MegaBLAST 
(Table A1). For the repetitive BAC ends, primers were designed from the overlapping 
BAC end sequences to internally sequence the BACs with repetitive ends.  
 
STS generation and STS content mapping 
STS primers were designed from all non-repetitive BAC end sequences using 
Primer 3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi11) and 
optimized on male and female horse genomic DNA and DNA of the BAC of sequence 
origin. The primers were used for STS content analysis on the BACs in the ECAY 
contig map to incorporate new clones into it. Details about all STS markers generated for 
the male specific region of ECAY are presented in Table A2. 
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Chromosome walking 
STS primers from the BAC ends that extended into gaps in the map were used to 
screen CHORI-241 BAC library to identify new clones. After end sequencing, primer 
design and STS content analysis the new clones were incorporated into map. Such 
‘chromosome walking’ continued until the gap was closed or the gap was flanked by 
repetitive BAC end sequences which made further walking impossible. In some cases, 
however, BAC library screening by PCR did not identify any new clones. Since only 
50% of CHORI-241 library has been pooled into PCR format, such BAC end sequences 
were used to design overgo primers for hybridizations on the high density filters 
containing the entire library. 
 
Overgo primer design and filter hybridization 
Filter hybridization was carried out with CHORI-241 BAC library filters using 
radioactively labeled oligonucleotide primers or overgos. Overgos were designed from 
non-repetitive end sequences of most outstretching BACs for each gap. The primers 
were constructed manually or using Overgo Maker program 
(http://www.genome.wustl.edu/tools/?overgo.html15) (Table 2).  
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Table 2: Overgo primers for EACY BACs. 
 
BACs 
 
Overgo Primers/Probes 5′ to 3′ Contig 
005.2A8T7 
 
F:GTGTTATCCAAGCTATGCTTCCTT 
R:CAACTCTTGTCAGGGCAAGGAAGC 
IV 
008.3G9T7 
 
F:GCAAGTTAAAGCAAGCAACATGGC 
R:CTGGCAATAATCAGAAGCCATGTT 
III 
015.2E9 M13 
 
F: GGTGGGTTATCGAGATCTTCTGGC 
R: AATGAATGTATGCAATGCCAGAAG 
II 
016.4C5M13 
 
F:GCCCCCACTTTTGTGGTTTCCTCC 
R:AAAGAAGAGTGAACACGGAGGAAA 
II 
017D15T7 
 
F:CCAGCTAGAGCAAAGGACACCTGC 
R:AAACCCACTGACAAGGGCAGGTGT 
I 
072G23SP6 
 
F:GATGAGAGAATAGAAGAACAGAGT 
R:AGAAGATACCCGAGACACTCTGTT 
III 
090B11SP6 
 
F:GAAGGTAACCTGGTGTGTTCCGCT 
R:TAATCACTGCTTTATTAGCGGAAC 
IV 
091.4G10M13 
 
F:CTCCGGTAGGAGAGGAAGAATAGG 
R:ATATTTAGGGTATTAACCTATTCT 
III 
110.3H12M13 
 
F:GAGTAGACTCTCAAAGAAGCCAGA 
R:CCTTGGAACTAACAAATCTGGCTT 
V 
112.1A9T7 
 
F:GCCCTCAGCCGAAGAGTTGAGAAA 
R:ACACTTACCGCCAGTGTTTCTCAA 
V 
118.1A9M13a F:CTGGGGAATGTCAGTTATTTTTGT 
R:AAAAAACCAAACCCAAACAAAAAT 
III 
118.1A9M13b 
 
F:CCATATCCTTATGTGTATCAGCCC 
R:ATCAGGGCTATTATGTGGGCTGAT 
III 
159F5SP6 
 
F:GGAGGAAAAACGTAATAAAATCTC 
R:GAGTGGTCAATCGTATGAGATTTT 
II 
168I4T7 
 
F:GGCTCACACTTCCTTCCTCTCTGA 
R:ACTTTCAAAGGGTAGGTCAGAGAG 
II 
180P20SP6 
 
F:CGTGAGCTGGTGGCTAGTCAGCCC 
R:TCCATGTAGAATTGCAGGGCTGAC 
IV 
190M2T7 
 
F:TCACCTTTGAATCATGAAACCCAA 
R:TTGAGAACTCTTTACCTTGGGTTT 
II 
331E10SP6 
 
F:GTTAAGGCAGGTTGTCCCCCAGTT 
R:CCTGCATCATCAGTGAAACTGGGG 
IV 
C-BWM13 
 
F:GATTCAGAGGCACAGACAGAAACA 
R:CCCTGCTTTCCAACTCTGTTTCTG 
I 
D-BWM13 
 
F:GCCAGTCCTGTCAGTGCTCCAATT 
R:TTATCTGTTTCACCTGAATTGGAG 
I 
 
 
 
 
 
  
59 
The overgos were labeled individually with 32P dATP and 32P dCTP and the 
unincorporated nucleotides were removed using Sephadex G-10 spin-columns. Labeled 
overgo probes were pooled in equal concentrations and hybridized onto the eleven high 
density filters of the CHORI-241 library using the protocol described by (Gustafson et 
al. 2003). The filters were washed three times at 42°C for 15 min in 2× SSPE and 
exposed to film over intensifying screens for four days at –80°C before developing the 
autoradiograms. The autoradiograms were inspected manually and positive BAC clones 
were identified. The clones were picked from the BAC library and grown overnight in 
96-deep-well plates containing 2YT with antibiotics. BAC clones corresponding to 
individual overgos were identified by PCR on cell lysates using STS primers from the 
same BAC end sequences from where overgos were designed. Newly identified BACs 
were used for further chromosome walking as described above. 
 
Fluorescence in situ hybridization (FISH) analysis 
FISH was used to confirm the Y-specificity of flow sorted ECAY and all BAC 
clones. FISH was also instrumental for distinguishing between single copy and 
multicopy cDNA sequences. Probe labeling, in situ hybridization, signal detection and 
image analysis was carried out according to our detailed protocol (Raudsepp and 
Chowdhary 2008). Briefly, 1 µg of probe DNA was labeled with biotin and/or 
digoxigenin using Bio-Nick or Dig-Nick Translation Kit (Roche Molecular 
Biochemicals) and hybridized to male horse metaphase and/or interphase chromosomes. 
Biotin labeled probes were detected with avidin-FITC (Vector) and digoxigenin labeled 
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probes with anti-digoxigenin-rhodamine (Roche Molecular Biochemicals). Images were 
captured and analyzed with a Zeiss Axioplan2 fluorescence microscope equipped with 
Isis v 5.2 (MetaSystems GmbH) software. 
 
RESULTS 
 
Isolation of Y-specific ESTs from horse testis 
Two rounds of cDNA selection were carried out using horse testis cDNA as a 
‘driver’ and flow sorted Y chromosome or ECAY BAC pools as ‘selectors’. From 
thousands of transcripts present in testis, such selective hybridization allowed isolation 
of only Y-specific cDNA sequences (Fig. 2). Selected cDNA was cloned and EcoRI 
digestion of 152 randomly chosen clones confirmed the presence of inserts with an 
average size of ~850bp (Fig. 3). A total of 2,400 clones (864 from BAC pools and 1,536 
from flow sorted Y) were picked, sequenced and analyzed. After vector and quality 
trimming, 1,678 sequences were assembled into 180 contigs and 100 singletons. PCR 
analysis showed that 321 sequences (19.1%; 30 contigs, 74 singletons) were male 
specific (Fig. 4). The remaining 1,357 sequences (150 contigs, 26 singletons) amplified 
both from male and female genomic DNA. Majority of these sequences aligned with 
known autosomal genes and were removed from further analysis. Fourtyfour non sex-
specific cDNA sequences which showed no significant BLAST hits, were analysed by 
STS content analysis for possible pseudoautosomal origin. 
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Figure 2: PCR results at different stages of testis cDNA selection. a. PCR 
amplified primary cDNA b. PCR amplified primary-selected cDNA, and c. 
PCR amplified secondary selected cDNA, with – 1µl (lane1) and 5µl (lane2) 
template DNA. M: molecular markers. 
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Figure 3: Restriction digestion analysis of cDNA clones. Randomly chosen 24 
cDNA clones digested with EcoRI showing inserts of different sizes (lower 
bands); upper bands represent the Topo TA vector (3.956 kb). M: molecular 
markers. 
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Figure 4: Male-specific PCR amplification. PCR amplification of  
a. CUL4BY; b. YIR2, and c. RFX5Y from genomic DNA of five male  
(lanes 1-5) and five female (lanes 6-10) horses. M: molecular markers. 
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Identification of horse Y chromosome genes and ESTs 
 
BLAST analysis of 321 male-specific cDNA sequences revealed significant 
(<1e-8) similarity with 13 known mammalian Y chromosome genes viz., DDX3Y, 
CUL4BY, CYorf15, NLGN4Y, RBMY, KDM5D (alias SMCY), SRY, TMSB4Y, TSPY, 
UBE1Y, USP9Y, YIR2, ZFY and 3 autosomal genes, (viz., EIF3C , RPS3A, ZNF33b) 
(Table 3). PCR primers for the latter three genes amplified two distinct bands: a higher 
molecular weight band which was present in both males and females, and a smaller band 
present only in male DNA (Fig. 5). Sequences of male-specific bands differed from 
autosomal PCR products by a short internal deletion and it was therefore not possible to 
design solely male-specific primers. 
Ten cDNA sequences were considered as equine specific because BLAST 
analysis did not show similarity to any mammalian sequences. These were named as 
ETSTY1-ETSTY6 and ETY1-ETY4 where ETSTY stands for Equine Testis Specific 
Transcript on Y and ETY for Equine Transcript on Y indicating whether the transcripts 
had testis-limited or broader expression profiles, respectively (will be discussed in detail 
in the following chapter). 
Finally, three cDNA sequences showed weak similarity (>1e-8) to one 
mitochondrial (MT-ND1Y), one autosomal (RFX5Y) and one Y chromosome (EIF1AY) 
gene and their annotation remains therefore tentative. 
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Figure 5: Autosomal and Y-chromosomal PCR 
amplification. PCR amplification of EIF3CY (lanes 1-2), 
RPS3AY (lanes 3-4) and ZNF33bY (lanes 5-6) from male 
(odd numbered lanes) and female (even numbered lanes) 
genomic DNA. Lower bands are present only in males 
indicating their Y-specific nature. M: molecular markers. 
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Table 3: Summary information about all genes and ESTs mapped to ECAY.  
 
Copy number Gene Symbol 
 
BAC 
 
cDNA 
Gene/EST category Presence 
of ORF 
No. of 
cDNA 
clones  
isolated 
Known homologs in other mammals 
*AMELY Single copy - X degenerate No 0 Human, pig, cattle AMELY 
CUL4BY Multicopy Heterochromatin X degenerate, multicopy Yes 1 Cat, dog CUL4BY 
CYorf15 Single copy - X-degenerate Yes 2 Human CXorf15, cat CYorf15  
DDX3Y  Single copy - X degenerate Yes 2 Human, mouse, cat, pig DDX3Y 
EIF1AY Single copy - X-degenerate No 2 Human EIF1AY 
*EIF2s3Y Single copy - X degenerate No 0 Mouse, pig, cat EIF2s3Y 
EIF3CY  Single copy - Autosomal Yes 85 Cattle, Dog, Human EIF3C 
ETSTY1 Multicopy Multicopy Novel, multicopy No 2 No significant similarity 
ETSTY2 Multicopy Multicopy Novel, multicopy No 7 No significant similarity  
ETSTY3 Multicopy Multicopy Novel, multicopy No 12 No significant similarity  
ETSTY4 Multicopy Multicopy Novel, multicopy No 9 No significant similarity  
ETSTY5 Multicopy Multicopy Novel, multicopy No 3 No significant similarity  
ETSTY6  Heterochromatin Novel, multicopy No 2 No significant similarity  
ETY1 Multicopy Multicopy Novel, multicopy No 1 No significant similarity  
ETY2 Single copy - Novel No 1 No significant similarity  
ETY3  Heterochromatin Novel, multicopy No 1 No significant similarity  
ETY4 Multicopy Multicopy Novel, multicopy No 1 No significant similarity  
*KAL1Y Single copy - X degenerate No 0 Pseudogene in human 
KDM5D 
(SMCY) 
Single copy - X degenerate Yes 3 Horse, dog, human SMCY 
*MAP3K7IP3
Y 
Single copy -  X degenerate No 0 Human MAP3K7IP3 on X chromosome 
MT-ND1Y Single copy - Mitochondrial No 1 Human MT-ND1 pseudogene on X 
chromosome, NADH dehydrogenase 1 
(MTND1) pseudogene on HSA1 
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Table 3 continued  
 
Copy number Gene Symbol 
BAC cDNA 
Gene/transcript category Presence 
of ORF 
No. of 
cDNA 
clones  
isolated 
Known homologs in other mammals 
NLGN4Y Single copy - X degenerate No 1 Human NLGN4Y, Macaca mulatta, 
chimp NLGN4X 
RBMY Multicopy Multicopy X degenerate, multicopy No 1 Human, mouse RBMY, Human, chimp 
RBMX 
RFX5Y Single copy - Autosomal No 1 Human RFX5 
RPS3AY Single copy - Autosomal Yes 1 Human RPS3A 
SRY Multicopy Single copy X degenerate Yes 43 Human, mouse, cat, pig, cattle SRY 
*STS-Y Single copy - X degenerate No 0 Mouse Stsy pseudoautosomal 
*TBL1Y Single copy - X degenerate No 0 Human TBL1Y 
TMSB4Y Single copy - X degenerate No 1 Human, mouse TMSB4Y, cattle, human 
TMSB4X  
TSPY Multicopy Multicopy X degenerate, multicopy Yes 12 Human, chimp, cat, cattle, pig TSPY 
UBE1Y Multicopy Multicopy X degenerate, multicopy Yes 54 Human UBE1, mouse, pig, cat UBE1Y 
USP9Y Single copy - X degenerate Yes 3 Human, chimp, rat, mouse USP9Y 
*UTY Single copy - X degenerate No  0 Human, mouse, pig, cat UTY 
YIR2 Multicopy Multicopy Inverted repeat, multicopy No 1 Human chromosome Y palindromes 
P1, P2, P3 and inverted repeat IR2 (P1-
P2-P3-IR2@) on chromosome Y 
ZFY Single copy - X degenerate No 3 Human gorilla, chimp ZFY, human 
ZFX 
ZNF33bY  Heterochromatin Autosomal, multicopy No 64 Equus caballus similar to zinc finger 
protein 33b (ZNF33b)  
 
* genes identified from BES only  
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Altogether, the analysis of all male specific cDNA sequences identified 29 
known or novel equine Y chromosome genes and ESTs. Four genes, viz., SRY, CUL4BY, 
RPS3AY and ZNF33bY were captured only from the experiments with flow sorted 
ECAY, 12 genes using ECAY BAC pools and the remaining 13 ESTs were identified 
from both types of experiments (Table 3).  
 
Relative abundance of Y-linked transcripts 
The most abundant male-specific transcripts were EIF3CY, ZNF33bY, UBE1Y 
and SRY represented by 85, 64, 54 and 43 cDNA sequences, respectively (Table 3). It is 
likely, that the number of EIF3CY and ZNF33bY transcripts is inflated because sequence 
analysis could not clearly distinguish between the sequences originating from Y-specific 
and autosomal transcripts of the two genes. Therefore, the most highly transcribed Y 
chromosome genes in adult horse testis are probably UBE1Y and SRY. In contrast, only 
one transcript was found for CUL4BY, ETY1-ETY4, MT-ND1Y, NLGN4Y, RBMY, 
RFX5Y, RPS3AY, TMSB4Y, and YIR2 (Table 3). 
 
Identification of open reading frames (ORFs) 
 
The presence of ORFs was identified in 10 sequences, viz., CUL4BY, CYorf15, 
DDX3Y, EIF3CY, RPS3AY, KDM5D (alias SMCY), SRY, TSPY, UBE1Y and USP9Y 
(Table 3). Because many captured cDNA sequences were short the final count for the 
presence or absence of ORFs can be done only after full-length cDNA sequences are 
available for all ECAY ESTs. 
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cDNA mapping on horse Y chromosome  
Twenty-six Y-linked genes and ESTs were mapped to ECAY contig map 
(Raudsepp et al. 2004b; Raudsepp et al. 2008b) by STS content analysis. The location of 
six genes (DDX3Y, KDM5D (alias SMCY), SRY, TSPY, USP9Y, ZFY) confirmed our 
earlier results (Raudsepp et al. 2004b) while the rest were new map assignments. 
Sequences of three ESTs (ZNF33bY, ETY3 and ETSTY6) were not found from the 
existing contig map and were used to isolate new clones from CHORI-241 library. From 
the total of 29 Y-specific genes and ESTs 12 mapped to the multicopy region, 14 to the 
remaining MSY, and ZNF33bY, ETY3 and ETSTY6 to the heterochromatic region (Fig. 
6). The linear order of all single-copy genes was determined. In the multicopy region it 
was possible to order only three genes, viz., RBMY, SRY and YIR2, because they are 
located in the same BAC clone and a complete sequence of this clone is available at 
NCBI Entrez Nucleotide, Accession AC214740. The order of the remaining genes and 
ESTs in multicopy and heterochromatic regions remain tentative. 
An additional seven genes viz., KAL1Y, TBL1Y, UTY, STSY, EIF2s3Y, 
MAP3K7IP3Y and AMELY were identified only from BAC end sequence (BES) analysis 
and not found from cDNA selection experiments. Therefore, the current gene map of 
horse MSY consists of 36 genes and ESTs (Fig. 6). 
Primers for 44 anonymous cDNA sequences that PCR amplified equally from 
male and female genomic DNA, were used for STS content analysis on the minimum 
tiling path (MTP) of horse PAR (Raudsepp and Chowdhary 2008). Three transcripts 
were initially assigned to the horse pseudoautosomal boundary (PAB) and one to ECAX, 
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adjacent to PAB. However, recent re-analysis of these sequences with RepeatMasker 
showed that all four cDNA sequences are completely repetitive and were hence 
eliminated from further study. None of the cDNA sequences analyzed in this research 
showed significant similarity to any known equine or other mammalian 
pseudoautosomal genes. 
 
Generation of a comprehensive map for ECAY  
The initial contig map of ECAY comprised of 73 BACs, 126 STS markers  and 8 
genes (KDM5D, SRY, TSPY, UTY, USP9Y, DDX3Y, ZFY, and AMELY) that were 
arranged into seven BAC contigs in MSY (Raudsepp et al. 2004b). Each contig 
contained 3-13 overlapping BACs with the exception of the multicopy region which had 
27 clones.  
Since then the map has been considerably expanded. cDNA selection in this 
study identified a number of new genes/ESTs which led to isolation of many new BAC 
clones and generation of STS markers for chromosome walking. If BAC ends were 
repetitive, internal BAC sequences were used to walk through the repeat region. An 
additional 39 new clones were found by overgo hybridizations to the CHORI-241 library 
high-density filters. Altogether, chromosome walking and BAC discovery identified 124 
new clones that added one new contig to the map (contig III with 27 BACs Figs. 6, A1) 
and were instrumental in closing two gaps. The final map spans the entire MSY and 
extends from the pseudoautosomal boundary to the heterochromatic region and even 
includes a small part of the latter. The map consists of 197 BAC clones which are 
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arranged into 5 contigs. Majority of the BAC clones (143) originate from CHORI-241 
male BAC library, though 54 BAC clones were incorporated from TAMU (42) and 
INRA (12) libraries. The use of Y chromosome from three different individuals did not 
affect the assembly of the contig map because ECAY exhibits overall very low genetic 
variability (Lindgren et al. 2004; Wallner et al. 2004). The present map contains 282 
STSs and 36 linearly ordered genes. A contig-wise summary of BES, STSs and genes 
present in horse MSY is provided in Table A3. 
Despite this progress, the map still contains four gaps (Fig. A1) which could not 
be closed because of the presence of massive repetitive sequences flanking the gaps. Co-
hybridization of BACs from either side of the gaps showed that GAP1 and GAP4 are the 
smallest, not larger than 2-3 BAC insert sizes or ~ 500 kb, while GAP2 and GAP3 are 
almost two times larger, about the size of 5-6 BAC inserts or ~ 1 megabase (Mb) each. 
Altogether, the four gaps cover at least 3 Mb of the horse MSY (Fig. A1). 
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Figure 6: Schematic representation of ECAY heterochromatic region, MSY and PAR showing the five MSY BAC contigs 
and location of 36 genes and ESTs. Gene symbols in black – newly added from cDNA selection; blue – previously mapped 
(Raudsepp et al. 2004) and red – identified from BES only. 
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FISH analysis and cDNA copy number evaluation 
FISH confirmed Y specificity of the flow sorted ECAY, the six BAC pools and 
all newly isolated BAC clones (Fig. 7a, b). FISH also allowed to distinguish between 
single-copy and multicopy BAC clones by showing the presence of one or more signals 
on metaphase or interphase chromosomes. However, FISH with multicopy BAC clones 
does not reveal whether the short cDNA sequences contained in these BACs are also 
multicopy. Therefore, direct FISH with short cDNA clones was used to evaluate copy 
number of individual genes and ESTs. The underlying rationale of this approach is the 
limited sensitivity of the FISH technique (Trask et al. 1993; Trask 2002) due to which 
signals from short (600-900 bp) cDNA sequences are visible only when these sequences 
are present in multiple copies. cDNA FISH showed that 15 genes and ESTs are present 
in multiple copies on the Y chromosome (Fig. 7c, d; Table 3, 4). Not coincidentally, 12 
markers are located in BAC clones from multicopy region (Fig. 6). The only exception 
was SRY cDNA which produced no detectable FISH signals though SRY co-localizes 
with three multicopy genes – RBMY, TSPY and YIR2 – in the same multicopy BAC 
clone (Fig. A1, Table 3). It is likely that horse SRY is a single copy gene but is inserted 
between multicopy sequences. 
cDNA from ETY3, ETSTY6 and ZNF33bY hybridized to ECAY and ECAXq21 
heterochromatin. Heterochromatic signals were obtained also with CUL4BY cDNA, 
though STS content analysis mapped this gene unequivocally to the multicopy region in 
Contig I (Fig. 6). 
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cDNA FISH allowed mainly to distinguish between single copy and multicopy 
sequences (Fig. 7), though in a few cases the signal intensity indicated also quantitative 
differences between the markers. For example, RBMY cDNA gave consistently brighter 
signals than ETSTY2 cDNA reflecting likely differences in copy numbers (Fig. 7f, g).  
 
DISCUSSION 
 
cDNA selection and ECAY gene map 
cDNA selection is a well established method to isolate expressed sequences from 
genomic regions of interest (Chen-Liu et al. 1995; Guan et al. 1996). In the case of the Y 
chromosome where gene discovery through direct sequencing or comparative mapping 
is complicated, cDNA selection has been an efficient way to obtain a broad 
representative sampling of expressed sequences from MSY and PAR in humans (Lahn 
and Page 1997; Makrinou et al. 2001) and more recently in carnivores (Murphy et al. 
2006; Pearks Wilkerson et al. 2008). The present study shows the efficacy of the method 
also in horse where 29 genes and ESTs were identified of which 23 were new for the 
horse Y chromosome. 
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Figure 7: Fluorescence in situ hybridization (FISH) using ECAY probes. FISH 
showing signals (arrows) on horse metaphase (a-d) and interphase (e-g) 
chromosomes using a. dig-labeled flow-sorted Y chromosome, b. biotin labeled pool 
of 33 ECAY BACs. An additional signal is seen on Xpter because the pool contains 
a few clones which are duplicated between MSY and PAR (Raudsepp & Chowdhary 
2008), c. dig-labeled ETSTY3 cDNA, d. biotin labeled UBE1Y cDNA,  e. co-
hybridization of BACs 124.3G9 (red) and 83H5 (green) containing single copy 
genes EIF2s3Y and AMELY, respectively, f. dig-labeled ETSTY2 cDNA, and g. dig-
labeled RBMY cDNA. 
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Although the search for ECAY genes using flow sorted Y chromosome and 183 
Y specific BAC clones was systematic, some previously mapped genes (Raudsepp et al. 
2004b; Raudsepp et al. 2008b) escaped detection. For example, AMELY was not found 
because it is expressed exclusively in tooth enamel and not in testis (Salido et al. 1992). 
STS-Y and KAL1Y escaped discovery probably because, like in humans, they might be 
non-transcribed pseudogenes (Skaletsky et al. 2003). UTY, MAP3K7IIP3Y, EIF2s3Y and 
TBL1Y were not recovered probably because they are not transcribed in sufficient 
amounts in horse testis to be captured by the cDNA selection method. A few more 
pseudogenes and low-abundance transcripts might have escaped detection. For example, 
two known mammalian Y-linked genes – HSFY and RPS4Y – have not yet been found in 
horses. It is also possible that these genes have been lost from ECAY. 
Surprisingly, we did not recover any known equine (Raudsepp and Chowdhary 
2008) or other mammalian PAR genes though initial cDNA capture for human Y 
chromosome identified all 9 PAR genes known at that time (Lahn and Page 1997). It is 
possible that PAR gene expression level in horse testis is lower than in humans and these 
transcripts escaped detection in the present study. Nonetheless, the cDNA selection 
enriched horse Y chromosome gene map with 23 new genes and ESTs. 
 
Comprehensive contig map of ECAY  
Using the initial ECAY contig map (Raudsepp et al. 2004b) as an important 
foundation, the construction of a comprehensive BAC contig map for horse MSY was 
completed in this study. The map covers most of the MSY and provides a highly 
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redundant tiling path for the sequencing of the horse Y chromosome (Fig. A1). The most 
proximal contig connects MSY to the heterochromatic portion of ECAY and four most 
distal clones extend over the peudoautosomal boundary and join MSY to the PAR 
(Raudsepp and Chowdhary 2008). The minimum tiling path (MTP) over MSY 
comprises of 59 BAC clones of which 44 are single-copy and 15 multicopy. The 
sequence-ready contig map of the horse Y chromosome is the only such resource for a Y 
chromosome among non-primate mammals. 
One of the goals of the present study was also to close gaps present in the intitial 
MSY BAC contig map (Raudsepp et al. 2004). For this several different approaches 
were used: i) cDNA selection from horse testis to enrich the map with randomly spaced 
genes and ESTs, ii)  filter hybridizations with overgo primers to identify new Y-specific 
BACs and iii) sequencing of BAC ends and internal sequences to develop more STSs for 
chromosome walking. This resulted in closing two of the six gaps  in the previous MSY 
map (Raudsepp et al. 2004b) (Fig. 6, A1). It is noteworthy that majority of the isolated 
cDNA clones mapped to the existing BACs and none to the gaps. This indicates that 
most likely the gaps do not contain any expressed sequences. It is possible that the gaps 
are enriched with repetitive sequences and have therefore largely escaped cloning into 
libraries. The gaps might also demarcate transition from euchromatic sequences into 
small interstitial heterochromatic islands. Such islands have been recently discovered 
from human MSY and are often flanked by segmental duplications (Kirsch et al. 2008). 
Whether ECAY contains similar interstitial heterochromatic islands needs further 
investigation. 
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Given that the CHORI-241 library average insert size is 171 kb 
(http://bacpac.chori.org/equine241.htm13), that the 59 MTP clones are overlapping by 
~20% and that the four gaps count for ~ 3 Mb, the size of equine MSY is estimated to be 
approximately 11 Mb. Together with PAR which is ~1.8 Mb (Raudsepp and Chowdhary 
2008) the size of the horse Y chromosome euchromatin is roughly 13 Mb. This estimate 
is close to the ~15 Mb proposed earlier (Raudsepp et al. 2004b) and will be validated 
once the complete sequence of the euchromatic ECAY becomes available.  
 
Horse Y chromosome gene catalogue 
Traditionally MSY sequences are classified as X degenerate or ampliconic 
(Skaletsky et al. 2003) reflecting their evolutionary origin and copy number. The two 
classes, however, are not always clearly distinguished. The best example is TSPY which 
represents both sequence categories. It has an ancestral single-copy and ubiquitously 
expressed homolog on the X chromosome (Delbridge et al. 2004), but has been 
amplified and has acquired testis-limited expression on the Y chromosome in human 
(Skaletsky et al. 2003), cat (Murphy et al. 2006), horse (Raudsepp et al. 2004b; this 
study), cattle, goat, sheep (Vogel et al. 1997a; Vogel et al. 1997b) and rat (Dechend et al. 
1998). In contrast, murine TSPY is a single copy gene but has lost its function (Schubert 
et al. 2000b).  
According to their evolutionary origin, the 36 horse MSY genes and ESTs 
identified and mapped in this study were classified as X degenerate, multicopy and 
acquired sequences (Fig. 6, Table 3). The former originate from ancestral proto-sex 
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chromosomes, have a gametologue on the X chromosome and are often shared between 
mammalian Y chromosomes (Graves 2006; Delbridge and Graves 2007; Waters et al. 
2007). Most of the multicopy genes have no detectable homologs in other species and 
are most likely Y-borne in horses. In contrast, acquired sequences have arrived to the Y 
chromosome from other genomic locations. 
 
X degenerate sequences 
The core set of horse X degenerate genes resembles, with minor variations, that 
of other mammals (Quilter et al. 2002; Rohozinski et al. 2002; Skaletsky et al. 2003; 
Raudsepp et al. 2004b; Murphy et al. 2006; Pearks Wilkerson et al. 2008). Like in other 
species, the majority of equine X degenerate genes are single copy sequences. Horse-
specific variations involve possible loss of some genes, viz., HSFY and RPS4Y and 
structural-functional changes in a few others. Besides TSPY, three more X degenerate 
genes - RBMY, CUL4BY and UBE1Y - have been amplified during ECAY evolution. 
RBMY is a multicopy gene in human and mouse (Mazeyrat et al. 1999; Skaletsky et al. 
2003), multiple copies of CUL4BY have been found also from carnivore Y chromosome 
(Murphy et al. 2006; Pearks Wilkerson et al. 2008), while amplification of UBE1Y 
seems to be a horse specific feature. This gene has been lost from human Y chromosome 
(Lahn et al. 2001; Skaletsky et al. 2003) but is present as a single-copy Y-linked 
sequence in cat (Murphy et al. 2006), pig (Quilter et al. 2002) and mouse (Mitchell et al. 
1991; Levy et al. 2000). Functional importance of UBE1Y in horse testis is reflected by 
the higher than average number of recovered cDNA clones (54 cDNAs, Table 3). 
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UBE1Y transcripts were so abundant that in some experiments, in order to efficiently 
recover single-copy sequences, the initial testis cDNA was pre-annealed with UBE1Y 
cDNA. However, given that similarity between UBE1Y and UBE1X coding sequences is 
high (95-98%), the recovered pool of cDNAs could originate from both gametologues 
and thus, artificially inflate the numbers. 
The most intriguing X degenerate gene, however, seems to be the male sex-
determining region on Y – SRY. Considering the known function of SRY in sex 
determination at early stages of mammalian embryonic development (Wilhelm et al. 
2007b), it comes as a surprise that SRY is transcribed at high levels from adult horse 
testis (43 cDNA clones recovered, Table 3). One explanation for elevated transcription 
levels could be gene amplification, especially in the light that SRY is a multicopy gene in 
rabbit (Geraldes and Ferrand 2006), rat (Turner et al. 2007) and cat (Pearks Wilkerson et 
al. 2008). Mapping SRY to a multicopy BAC clone, very close to three other multicopy 
transcripts (RBMY, TSPY and YIR2) (Fig. 6) indicates a possible multicopy nature of 
horse SRY. However, SRY cDNA FISH showed no hybridization signal and we infer that 
equine SRY is a single copy gene which is located in the middle of amplified sequences. 
Finally, horse SRY exhibits one more unusual feature – the sequence of the single 1420 
bp coding exon (Hasegawa et al. 1999, this study) contains a ~20 bp LTR repeat which 
was discovered during cDNA selection. It appeared that SRY transcripts could be 
recovered only when the amount of Cot1 DNA used for pre-annealing testis cDNA was 
reduced from 7.5X to 2X. Sequence analysis indicates that intra-exonic LTR or simple 
repeats are present also in mouse, rat, rabbit, dog and donkey SRY (Ensembl, 
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http://www.ensembl.org/index.html3; NCBI Entrez Nucleotide, http://www.ncbi. 
nlm.nih.gov/sites/entrez?db=nucleotide16). The functional significance of these repeat 
sequences is yet to be determined. 
 
Multicopy sequences – novel equine-specific Y-borne transcripts 
The presence of species specific, Y-borne or acquired multicopy sequences 
seems to be one of the unique and characteristic features of all Y chromosomes studied 
so far – from mammals to the fruit fly (Skaletsky et al. 2003; Raudsepp et al. 2004b; 
Gvozdev et al. 2005; Toure et al. 2005; Murphy et al. 2006; Delbridge and Graves 
2007). The horse MSY is no exception as we recovered 15 different multicopy cDNA 
sequences of which 9 were considered novel, equine-specific and Y-borne because none 
showed similarity to known autosomal or X-linked sequences. The remaining 6 ESTs 
showed sequence similarity to putative human, mouse and cat Y orthologs and human 
autosome (Table 3). It is worth mentioning that out of 10 novel ESTs found in this study 
only one (ETY2) was a single copy sequence. 
In humans where MSY sequence is available, ampliconic regions are defined as 
amplified segments of euchromatic sequences that exhibit as much as 99.9% identity 
over 10-100 kilobases to other MSY sequences (Skaletsky et al. 2003). In species where 
Y chromosome sequence information is not available, ampliconic nature of sequences is 
determined indirectly by genotyping on radiation hybrid panel (Murphy et al. 2006) or 
by FISH (Raudsepp et al. 2004b; Murphy et al. 2006). In the present study multicopy 
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status of all 15 sequences was determined solely by FISH and therefore exact copy 
number and rates of sequence similarities between amplicons remain unknown. 
Most of the novel cDNA sequences mapped to a region in the distal part of MSY 
Contig I and two sequences to the heterochromatic region (Fig. 6). Such regional 
localization of multicopy sequences, as far as known, is unique to the horse Y 
chromosome. Human ampliconic sequences are distributed among at least 5 distinct 
regions and the sequence with the highest copy number (35 copies) is TSPY (Skaletsky 
et al. 2003). In cat and mouse high numbers of amplified and expressed sequences are 
dispersed over the entire long arm of the Y chromosome and in mouse some testis-
specific gene families (Ssty, Asty) each are present in as many as 65-100 copies (Toure et 
al. 2004a; Toure et al. 2004b; Ellis et al. 2005; Murphy et al. 2006). Copy number 
difference between different multicopy cDNA sequences (based on variable intensity 
and numbers of FISH signals) was noted also in this study (Fig. 7 d, e, f). These 
observations, however, need validation and refinement by quantitative PCR and/or 
complete sequencing of horse MSY. 
Notably, we did not detect ORFs in any of the novel multicopy transcripts (Table 
3). It is possible that like in human and cats, the multicopy region of horse MSY consists 
of tandemly repeated transcription clusters that lack strong protein-coding evidence 
(Skaletsky et al. 2003; Murphy et al. 2006). Protein coding potential of these novel 
multicopy sequences will be re-evaluated once full length cDNA sequences are 
available. 
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Acquired sequences from autosomes and the mitochondrial genome 
Transposition and retroposition of genes and mRNA sequences from autosomes 
to the Y chromosome is another characteristic feature of Y chromosome evolution 
(Gvozdev et al. 2005; Delbridge and Graves 2007) and has been shown for human DAZ 
and CDY gene families (Saxena et al. 2000; Dorus et al. 2003; Skaletsky et al. 2003), 
mouse RhoA genes (Boettger-Tong et al. 1998) and cat FLJ36031Ya, TETY1 sequences 
(Murphy et al. 2006). Such gene traffic, however, is species or group specific because in 
different species different autosomal genes have acquired Y-linked counterparts. This is 
consistent with the results of the present study showing that none of the autosome-
derived genes on horse MSY (Fig. 5) are Y-linked in other mammals (Table 3). 
Identification of a tentative Y-linked homolog for regulatory factor X, 5 on Y (RFX5Y) 
is of particular interest. Autosomal RFX5 is a part of conserved upstream elements in the 
major histocompatibility complex (MHC) class-II promoter (Lochamy et al. 2007). It is, 
therefore, possible that the horse Y-linked counterpart is associated with the minor 
histocompatibility complex and Y chromosome encoded H-Y antigens (Rosinski et al. 
2008), but this conjecture needs verification in future studies. 
Lastly, one Y-linked transcript is probably a mitochondrial insertion showing 
tentative similarity (>1e-8) to MT-ND1. Though nuclear sequences of mitochondrial 
origin (NUMTs) have not yet been studied in the horse genome, the discovery of one 
from the Y chromosome is consistent with the findings in human where HSAY is highly 
susceptible for colonization by NUMTs (Ricchetti et al. 2004). An overview of all 
ECAY genes that have orthologs in other mammalian species is presented in Table 4.
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 Table 4: Comparative analysis of ECAY orthologs on the Y chromosomes of other mammalian species. 
 
Horse gene 
/transcript 
 
ECAY HSAY MMUY FCAY Other Mammalian Y 
orthologs 
References 
AMELY SC SC not found SC Chimpanzee, pig, cattle SC Skaletski et al. 2003; Pearks 
Wilkerson et al. 2008; Kuroki 
et al. 2006; Quilter et al. 2002; 
Liu et al. 2002 
CUL4BY MC not found not found MC Dog MC Murphy et al. 2006; Pearks 
Wilkerson et al. 2008 
CYorf15 SC SC, 2 isoforms not found MC Chimpanzee 2 isoforms Skaletski et al. 2003; Murphy 
et al. 2006; Pearks Wilkerson 
et al. 2008; Kuroki et al. 2006 
DDX3Y  SC SC SC SC Chimpanzee, rat, pig, cattle 
SC 
Skaletski et al. 2003; Pearks 
Wilkerson et al. 2008; Kuroki 
et al. 2006; Quilter et al. 2002; 
Liu et al. 2002 
EIF1AY SC SC not found SC Chimpanzee SC Skaletski et al. 2003; Pearks 
Wilkerson et al. 2008; Kuroki 
et al. 2006 
EIF2s3Y SC not found SC SC Pig SC Pearks Wilkerson et al. 2008, 
Quilter et al. 2002 
EIF3CY SC not found not found not found not found  
KAL1Y SC SC, pseudogene not found not found Pig, cattle PAR Skaletski et al. 2003; Quilter 
et al. 2002; Das et al. 
unpublished 
KDM5D 
(SMCY) 
SC SC SC SC Chimpanzee, dog, cattle, pig 
SC 
Skaletski et al. 2003; Pearks 
Wilkerson et al. 2008; Kuroki 
et al. 2006; Liu et al. 2002; 
Quilter et al. 2002  
MAP3K7IP3Y SC not found, X-
linked 
not found not found not found  
  
85
Table 4 continued 
 
Horse gene 
/transcript 
 
ECAY HSAY MMUY FCAY Other Mammalian Y 
orthologs 
References 
MT-ND1Y SC SC, pseudogene,  not found not found 
not found Skaletski et al. 2003 
NLGN4Y SC SC SC not found Chimpanzee SC, cattle PAR Skaletski et al. 2003; Kuroki 
et al. 2006; Das et al. 
unpublished 
RBMY MC MC MC not found not found Skaletski et al. 2003; Toure et 
al. 2004 
RFX5Y SC not found not found not found not found  
RPS3AY SC not found not found not found not found  
SRY SC SC SC MC Chimpanzee, cattle, pig SC, 
rat MC 
Skaletski et al. 2003; Murphy 
et al. 2006; Pearks Wilkerson 
et al. 2008; Kuroki et al. 2006; 
Quilter 2002; Moore et al. 
2001; Turner et al. 2007 
STS-Y SC pseudogene PAR not found Chimpanzee pseudogene, 
cattle, pig, dog PAR 
Skaletski et al. 2003; Kuroki 
et al. 2006; Perry et al. 2001; 
Liu and de Leon 2004 
TBL1Y SC SC not found not found Chimpanzee SC, cattle PAR Skaletski et al. 2003; Kuroki 
et al. 2006; Van Laere et al. 
2008 
TMSB4Y SC SC not found not found Chimpanzee SC Skaletski et al. 2003; Kuroki 
et al. 2006 
TSPY MC MC pseudogene MC Chimpanzee, rat, cattle, 
goat, pig MC 
Skaletski et al. 2003; Mazeyrat 
and Mitchell 1998; Murphy et 
al. 2006; Pearks Wilkerson et 
al. 2008; Dechend et al. 1998; 
Kuroki et al. 2006; Quilter et 
al. 2002  
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Table 4 continued 
 
Horse gene 
/transcript 
 
ECAY HSAY MMUY FCAY Other Mammalian Y 
orthologs 
References 
UBE1Y MC not found SC 2 copies Rat SC, pig SC Murphy et al. 2006; Pearks 
Wilkerson et al. 2008; Quilter 
et al. 2002 
USP9Y SC SC SC SC Chimpanzee, rat, pig SC Skaletski et al. 2003; Pearks 
Wilkerson et al. 2008; Kuroki 
et al. 2006; Quilter et al. 2002 
UTY SC SC SC SC Chimpanzee, pig SC  Skaletski et al. 2003; Pearks 
Wilkerson et al. 2008; Kuroki 
et al. 2006; Quilter et al. 2002 
YIR2 SC palindromes P1, 
P2, P3 and 
inverted repeat 
IR2  
not found not found not found Skaletski et al. 2003 
ZFY SC SC 2 copies SC Chimpanzee, rat, pig SC Skaletski et al. 2003; Pearks 
Wilkerson et al. 2008; Kuroki 
et al. 2006; Quilter et al. 2002 
ZNF33bY MC not found not found not found not found  
 
SC: single copy, MC: multicopy 
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Heterochromatic transcripts 
One of the most intriguing findings of this study is the discovery that three 
expressed sequences (ETY3, ETSTY6 and ZNF33bY) map to the heterochromatic portion 
of ECAY. This was confirmed by STS content analysis and by BAC and cDNA FISH. 
All three ESTs are Y-linked only in horses. Transcripts ETY3 and ETSTY6 share no 
homology with the genomes of other mammals while ZNF33bY has an autosomal 
homolog in horse (ECA1: 66.5 Mb; UCSC, http://genome.ucsc.edu/4) and other species. 
At this stage it is not clear whether the sequences are translated because no ORFs were 
found (Table 3). This is the first time that transcriptional activity has been found in Y 
chromosome heterochromatin and has not yet been reported for any other species 
including humans (Skaletsky et al. 2003). 
Taken together, we have constructed a comprehensive sequencing-ready map for 
the horse Y chromosome and generated a detailed catalogue of 36 ECAY-linked genes. 
This is a unique resource to further investigate the Y-linked component of male fertility 
in horses. Identification of the potential ECAY candidate genes for stallion fertility will 
be the main focus of the next part of this Dissertation.  
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CHAPTER III 
 
 
EVALUATION OF THE Y-LINKED GENES AS POTENTIAL CANDIDATES 
FOR STALLION FERTILITY 
 
INTRODUCTION  
 
General observation from Y chromosomes studies in human, mouse and a few 
other mammals is that all species share a core set of X-degenerate genes. In addition, 
they also contain a number of multicopy genes. Some of the multicopy genes are 
common between species, while others are unique to a particular species or a group of 
related species (Mazeyrat et al. 1998; Liu et al. 2002; Quilter et al. 2002; Skaletsky et al. 
2003; Raudsepp et al. 2004b; Hughes et al. 2005; Kuroki et al. 2006; Murphy et al. 
2006). In some instances, a few X-degenerate genes have been amplified and acquired 
testis-limited expression in one species but have remained single copy and ubiquitously 
expressed in others (Mazeyrat and Mitchell 1998; Schubert et al. 2000b; Skaletsky et al. 
2003). Additionally, in some species Y chromosome has recruited new genes from 
autosomes or mitochondrial genome (Skaletsky et al. 2003; Murphy et al. 2006; Pearks 
Wilkerson et al. 2008). The most fascinating and unique feature of the Y chromosome, 
however, is that despite differences in the evolutionary origin of Y-linked genes, most of 
these genes tend to carry out similar male reproduction related functions in all species 
studied so far (Affara and Mitchell 2000; Ellis and Affara 2006). 
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The human Y chromosome harbors 9 ampliconic genes or gene families, viz., 
TSPY, RBMY, VCY, XKRY, CDY, HSFY, PRY, DAZ, BPY2 (Skaletsky et al. 2003). Of 
these, VCY, RBMY, TSPY, XKRY and HSFY have functional gametologs on the X 
chromosome (VCX, RBMX, TSPYL2, XKRX and HSFX1) whereas CDY and DAZ have 
autosomal homologs - CDYL and DAZL, respectively. TSPY, RBMY and HSFY are Y-
linked, multicopy genes also in several other mammals, like chimpanzee, cat, cattle and 
pig (Vogel et al. 1997a; Vogel et al. 1997b; Quilter et al. 2002; Tessari et al. 2004; 
Murphy et al. 2006). Human TSPY studies provide evidence that this gene might be 
involved in early spermatogenesis, immediately prior to the spermatogonia-to-
spermatocyte transition, it is also known to be involved in early testicular tumorigenesis 
(Schnieders et al. 1996; Lau et al. 2009). In contrast, mouse TSPY has become single 
copy and subsequently lost its function whereas TSPY in closely related rat is still 
functional (Mazeyrat et al. 1998). Notably, Y-linked homologs for human DAZ, BPY2, 
CDY and PRY have not yet been found in any of the non-primate mammalian Y 
chromosomes. Human DAZ belongs to a multicopy gene family while CDY and PRY 
each have two and BPY2 has three nearly identical copies in the palindromic region of 
HSAY. All four genes are specifically expressed in testis. The function of PRY is not yet 
known, DAZ is a critical azoospermia factor, CDY protein facilitates the replacement of 
chromatin histones with protamines, and BPY2 (VCY2) encoded protein interacts with 
ubiquitin protein ligase E3A and may be involved in male germ cell development and 
male (in)fertility (Wong et al. 2002; Dada et al. 2004; Kimmins and Sassone-Corsi 
2005). Absence of these critical male fertility genes on non-primate mammalian Y 
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chromosomes suggests that other genes or gene families must have acquired similar 
functions in other species. 
Partial sequencing of chimpanzee (Pan troglodytes, PTR) Y chromosome 
(PTRY) has identified at least 5 ampliconic structures and orthologs for 16 human X-
degenerate genes (Hughes et al. 2005; Kuroki et al. 2006). It is necessary to emphasize 
that to date there is no experimental data showing expression profiles or possible 
fertility-related functions of any of chimpanzee Y-linked genes. However, comparative 
sequencing analysis of reading frames and splice sites of the 16 human X-degenerate 
genes in chimpanzee and gorilla indicates that while all genes are intact in gorilla, 
structural and likely functional changes have taken place in chimpanzee lineage (Kuroki 
et al. 2006; Perry et al. 2007; Goto et al. 2009). Six PTRY genes, viz., CYorf15b, TBL1Y, 
TMSB4Y, USP9Y, VCY and VCY1B, have disruptions and mutations causing possible 
loss of function or production of truncated proteins (Hughes et al. 2005; Kuroki et al. 
2006; Perry et al. 2007). 
Besides human, detailed functional studies of Y-linked genes have been carried 
out only in mouse. It is well established that deletions on the long arm of mouse (Mus 
musculus, MMU) Y chromosome (MMUYq) involving highly amplified genes Sly, Asty 
and Orly cause male infertility (Toure et al. 2005; Ellis et al. 2007; Reynard et al. 2009). 
Notably, none of these gene families have been found in HSAY or other mammalian Y 
chromosomes. Analysis of gene expression profiles on a testis transcript microarray 
recently identified two more critical spermatogenesis-related murine Y-linked genes. 
Both are located on MMUYp and are significantly upregulated in the testis RNA from 
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mice with the MMUYq deletions (Ellis et al. 2005; Ferguson et al. 2009). One of the 
genes - H2al2y- encodes a novel histone family protein associated with centromeric 
heterochromatin during spermatogenesis, and has related genes on the X chromosome 
(H2al1) and an autosome (H2al2). Another gene - AK006152 - is not related to any 
known genes and appears to be MMUY-specific without any X-linked or autosomal 
homologs (Ferguson et al. 2009). 
Recently, expression profiles of Y-linked genes were studied also in cats 
(Murphy et al. 2006; Pearks Wilkerson et al. 2008). Like in humans and mice, the cat Y 
chromosome contains genes which have multiple copies, are expressed specifically in 
testis and some of these transcripts such as TETY1, TETY2 and FLJ36031Ya are novel 
and cat or carnivore specific. Furthermore, many multicopy, but not single-copy genes 
are significantly downregulated in domestic cat x Asian leopard cat sterile hybrids (W. 
Murphy unpublished observations) emphasizing the correlation between the function of 
multicopy Y-linked genes and the status of spermatogenesis. 
Proceeding from this overall compelling evidence that the male-specific region 
of the mammalian Y chromosome is evolutionarily predisposed to accumulate genes 
important for spermatogenesis, the aim of this study is to investigate whether Y-
chromosome genes are associated with fertility also in stallions. We have identified 36 
genes and ESTs in the horse Y chromosome (ECAY). All genes will be analyzed for 
their expression profiles in a panel of different body tissues including testis. The 
genes/ESTs showing testis-specific expression will be used for qRT-PCR to compare 
their expression in the testes of normal fertile stallions and stallions with various fertility 
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problems to identify potential candidate genes for stallion fertility. These goals will be 
achieved through the following specific objectives. 
 
OBJECTIVES 
 
1. Analyze the expression profiles of all ECAY genes/ESTs in a panel of normal, adult 
body tissues to identify candidate genes for stallion fertility. 
2. Compare the expression levels of all testis-specific genes/ESTs between fertile and 
infertile/subfertile stallions to identify genes that are differentially expressed between 
the two groups of animals. 
3. Generate full-length or nearly full length cDNA sequences for testis-specific ECAY 
genes/ESTs to acquire knowledge about their structure. 
This research will identify ECAY genes that are differentially expressed in 
infertile/subfertile stallions compared to normal animals and can hence, be considered as 
candidate genes for stallion fertility. The results are expected to establish an important 
foundation for the development of diagnostic tests for reproductive disorders in stallions 
in the future. 
 
MATERIALS AND METHODS 
 
Collection of tissue samples from normal horses 
Fresh necropsy samples of nine tissues (brain, kidney, heart, skeletal muscle, 
liver, lungs, spleen, seminal vesicle and testis) were obtained from two reproductively 
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normal adult male horses. Several pieces (approximately 0.5 cm3) of each tissue were 
collected in 1 ml of RNA-later (Ambion) to avoid degradation of RNA and stored at -80 
oC until needed. These samples were used for isolation of messenger RNA (mRNA) and 
total RNA. 
 
Isolation of messenger RNA (mRNA) from horse tissues 
Messenger RNA (mRNA) was isolated using Fast Track 2.0 mRNA isolation kit 
(Invitrogen) following the manufacturer’s instruction with minor modifications 
(described in Chapter II).  
 
Primer design for Reverse Transcriptase PCR (RT-PCR) 
Primers for RT-PCR were designed, if possible, from two neighboring exons 
flanking an intron, using Primer 3 software (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi11). In cases where cDNA sequences were short or it was 
not possible to determine exon/intron boundaries, intra-exonic primers were used. 
Details about all primers and PCR conditions are presented in Table 5. 
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Table 5: Information about primers, reaction conditions and expected product sizes for RT-PCR analysis of all  
ECAY genes. 
 
Gene Symbol RT-PCR primers 
5′ - 3′ 
Same as  
genomic primers 
 
Ta, °C cDNA 
product size, 
bp 
Genomic DNA 
product size, bp 
ACTB F: CCCAGATCATGTTTGAGACCT 
R: CCTCGTAGATGGGCACAGT 
No 58 144 585 
AMELY F: CCAACCCAACACCACCAGCCAAACCTC 
CCT 
R: AGCATAGGGGGCAAGGGCTGCAAGGG 
GAAT 
Yes 65 160 160 
CUL4BY F:TGTGGGGTTCGTGTGAAATA 
R:CAAGGATCGCTGGGTCTTAC 
Yes 58 172 172 
CYorf15 F:CTAGGTGGCGACGCAAGTGA 
R:TGCACTCCGATTCTTGTTGA 
No 58 358 2342 
DDX3Y  F:CTCGAGATCCAAAACTGCTG 
R:GCTGGTCTGGACCTGAACTC 
No 58 181 4378 
EIF1AY F:GATCGTGGCCTTCTGACATT 
R:TTATTTTTGGGCATGGTGGT 
Yes 58 187 187 
EIF2s3Y F:GAGCCATCTGTGTGATCGTC 
R:TATTCCTGGCCCTAAGCACA 
Yes 58 223 223 
EIF3CY 
 
F:CCCAAGCAGGGTACCTATGG 
R:GGACAGAAGTGACGCAATCA 
Yes 58 134 134, 230 
ETSTY1 F:GACGGACGACCTTGTGTTTT 
R:CTAGTGGCGAGTCCTTTTGG  
Yes 58 234 234 
ETSTY2 F:ATCATCGTGGAAAGCCTCAC 
R:AGTGCTGAAGAGGCTGTGGT  
Yes 58 223 223 
ETSTY3 F:TTACATTTGTTGCGCCATGT 
R:GCCCAAAGAAGTAACCGACA  
Yes 58 134 134 
ETSTY4 F:TAAGGCTTCCCTCCTCCAAT 
R:CCAGTGACCCGACATACTGA 
Yes 58 175 175 
ETSTY5 F:CAAAACCAAGAGGAGGACCA 
R:CTCCAGAGGCAGGTACTTCG 
Yes 58 210 210 
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Table 5 continued 
 
Gene Symbol RT-PCR primers 
5′ to 3′ 
Same as genomic 
primers 
 
Ta, °C cDNA 
product size, 
bp 
Genomic DNA 
product size, bp 
ETSTY6 F:ACATGGCGCAACAAATGTAA 
R:TAGCTGTTTGCTGCAGTGCT 
Yes 58 245 245 
ETY1 F:TCCAGAGCAACAACAGCAAC 
R:CATCAGTCTGCCCAAACCTT 
Yes 58 127 127 
ETY2 F:TAAGGCTTCCCTCCTCCAAT 
R:CCAGTGACCCGACATACTGA 
Yes 58 150 850 
ETY3 F:TTTTGGCTTGTGTCTTTCTCTG 
R:ATAGGGCCAGACTTTCACAGC 
Yes 58 350 350 
ETY4 F:TGGGGATATTGGCTTAGCTG 
R:CTGGGAGCACGTCTGTATCA 
Yes 58 180 180 
KAL1Y F:AGGCACAGTCTTAGGGCAAA  
R: TTTTGGCATTCCCTTCTCTG 
Yes 58 231 231 
KDM5D 
(SMCY) 
F:AACAGCGAGCCAATGTTTTT 
R:GCAAAATTCTGGGAAATCCA 
Yes 58 191 400 
MAP3K7IP3Y F: GTGGAATCCCTATTGCTAAAGTTAC 
R: CCAGAGAGCTGTGACCAAG 
Yes 58 138 138 
MT-ND1Y F:CCCTCCGCTTTCCTAGACC 
R:CAACGATGGCTTGAAAGGAT 
Yes 58 100 100 
NLGN4Y F:GGGGATCCATCTTTGTGTTG 
R:GTCACACAGCAGGCTCTGAC 
Yes 58 156 156 
RBMY F:TTCGGCCTTCTCTTTCACAT 
R:ACTCAAGCAGCCGAAATGAT 
Yes 58 180 180 
RFX5Y F:ACCCTTAGGGGGAAAAATCC 
R:TTTCGTCCCTCAAGTTCCTG 
Yes 58 201 201 
RPS3AY F:CCGGAAGAAGATGATGGAAA 
R:CAAACTTGGGCTTCTTCAGC 
Yes 58 179 179, 790  
SRY F:TGCATTCATGGTGTGGTCTC 
R:ATGGCAATTTTTCGGCTTC 
Yes 58 200 200 
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Table 5 continued 
 
Gene Symbol RT-PCR primers 
5′ to 3′ 
Same as genomic 
primers 
 
Ta, °C cDNA 
product size, 
bp 
Genomic DNA 
product size, bp 
STS-Y F:TGTGTGTTTCTGTCATGGGGATTACATC 
R:CAGACAATGTTTCCCAGTGACAATTGATTA 
n/a 58 n/a 210 (M/F) 
TBL1Y F: CACTCGAAACCAATGGAA   
R: TTCCATATCCTGGCAGTCGA 
 
n/a 50 n/a 500 (M/F) 
TMSB4Y F:ACCCACCCAGCCTCTTACTT 
R:TTGAAGAAGACGGAAACGC 
No 58 334 1123 
TSPY F:GAAGTCAGGCACACCAGTGA 
R:TAAGGCTGCAGTTGTCATGC 
Yes 58 189 280 
UBE1Y F:TGGCCAACTCACGGCTGATCCAA 
R:CTTCTCCACTCACCCTACTTGGG 
Yes 58 210 210 
USP9Y F:GGTTATGAAATGGTCTCTGC 
R:CGAGTCTGTCCATCAGGAGTC 
Yes 58 228 228 
UTY F: CAGCTGTTTTCGGTGATGAG 
R: GCCTCCTTCTCTTCGGTTG 
Yes 54 110 110 
YIR2 F:AGGGTTGGGCTAAGTCACCT 
R:ACCTTGGATCCAGACTCACG 
Yes 58 170 170 
ZFY F:TGAGCTATGCTGACAAAAGGTG 
R:TCTTTCCCTTGTCTTGCTTGA 
Yes 58 186 186 
ZNF33bY F:CCACAGCAAATACAGGAGCA 
R:GTCTGACTCCTCCCCCTTTC 
Yes 58 242 800, 3000 
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Reverse Transcriptase PCR for expression analysis 
 
RT-PCR was carried out using Superscript III One-Step RT-PCR System and 
Platinum Taq DNA polymerase (Invitrogen) in 15µl reactions containing 40 pmol of 
each primer and 10 ng of DNase-treated mRNA. RT-PCR with STS primers from a non-
transcribed sequence served as a control for mRNA possible contamination with 
genomic DNA. A housekeeping gene, beta actin (ACTB) was used as a control for RT-
PCR reactions. RT-PCR started with 30-min incubation at 50ºC, followed by 2-min hot-
start incubation at 94ºC and proceeded with 30 cycles as follows: 15 sec 94ºC, 30 sec 
58ºC, 1 min 68ºC and final extension 5 min at 68ºC. Genomic controls were run 
simultaneously with mRNA samples and RT-PCR products were visualized on 2.0% 
agarose gels. 
 
Isolation of total RNA from horse testis 
Testis tissue samples were collected from normal and infertile/subfertile horses 
(Table 9) and stored in RNA-later (Ambion) at -80ºC. Total RNA was extracted from 
testis tissues using RNeasy Mini Kit (Qiagen) following manufacturer’s protocol. In 
brief, tissue samples were carefully transferred from RNA-later into 600 µl of RLT 
buffer (with β-Mercaptoethanol) and homogenized using a glass homogenizer. The 
homogenate was centrifuged at 10,000 x g for 3 min and the supernatant was transferred 
carefully into a new tube. An equal volume of 70% ethanol was added to the clear lysate 
and mixed immediately. The solution was transferred to RNeasy spin column and 
centrifuged at 10,000 x g for 1 min to bind the RNA to the column. After on-column 
  
98 
DNA digestion with DNase in RDD buffer at room temperature for 15 min, 700 µl of 
RW1 buffer was added to the column and centrifuged at 10,000 x g for 1 min. The 
columns were washed twice with RPE buffer. RNeasy spin columns were then placed 
into fresh collection tubes, 50µl of RNase-free water was added directly into column and 
left for 2 min. Finally, the column was centrifuged at 10,000 x g for 1 min to elute total 
RNA. The quality and quantity of total RNA was analyzed using NanoDrop 
spectrophotometer and Agilent Bioanalyzer (Agilent, CA) with the RNA 6000 Nano 
chip kit (Agilent, CA). 
 
Primer design for quantitative Real Time PCR (qRT-PCR) 
Primers for qRT-PCR were designed, if possible, from two neighboring exons 
flanking an intron or from one exon using Primer 3 software (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi11). The product size of primers varied from 100 to 250 bp 
(Table 6) which is the ideal product range for qRT-PCR. The primers were first 
optimized in 10 µl volume PCR reactions containing 1X buffer (Sigma Aldrich), 0.3 
pmol of each primer, 0.2 mM dNTPs, 1.5 mM MgCl2 and 0.25 units JumpStart REDTaq 
DNA polymerase (Sigma Aldrich), and products were resolved on 2.0% agarose gels. 
Only the primers that amplified single products of the expected size and gave no extra 
bands or primer-dimers were used for qRT-PCR. 
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Table 6: Information about primers, reaction conditions and expected product sizes 
for qRT-PCR analysis of multicopy and testis specific ECAY genes. 
 
Gene Symbol qRT-PCR  primers 
5′ to 3′ 
Same as RT-
PCR 
primers 
 
Ta, °C qRT-PCR 
product size, bp 
ACTB 
Housekeeping 
control 
F: CCCAGATCATGTTTGAGACCT 
R: CCTCGTAGATGGGCACAGT 
Yes 58 144 
DDX3Y 
single copy 
control 
F:CTCGAGATCCAAAACTGCTG 
R:GCTGGTCTGGACCTGAACTC 
Yes 58 181 
ETSTY1 F:GACGGACGACCTTGTGTTTT 
R:CGCTCACAGATGACAGTAGCA 
No 58 165 
ETSTY2 F:AACCAGGAAGCCCAGTTACA 
R:GTTTGCCTCTTTGGATGAGC 
No 58 227 
ETSTY3 F:CCTAACCGACAGCCAAAGAG 
R:GCCCAAAGAAGTAACCGACA 
No 58 198 
ETSTY4 F:TAAGGCTTCCCTCCTCCAAT 
R:CCAGTGACCCGACATACTGA 
Yes 58 175 
ETSTY5 F:CGAGGTCAAAACCAAGAGGA 
R:CTCCAGAGGCAGGTACTTCG 
No 58 216 
ETSTY6 F:GCAGTAGGCAGTCGAAGGAA 
R:AATGGAAGAAGGGGCACAAT 
No 58 153 
GAPDH 
Housekeeping 
control 
F: CCTTCTCTTGCTGGGTGATTG 
R: GACAATGAATTTGGCTACAGCA 
Not used in 
RT 
58 103 
RBMY F:TTCGGCCTTCTCTTTCACAT 
R:ACTCAAGCAGCCGAAATGAT 
Yes 58 180 
TSPY F:GAAGTCAGGCACACCAGTGA 
R:TAAGGCTGCAGTTGTCATGC 
Yes 58 189 
UBE1Y F:TGGCCAACTCACGGCTGATCCAA 
R:CTTCTCCACTCACCCTACTTGGG 
Yes 58 210 
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Gene expression analysis using qRT-PCR 
The LightCycler® 480 DNA SYBR Green chemistry technique (Roche Applied 
Sciences, (Gibson et al. 1996; Heid et al. 1996) was utilized to analyze the expression 
profiles of testis-specific ECAY genes/ESTs in testis of normal and subfertile/infertile 
horses. Total RNA was directly reverse transcribed to cDNA using the TaqMan Reverse 
Transcriptase reagents (Applied Biosystems). Serial dilutions of pooled cDNA samples 
were used to generate relative standard curves and test the amplification efficiency of 
each primer. In addition to testis-specific genes of interest, one Y-linked X-degenerate 
gene (DDX3Y) and two autosomal house-keeping genes Beta Actin (ACTB) and 
Glyceraldehyde Phosphate Dehydrogenase (GAPDH) were used as references for qRT-
PCR. For each qRT-PCR assay a 20µl reaction containing ~100 ng of cDNA, 1x 
LightCycler® 480 DNA SYBR Green Master I Mix (Roche Applied Sciences) and 
10µM primers was amplified on a LightCycler® 480 Detection System (Roche Applied 
Sciences).  
 
qRT-PCR data analysis 
qRT-PCR raw data was initially analyzed using LightCycler® 480 v.1.2 software 
to generate standard curve, evaluate the efficiency of each primer pair and obtain 
maximum crossing point (Cp) values for all experimental samples. The software analysis 
of real-time PCR data is generally based on a method called "cycle-threshold" method. 
The cycle-threshold is defined as the fractional cycle number in the log-linear region of 
PCR amplification in which the reaction reaches fixed amounts of amplicon DNA. One 
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method for calculating the cycle threshold value is second derivative method which 
calculates the fractional cycle where the second derivative of the real-time fluorescence 
intensity curve reaches the Cp value (Luu-The et al. 2005; Guescini et al. 2008). The 
data obtained from LightCycler® 480 v.1.2 software were imported to qBase software 
and analyzed for relative quantitative expression of genes (Hellemans et al. 2007). p-
values to test the statistical significance of relative expression differences (fold 
induction) for each primer set were calculated using SPSS v.17 software at a cut-off 
threshold of p<0.05. 
 
Copy number analysis using qRT-PCR 
The primers designed for gene expression analysis by qRT-PCR (Table 6) were 
used also to analyze the genomic copy number of multicopy genes on a panel of 8 
normal and 12 infertile/subfertile stallions. First, primers for each gene were used to 
amplify from DNA of a normal fertile stallion. PCR products were directly cloned into 
TOPO-TA cloning vector and transformed into TOP-10 chemically competent E. coli 
cells (Procedure described in CHAPTER II). Plasmid DNA containing inserts of ECAY 
genes was isolated using QuickLyse Miniprep Kit (Qiagen) following manufacturer’s 
instructions. Standard curve was generated using serial dilutions of plasmid DNA of 
each gene as single copy control and efficiency values were calculated. Duplicate 
samples of 50 ng of genomic DNA from all 20 animals were used as templates for each 
Real Time copy number experiment. Each experiment was replicated at least twice. The 
standard curve generated for each transcript was used to calculate the concentration of 
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the genomic samples. Copy number of each gene per 3.65 pg of DNA (amount of DNA 
in a haploid cell) was calculated using a copy number calculation formula provided by 
Roche.  
 
Primer design for RACE  
Rapid Amplification of cDNA Ends (RACE) was performed using GeneRacerTA 
Kit (Invitrogen). For the 5′ end of each partial cDNA sequence, one 5′ reverse primer 
and one 5′ nested reverse primer were designed using Primer 3 software 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi11) in conjunction with 
GeneRacer 5′ forward primer and GeneRacer 5′ nested forward primer, respectively 
(provided with the kit) (Table 7). Similarly, for the 3′ end of each partial cDNA 
sequence, one 3′ forward primer and one 3′ nested forward primer were designed in 
conjunction with GeneRacer 3′ reverse primer and GeneRacer 3′ nested reverse primer, 
respectively (provided with the kit). In both cases, manufacturer’s instructions were 
taken into consideration while designing the primers. The nested primers had sequence 
overlap with the respective gene-specific primers to obtain more specificity of the genes 
subjected to RACE.  
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Table 7: Information about RACE primers.  
Primers 
 
Sequences 5′ to 3′ 
ETSTY1-RACE-5′R TCAGGGCCAAAAACACAAGGTCGTC 
ETSTY1-RACE-N-5′R AAAACACAAGGTCGTCCGTCCAC 
ETSTY1-RACE-3′’F CTTTCCAGATCTGCTCCGTGTGACT 
ETSTY1-RACE-N-3′F GATCTGCTCCGTGTGACTGGTGCTA 
ETSTY2-RACE-5′R GGAGGTGTGGTTACTCTCCTTGGGTTGA 
ETSTY2-RACE-N-5′R TGGTTACTCTCCTTGGGTTGAGTGC 
ETSTY2-RACE-3′F CAGCCCAAAGAAGTAACCGACACG 
ETSTY2-RACE-N-3′F CAGAAAGCCAAACCACAGCCTCTTC 
ETSTY3-RACE-5′R CCCGGGAAGGCTAACCGGAAACTAT 
ETSTY3-RACE-N-5′R CTCTGCCAAAGCTGACTGAGGAAAC 
ETSTY3-RACE-3′F ATGTGTAGGGCCAGTTGAACAGCAG 
ETSTY3-RACE-N-3′F CCAAAGAAAAACCCAGCCTCAGC 
ETSTY4-RACE-5′R GCTGTGGAGGTTATGGTTTGCCCTTG 
ETSTY4-RACE-N-5′R CGGTTTGGTTAGTTCGTGGAGGTT 
ETSTY4-RACE-3′F AACCGTACCTTCTGCAGCAACCAG 
ETSTY4-RACE-N-3′F AGGGAGCCTAGCCACAAACTGCAC 
ETSTY5-RACE-5′R TGCTCCAACTTGCCTCTCTTTTGCAG 
ETSTY5-RACE-N-5′R CTCTGCCTTTACGCATTCCCTCATAC 
ETSTY5-RACE-3′F AAGCTCACGGCATAACGGGCTAGTA 
ETSTY5-RACE-N-3′F CTGGAGGCGACGAAGTACCTCAGAA 
ETSTY6-RACE-5′R GGGTCCTGGGTCAGTTACCACAGAGG 
ETSTY6-RACE-N-5′R GCAGATGTAGTCTGGCTTCCTGGAT 
ETSTY6-RACE-3′F ATACAGACGTGCTCCCAGGCACTT 
ETSTY6-RACE-N-3′F AGGACACTGGTGGCCTTGGTCTCT 
TSPY-RACE-5′R TGGCTGACATCTGGGGGTGGTTCA 
TSPY-RACE-N-5′R TGGCTGACATCTGGGGGTGGTTCA 
TSPY-RACE-3′F GCAGCCGGAGACGGGACTGAGAGTAGG 
TSPY-RACE-N-3′F GCAGCCGGAGACGGGACTGAGAGTAGG 
RBMY-RACE-5′R GGGGGAGAGGCGTATATTGGCTTT 
RBMY-RACE-N-5′R CGATGTGAAAGAGAAGGCCGAAG 
RBMY-RACE-3′F CAGAGGGAGTGCTCGTGGTG 
RBMY-RACE-N-3′F  GCTCGTGGTGGTGGCGCACC 
GeneRacer™ 5′ Primer F CGACTGGAGCACGAGGACACTGA 
GeneRacer™ 5′ Nested 
(N)Primer F 
GGACACTGACATGGACTGAAGGAGTA 
GeneRacer™ 3′ Primer R GCTGTCAACGATACGCTACGTAACG 
GeneRacer™ 3′ Nested (N) 
Primer R 
CGCTACGTAACGGCATGACAGTG 
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Generation of full length cDNA using RACE  
To generate full length cDNA from a partial cDNA sequence, RACE was carried 
out separately for 3′ and 5′ ends. 3′ RACE was done using 3′ RACE primers and 
GeneRacer systems (Invitrogen) according to manufacturer's specifications. 
Approximately, 1 µg of total testis RNA was directly used for reverse transcriptase PCR 
for 3′ RACE. For 5′ RACE, 1 µg of total RNA was dephosphorylated, decapped and 
GeneRacer RNA oligo was ligated to the full length mRNA. The dephosphorylation of 
total RNA used for 5′ RACE helped to eliminate the truncated mRNA and non-mRNA 
from subsequent ligation with the GeneRacer oligo. However, full-length mRNA 
remained intact after dephosphorylation due to the presence of 7mG cap at the 5′ end. 
This 5′ cap was removed by pyrophosphatase keeping the full-length mRNA structure 
intact. This treatment also left available a 5′ phosphate that is required for the ligation to 
the GeneRacer RNA oligo (provided with the GeneRacer kit).  
After the modification of 5′ mRNA end, both 5′ and 3′ testis RNA were 
separately subjected to reverse transcription to synthesize cDNA as templete for RACE 
PCR using random primers for 5′ end and oligo dT primers for 3′ end reactions. The 5′ 
and 3′ RACE-ready cDNA were then used for RACE PCR amplification using gene-
specific primers (Table 7). The first-round PCR cycling conditions for RACE were: hot-
start at 94°C for 2 min; 5 cycles of 94°C for 30 sec, 72°C for 1 min; 5 cycles of 94°C for 
30 sec, 70°C for 1 min; 20 cycles of 94°C for 30 sec, 65°C for 30 sec and 68°C for 1 
min. A final extension of 10 min at 68°C completed the reaction. The PCR product 
obtained from the first round of amplification was diluted 10 times (1:10 dilution) and 1 
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µl of the dilution was used as a template for the second round of amplification (Nested 
RACE PCR) with nested primers. Nested RACE PCR was performed using the cycling 
conditions as follows: hot-start at 94°C for 2 min; 20 cycles of 94°C for 30 sec, 65°C for 
30 sec and 68°C for 2 min followed by a final extension of 10 min at 68°C. Products of 
nested RACE PCR were visualized on a 2% agarose gel. The bands were cut from gel 
and PCR products were eluted using S.N.A.P. columns provided with the kit. PCR 
products were thereafter cloned using TOPO TA Cloning Kit for Sequencing 
(Invitrogen). Transformed cells were plated on LB agar with 50 µg/ml ampicillin. 
Colonies were picked after an overnight incubation at 37°C and cultured overnight at 
37°C in LB medium with 50 µg/ml ampicillin. Plasmid DNA was extracted using either 
REAL Prep 96-well Kit (Qiagen), for large number of clones or QuickLyse Miniprep Kit 
(Qiagen), for a few number of clones depending on the number of clones to be analyzed 
at a time. Plasmid DNA was digested with EcoR1 and visualized on a 1% agarose gels. 
Plasmids containing appropriate size inserts were sequenced using universal primers as 
described in Chapter II. 
 
RESULTS 
 
Gene expression analysis by RT-PCR 
Reverse transcriptase PCR using primers for 34 ECAY genes and ESTs was 
carried out on nine equine body tissues. Primers for TBL1Y and STS-Y amplified both 
male and female genomic DNA and were not used for analysis. In total, 31 genes/ESTs 
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showed expression in one or more tissues while no expression was observed for ETY3, 
KAL1Y and AMELY. This explains why the latter two were not found from cDNA 
selection. Expression profiles could be divided into three distinct categories: i) ten 
multicopy genes/ESTs (ETSTY1-6, RBMY, TSPY, UBE1Y, ZNF33bY) were expressed 
only in testis (Fig. 8a); ii) six genes/ESTs (CUL4BY, ETY1, NLGN4Y, RFX5Y, SRY, 
YIR2) showed intermediate expression being expressed in testis and in a few other 
tissues; two genes in this group - YIR2 and SRY - were expressed predominantly in testis 
(Fig. 8b) and, iii) 15 genes/ESTs (CYorf15, DDX3Y, EIF1AY, EIF3CY, EIF2s3Y, ETY2, 
ETY4, MAP3K7IP3Y, MT-ND1Y, RPS3AY, KDM5D (alias SMCY), TMSB4Y, USP9Y, 
UTY, ZFY) were expressed in all nine tissues (Fig. 8c, Table 8). The 10 multicopy 
genes/ESTs showing testis-specific expression (Table 8) were considered as potential 
candidates for stallion fertility and were used for quantitative gene expression studies 
across a panel of testis RNA isolated from normal and infertile/subfertile stallions. 
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Table 8: Summary of the expression profiles of ECAY genes and ESTs. 
 
Gene Symbol Expression 
Pattern 
 
Expression in horse tissues 
 
Expression in 
human tissues 
Copy number 
AMELY No expression - Expressed in tooth 
enamel 
Single copy 
CUL4BY Intermediate Predominantly testis; limited in kidney, heart, spleen Not found in 
human 
Multicopy 
CYorf15 Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Ubiquitous Single copy 
DDX3Y 
 
Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Ubiquitous Single copy 
EIF1AY Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Ubiquitous Single copy 
EIF2s3Y Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Not found in 
human 
Single copy 
EIF3CY 
 
Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis n/a Single copy 
ETSTY1 Testis-specific Testis Not found in 
human 
Multicopy 
ETSTY2 Testis-specific Testis Not found in 
human 
Multicopy 
ETSTY3 Testis-specific Testis Not found in 
human 
Multicopy 
ETSTY4 Testis-specific Testis Not found in 
human 
Multicopy 
ETSTY5 Testis-specific Testis Not found in 
human 
Multicopy 
ETSTY6 Testis-specific Testis Not found in 
human 
Multicopy 
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Table 8 continued 
 
Gene Symbol Expression 
Pattern 
 
Expression in horse tissues 
 
Expression in 
human tissues 
Copy number 
ETY1 Intermediate Predominantly testis and liver, limited in brain, kidney, heart, lungs, spleen Not found in 
human 
Multicopy 
ETY2 Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Not found in 
human 
Single copy 
ETY3 No expression - Not found in 
human 
Multicopy 
ETY4 Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Not found in 
human 
Multicopy 
KAL1Y No expression - Pseudogene, not 
expressed 
Single copy 
KDM5D 
(SMCY) 
Ubiquitous Ubiquitous Ubiquitous Single copy 
MAP3K7IP3Y Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Not found in 
human 
Single copy 
MT-ND1Y Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Pseudogene, not 
expressed 
Single copy 
NLGN4Y Intermediate Testis, seminal vesicle, brain Testis, prostate, 
brain 
Single copy 
RBMY Testis-specific Testis Testis Multicopy 
RFX5Y Intermediate Testis, kidney, liver, spleen Expression data not 
available 
Single copy 
RPS3AY Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Expression data not 
available 
Single copy 
SRY Intermediate Predominantly testis; limited in kidney, seminal vesicle Predominantly 
testis 
Single copy 
STS-Y n/a n/a Not found in 
human 
Single copy 
TBL1Y n/a n/a Ubiquitous Single copy 
TMSB4Y Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Ubiquitous Single copy 
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Table 8 continued 
 
Gene Symbol Expression 
Pattern 
 
Expression in horse tissues 
 
Expression in 
human tissues 
Copy number 
TSPY Testis-specific Testis Testis Multicopy 
UBE1Y Testis-specific Testis Not found in 
human 
Multicopy 
USP9Y Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Ubiquitous Single copy 
UTY Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Ubiquitous Single copy 
YIR2 Intermediate Testis, heart; limited in kidney, liver, lungs, spleen n/a Multicopy 
ZFY Ubiquitous Brain, kidney, heart, skeletal muscle, liver, lung, seminal vesicle, testis Ubiquitous Single copy 
ZNF33bY Testis-specific Testis Expression data not 
available 
Multicopy 
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Figure 8: RT-PCR results showing the expression of ECAY genes in nine body tissues. Lanes 1-brain, 
2-kidney, 3-heart, 4-muscle, 5-liver, 6-lung, 7-spleen, 8-seminal vesicle, 9-testis, 10-no mRNA 
control, 11-no RT control, 12-no genomic DNA control, 13-male genomic DNA control, 14- female 
genomic DNA control, M-100 bp marker. a. Testis-specific expression. M: molecular markers. 
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b
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CUL4BY
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YIR2
 
 
Figure 8 (contd.) 
b. Intermediate expression; c. Ubiquitous expression. 
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Comparison of gene expression between fertile and subfertile/infertile stallions 
According to our hypothesis, transcripts with testis-limited expression and with 
multiple copies on the horse Y chromosome are potential candidates for stallion fertility. 
Therefore, all 10 multicopy and testis-specific ESTs, viz., ETSTY1-6, RBMY, TSPY, 
UBE1Y and ZNF33bY were selected for quantitative gene expression studies between 
normal and subfertile/infertile stallions. DDX3Y, a ubiquitously expressed single copy 
gene, and two autosomal reference genes, ACTB and GAPDH, were used as controls. All 
primers were first optimized by regular PCR on a genomic DNA template. All markers, 
except ZNF33bY, amplified one single PCR product of the expected size. Primers for 
ZNF33bY amplified multiple products and designing new set of primers for this gene did 
not change this pattern. Since the presence of a specific PCR product is extremely 
important for quantitative real time PCR using SYBR Green Chemistry, ZNF33bY was 
excluded from further study. Testis samples from 10 normal, fertile, unrelated stallions 
and 14 infertile/subfertile stallions were used for this study (Table 9). Total testis RNA 
from three normal stallions was pooled and reverse transcribed into cDNA. Sequential 
1:2 serial dilutions were used to obtain a range of template cDNA quantities (from 
200ng to 6.25ng) for qRT-PCR reactions to generate standard curves for each primer set. 
The standard curves produced amplification efficiency values for each primer set and 
were used for final calculations (discussed later). Optimal quantity of template cDNA 
was about 100 ng, thus, this amount of cDNA from each animal was used in duplicate 
reactions for qRT-PCR assays. 
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Table 9: Information about the samples used for gene expression analysis by qRT-PCR. 
 
Sample Id 
 
Category Breed Age Clinical description 
Normal 1 
 
Normal, fertile QuarterHorse  4 yr Normal 
Normal 2 
 
Normal, fertile QuarterHorse  4 yr Normal 
Normal 3 
 
Normal, fertile QuarterHorse  4 yr Normal 
Normal 4 
 
Normal, fertile Thoroughbred 4 yr Normal 
Normal 5 
 
Normal, fertile Gypsy Vanner  n/a Normal 
Normal 6 
 
Normal, fertile n/a n/a Normal 
Normal 7 
 
Normal, fertile n/a n/a Normal 
Normal 8 
 
Normal, fertile QuarterHorse  4 yr Normal 
Normal 9 
 
Normal, fertile QuarterHorse  2 yr Normal 
Normal 10 
 
Normal, fertile n/a 2 yr Normal 
Abnormal 1 Infertile/subfertile Arabian 
 
n/a Sterile. Normal sperm count but 97% of sperm morphologically abnormal (head 
abnormalities). Low motility. 
Abnormal 2 Infertile/subfertile QuarterHorse 
 
23 yr 
 
Sterile. Very small testes and very low sperm count. Low percentage of normal 
sperm. 
Abnormal 3 Infertile/subfertile Standardbred 3 yr Autosomal trisomy (65, XY+27). Sterile, azoospermia,  
bilateral cryptorchid. 
Abnormal 4 
 
Infertile/subfertile Connemara 7 yr Sterile, azoospermia.  
Abnormal 5 
 
Infertile/subfertile n/a n/a Bilateral cryptorchid. Both testes abdominal 
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Table 9 continued 
 
Sample Id 
 
Category Breed Age Clinical description 
Abnormal 6 
 
Infertile/subfertile n/a n/a Unilateral cryptorchid 
Abnormal 7 
 
Infertile/subfertile n/a n/a Unilateral cryptorchid 
Abnormal 8 
 
Infertile/subfertile n/a  n/a Unilateral cryptorchid 
Abnormal 9 
 
Infertile/subfertile n/a n/a Unilateral cryptorchid 
Abnormal 10 
 
Infertile/subfertile n/a n/a Bilateral cryptorchid. 
Abnormal 11 
 
Infertile/subfertile Appaloosa 2 yr Bilateral cryptorchid. Both testicles deeply abdominal, close to the kidneys.  
Abnormal 12 
 
Infertile/subfertile Mustang  6 yr Unilateral cryptorchid.  
Abnormal 13 
 
Infertile/subfertile QuarterHorse  1 yr Unilateral cryptorchid.  
Abnormal 14 
 
Infertile/subfertile Thoroughbred 19 yr Infertile due to impaired acrosomal exocytosis. 
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qRT-PCR assays with each set of primers were carried out on a panel of testis 
cDNA from 24 animals. All assays were repeated at least twice to verify the consistency 
of results. The cDNA from normal stallion number 2 (Normal 2, Table 9) was used as 
inter-run calibrator to eliminate plate-to-plate variation in cases where all samples could 
not be run in a single plate. After each experiment, Cp values for each sample were 
obtained using 2nd derivative max option within absolute quantification program of Light 
Cycler 480 software v. 1.2. After importing these data to the qBase software, relative 
quantification was done using ACTB and GAPDH as reference genes and the remaining 
10 genes as genes of interest. Efficiency values that were calculated for each gene earlier 
were taken into consideration while analyzing data in qBase. The results demonstrated 
that the reference genes, ACTB and GAPDH, and single copy DDX3Y were expressed at 
the same level in all animals (Fig. A2a, b), whereas all multicopy testis-specific genes 
showed differential expression between fertile and infertile stallions (Fig. A2c, d). In 
summary, ETSTY1, ETSTY5, TSPY and UBE1Y were upregulated in infertile individuals 
while all other genes demonstrated downregulation. This result was further analyzed for 
statistical significance using SPSS v. 17 software. p-values were calculated with Mann 
Whitney non- parametric test which is specifically designed for sample numbers less 
than 15 in each group (10 fertile and 14 infertile individuals). Five ESTs viz., ETSTY3-6 
and RBMY showed statistically significant differential expression between fertile and 
infertile groups with cut-off p-value 0.05 (95% level of confidence) (Fig. 9).  
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   Figure 9: qRT-PCR results showing differential expression of ECAY genes between normal fertile stallions and stallions     
   with fertility problems; * p value < 0.05, statistically significant (Mann Whitney non-parametric test). 
 
  
117 
Notably, ETSTY5 was significantly upregulated in infertile individuals while 
ETSTY3, 4, 6 and RBMY were significantly downregulated. Since the 14 “abnormal” 
samples were collected from stallions with a broad range of different 
infertility/subfertility phenotypes there was variation in the expression levels of the same 
genes across these individuals. For example, ETSTY1 was downregulated in seven and 
upregulated in the remaining seven infertile stallions. Interestingly, out of the seven 
stallions where ETSTY1 was downregulated, six animals were cryptorchids whereas in 
three other cryptorchids ETSTY1 was slightly upregulated (Fig. A2c). 
 
Copy number analysis by qRT-PCR 
Copy numbers for nine testis-specific multicopy genes/ESTs (ETSTY1-6, TSPY, 
RBMY, UBE1Y) were analyzed using Real Time PCR absolute quantification method 
and a panel of genomic DNA from 8 normal stallions and 12 stallions with fertility 
problems. After obtaining individual copy numbers of each animal, the average copy 
numbers of each gene across fertile and infertile/subfertile stallions (Table 10) was 
compared. The average copy numbers of the nine multicopy ECAY genes in fertile and 
infertile/subfertile stallions are summarized in Table 10 and Fig. 10. Overall, average 
copy numbers of all studied genes showed a tendency to decrease in infertile animals. 
For four ESTs, viz., ETSTY2, ETSTY6, RBMY and UBE1Y this decrease was statistically 
significant (SPSS v.17, MannWhitney non parametric test for unrelated samples). Genes 
with the highest copy numbers in both normal and abnormal animals were RBMY and 
UBE1Y (Table 10). It is, however, intriguing that during cDNA selection procedure only 
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one transcript was isolated for RBMY, while 54 cDNA clones contained UBE1Y 
(discussed in Chapter II).  
 
 
Table 10: Results of copy number analysis of multicopy ECAY genes/ESTs. 
 
Average copy number Gene 
 Normal fertile 
stallions 
Subfertile/ infertile 
stallions 
Copy number change in 
subfertile/infertile stallions 
 
ETSTY1 29 24 decrease 
ETSTY2 6 2 decrease * 
ETSTY3 22 14 decrease 
ETSTY4 39 33 decrease 
ETSTY5 2 1 decrease 
ETSTY6 2 1 decrease* 
TSPY 49 32 decrease 
RBMY 393 155 decrease* 
UBE1Y 321 205 decrease* 
 
* statistically significant change (SPSS v.17, MannWhitney non parametric test for 
unrelated samples) 
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                        Figure 10: Summary of copy number variation of ECAY genes between normal stallions and stallions  
                        with fertility problems; * p value < 0.05, statistically significant (Mann Whitney non-parametric test).
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Generation of full length cDNA 
Full length cDNA sequences were generated for three testis-specific transcripts - 
TSPY, ETSTY2 and ETSTY5 using 5′ and 3′ RACE PCR. The available partial cDNA 
sequences were used to generate sequences for the 5′ and the 3′ ends. The cDNA RACE 
PCR products for both ends were gel purified, cloned into plasmid and sequenced. The 
sequences were quality trimmed, aligned with the original cDNA sequence using 
Sequencher v1.7. The full length cDNA sequences obtained for the three genes were as 
follows: TSPY 1079 bp, ETSTY2 is 2323 bp and ETSTY5 is 1635 bp. The size of the 
horse TSPY cDNA is similar to that of human TSPY1 which is 1159 bp and the two 
sequences show 79% identity with an e-value of 6e-97. 
Y-specific RACE primers could not be designed for horse UBE1Y because its 
sequence is highly similar to UBE1X on the X chromosome. Due to the uncertainty of 
RACE-PCR procedure, full length cDNAs could not be obtained for the remaining testis 
specific transcripts. However, for some transcripts the lengths of partial cDNA 
sequences were increased as follows: ETSTY1 448 bp, ETSTY3 2591 bp, ETSTY4 2452 
bp, ETSTY6 1066 bp, RBMY 712 bp, UBE1Y 2924 bp and ZNF33bY 3602 bp. 
 
Analysis of novel equine Y sequences 
Sequences of the ten novel equine Y-specific multicopy ESTs were aligned with 
each other using Sequencher V1.7 and assembly parameters 20 for minimum overlap 
and 90% for minimum match. None of the ten ESTs showed any overlap with each 
other. However, when assembly parameters were relaxed to 10 for minimum overlap and 
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75% for minimum match, ETSTY2, ETSTY3 and ETSTY6 demonstrated substantial 
alignment identity with each other. Similarly, when the same three sequences were 
aligned in pairs using BLAST tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi9), short 
stretches of sequences showed 75-90% identity. The remaining three sequences, 
however, did not align even at the least stringent assembly parameters and are unique to 
each transcript. 
 
Presence of open reading frames (ORFs) and evaluation of protein coding ability 
The presence of open reading frames was analyzed for all three ESTs for which 
full length cDNA sequences were obtained. TSPY cDNA has eight ORFs of which the 
longest is 807 nucleotides. The remaining seven ORFs are present at different 
overlapping regions of the longest ORF and are 693 bp, 375 bp, 366 bp, 342 bp, 330 bp, 
276 bp and 237 bp, respectively. All seven ORFs, except the shortest, encode TSPY 
protein of 269, 231, 125, 122, 114, 110 and 92 amino acids, respectively. BLASTP 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi9) analysis showed that horse TSPY protein is 
highly similar to TSPY proteins in human and several other mammals. However, the 79 
amino acid protein encoded by the shortest equine ORF did not show any significant 
similarity to TSPY proteins in other species. Using NCBI conserved domain database 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi17) a conserved domain, NAP 
(nucleosome assembly protein) was identified in horse TSPY protein. This domain is 
conserved in different mammalian TSPY proteins, including human, and is important for 
a diverse spectrum of cellular and molecular functions.  
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Two non-overlapping ORFs (348 bp and 333 bp) were found in ETSTY2 and 
three non overlapping ORFs (219 bp, 381 bp and 180 bp) in ETSTY5. ETSTY2 can 
potentilly encode two proteins consisting of 116 and 111 amino acids and ETSTY5 for 
three proteins with 73, 127 and 60 amino acids, respectively. No conserved domains 
were identified for ETSTY2 and ETSTY5 full length transcripts using NCBI conserved 
domain database search (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi17). ORF 
analysis with other novel partial cDNA sequences revealed the presence of non-
overlapping ORFs in ETSTY3 (255 bp and 159 bp), ETSTY4 (237 bp), ETSTY6 (153 bp, 
165 bp and 159 bp), ETY1 (288 bp and 276 bp) and ETY4 (123 bp and 129 bp). Each 
ORF can potentially code for proteins consisting of 85, 53 (ETSTY3), 79 (ETSTY4), 51, 
55, 53 (ETSTY6), 96, 92 (ETY1), 41 and 43 (ETY4) amino acids, respectively. None of 
these amino acid sequences showed homology with existing non-redundant protein 
sequences and reference sequence databases using NCBI protein BLAST (BLASTP) 
algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi9). This supports our assumption that 
these are horse-specific expressed sequences and have no counterparts in other 
mammalian species. 
 
DISCUSSION 
 
Expression analysis of equine Y-chromosome genes 
Reverse transcriptase PCR identified 10 ECAY transcripts (ETSTY1-6, RBMY, 
TSPY, UBE1Y, ZNF33bY) that are expressed only in testis. All 10 transcripts are present 
  
123 
in multiple copies on equine Y chromosome. This is in agreement with findings in 
human, mouse and cat where multicopy Y-linked genes also tend to be expressed only in 
testis (Skaletsky et al. 2003; Murphy et al. 2006; Pearks Wilkerson et al. 2008). Besides 
these similarities, there are also lineage-specific differences. For example, RBMY is a 
multicopy and testis-specific gene in horse, human and mouse while TSPY is a 
multicopy and testis-specific gene in horse, human and cat but a single copy in mouse 
(Schubert et al. 2000a; Schubert et al. 2000b; Skaletsky et al. 2003; Murphy et al. 2006). 
UBE1Y is a single copy and intermediately expressed gene in cat (Murphy et al. 2006), 
whereas the single copy murine UBE1Y is expressed exclusively in testis (Mitchell et al. 
1991). In contrast, horse UBE1Y is present in multiple copies and like its murine 
ortholog, has testis limited expression (Fig. 8a). It is likely that horse Y-linked ubiquitin-
activating enzyme has acquired functions that are restricted to ubiquitin activation and 
protein turnover (Levy et al. 2000) specific to germ cell proliferation and is, thus, a part 
of factors regulating stallion fertility. Notably, this gene has been lost from the Y 
chromosome in human lineage (Lahn et al. 2001; Skaletsky et al. 2003). Finally, 
ZNF33b is an autosomal gene in human and other mammals, including horse, but has 
acquired multiple copies and testis-limited expression in the horse Y chromosome. 
However, ZNF33bY demonstrated the presence of multiple bands in horse testis (Fig. 
8a). This observation suggests that ZNF33bY might be a member of a multicopy gene 
family rather than being a single gene on the horse Y chromosome. The function of this 
gene is as yet unknown.  
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Six ECAY genes and ESTs (CUL4BY, ETY1, NLGN4Y, RFX5Y, SRY, YIR2) 
showed intermediate expression pattern. Until now, CUL4BY has been found to be Y-
linked only in cat and dog where it is highly amplified and has testis-limited expression 
(Murphy et al. 2006; Pearks Wilkerson et al. 2008). Horse CUL4BY is also multicopy 
but has a broader expression profile (Table 8). It is possible that equine CUL4BY is in a 
transitional stage from ubiquitous towards testis-restricted expression – a transition from 
its original housekeeping duties to spermatogenesis-related functions. NLGN4Y shows 
intermediate expression pattern in all species studied so far (mouse, human, cat and 
horse) and is expressed in reproductive tissues (testis, seminal vesicle, prostate) and 
brain (Skaletsky et al. 2003). RFX5Y is an autosomal gene in other mammals and has 
acquired a Y-linked copy only in horse. YIR2 is present in human Y chromosome but its 
expression data is not known. However, SRY - the male sex-determining region on Y 
seems to be the most interesting intermediately expressed gene. It plays the key role in 
male sex determination and is expected to be functional at early stages of embryonic 
development in mammals (Wilhelm et al. 2007b). High levels of SRY transcription in 
adult horse testis and to a lesser extent in a few other adult tissues (Table 8) indicates 
that SRY is functional in adult horses as well. It is likely that SRY has acquired some new 
functions in adult horse testis. Given its high expression level in testis compared to other 
tissues, it is possible that SRY is involved in spermatogenesis or some other male fertility 
related functions. 
The functions of the 15 ubiquitously expressed genes, viz., CYorf15, DDX3Y, 
EIF1AY, EIF3CY, EIF2s3Y, ETY2, ETY4, MAP3K7IP3Y, MT-ND1Y, RPS3AY, KDM5D 
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(alias SMCY), TMSB4Y, USP9Y, UTY and ZFY are not clear but the expression profile 
suggests that many of them might be involved in housekeeping activities. However, a 
few of these genes, viz., DDX3Y and USP9Y are located in human AZFa region which is 
one of the critical regions for spermatogenesis (Vogt et al. 1996; Skaletsky et al. 2003). 
Deletions in AZFa cause Sertoli cell only (SCO) syndrome and affect RNA metabolism 
of human spermatogenesis (Ditton et al. 2004). Decreased transcriptional activity of 
testicular DDX3Y is associated with severe spermatogenic failure and sperm maturation 
arrest in humans (Lardone et al. 2007b). In contrast, the role of murine Ddx3y in 
spermatogenesis is not so prominent and it is proposed that biological activity of Ddx3y 
might be taken over by its X-linked and autosomal homologs, Dbx and D1Pas1, 
respectively (Vong et al. 2006). USP9Y is another human AZFa gene and recent studies 
suggest that it acts as a fine tuner to improve the efficiency of male fertility related 
function but is not directly involved in spermatogenesis and sperm maturation (Krausz et 
al. 2006). This is supported by another recent study that reported a complete deletion of 
USP9Y in a normospermic, fertile man (Luddi et al. 2009). However, murine Usp9y gene 
encodes a potentially functional ubiquitin-specific protease possessing a core promoter 
region that shares several features characteristic to other testis-specific genes and thus 
might be involved in important male fertility functions (Hall et al. 2003). More 
specialized functions than housekeeping have been attributed also to KDM5D (alias 
SMCY). In mouse it is expressed in male meiosis from leptotene spermatocytes to 
spermatids and might be essential for the progression of spermatogenesis (Akimoto et al. 
2008). Possible fertility related functions of the remaining ubiquitously expressed genes 
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are not known yet but it is likely that at least some of them have roles beyond strictly 
housekeeping activities. 
Male-specific BAC clones containing TBL1Y and STS-Y were initially isolated 
using radiation hybrid mapping primers for their X-linked gametologs TBL1X and STS-
X, respectively (Raudsepp et al. 2004a). Since the BACs containing the two genes FISH 
mapped to ECAY only, they were incorporated in the ECAY contig map (Fig. 6). 
However, because of high degree of sequence similarity between the X- and Y-linked 
gametologs of TBL1 and STS we have not been able to design specific primers for 
TBL1Y and STS-Y, and therefore the two genes were excluded from expression analysis.  
 
Primary candidate genes for stallion fertility 
The ultimate goal of these Y-chromosome studies in horses is to identify markers 
and regions which are most critical for stallion fertility. The collection of genes and 
ESTs isolated in this study provides an important foundation to initiate systematic search 
for Y-linked mutations that might lead to male infertility in horses. Valuable clues about 
likely candidate genes can be found from human and mouse studies where the link 
between Y chromosome mutations and male infertility is well established (Ellis and 
Affara 2006; Ellis et al. 2007; Lange et al. 2008). Although a few single-copy Y-linked 
genes might be involved in spermatogenesis in human and/or mouse, studies indicate 
that mutations in testis-specific and multicopy transcripts are primarily associated with 
impaired spermatogenesis and male fertility. Therefore, all multicopy and testis specific 
ECAY transcripts have been chosen as the primary candidates (Fig. 8a, Table 8) to start 
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analysis with. These sequences might share functional similarity with human AZFb and 
AZFc – regions critically involved in human male infertility (Saxena et al. 1996; Saxena 
et al. 2000; Ferlin et al. 2003; Skaletsky et al. 2003). 
 
Quantitative expression analysis of primary candidate genes 
Expression levels of nine testis-specific, multicopy genes, viz., ETSTY1-6, TSPY, 
RBMY, UBE1Y were evaluated to identify their potential involvement in stallion fertility. 
Five ESTs (ETSTY3-6, RBMY) showed statistically significant differential expression 
between fertile and infertile/subfertile stallions. ETSTY5 was upregulated in all 
infertile/subfertile individuals depicting that this transcript might be related to impaired 
spermatogenesis in horses. The remaining four transcripts (ETSTY3-4, ETSTY6 and 
RBMY) were downregulated in infertile/subfertile individuals. RBMY is known to play 
an important role in human and mouse spermatogenesis (Elliott et al. 1996; Elliott et al. 
1997; Elliott et al. 1998; Kostiner et al. 1998; Affara and Mitchell 2000). Mice deficient 
in Rbmy develop abnormal sperm and are infertile (Szot et al. 2003). Downregulation of 
RBMY in stallions with fertility problems indicates that this gene might have similar 
functions also in horses. The three equine specific transcripts, viz., ETSTY3-4 and 
ETSTY6 share no homology with other mammalian genes/ESTs and there is no 
comparative information about their possible functions. However, being equine-specific, 
multicopy, testis-limited, and downregulated in infertile/subfertile stallions, make 
ETSTY3, ETSTY4 and ETSTY6 strong candidate genes for stallion fertility. 
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Four genes and ESTs (ETSTY1-2, TSPY, UBE1Y) did not show statistically 
significant differential expression between the fertile and infertile/subfertile groups of 
stallions but showed up-or downregulation in one or two individual animals. For 
example, TSPY was strongly overexpressed in only one infertile stallion but expressed at 
the same level in the remaining infertile animals and all normal controls. The stallion 
with elevated TSPY expression had a unique infertile phenotype which was not found in 
any other animals studied. The stallion had normal sperm count but reduced sperm 
motility, and 97% of his sperm were morphologically abnormal. It is therefore likely, 
that TSPY is involved in the processes that are responsible for sperm structural integrity 
and motility. It can be anticipated that if more individuals with sperm structural 
abnormalities could be analyzed, differential expression of TSPY might reach 
statistically significant values. Inclusion of more animals and more diverse infertile 
phenotypes into analysis might give significant values also to the differential expression 
profiles of ETSTY1, ETSTY2 and UBE1Y and indicate what kind of role they might have 
in stallion spermatogenesis. 
Because of the contrasting role of DDX3Y in human and mouse spermatogenesis 
(discussed above), this gene was chosen as our X-degenerate, ubiquitously expressed Y-
linked control for expression analysis. DDX3Y did not show any statistically significant 
differential expression between fertile and infertile/subfertile individuals and at this 
stage of research this gene is therefore not considered as a potential candidate for stallion 
fertility. This observation complies with mouse studies where DDX3Y  transcript does 
not show any association with spermatogenesis (Vong et al. 2006). 
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Finally, we observed individual differences in the expression levels of the same 
gene within the group of normal animals and within the group of stallions with fertility 
problems. Given that male fertility is governed by thousands of genes, it is likely that 
there are additional factors that modulate the expression of the Y-linked genes analyzed 
in this study. 
 
Effect of copy number variation on gene expression levels and male infertility 
The expression and copy number data obtained from qRT-PCR analysis allowed 
to investigate whether differential expression of a gene is correlated with its copy 
numbers and whether gene expression and copy numbers are correlated with a 
reproductive phenotype. It appeared that out of the four genes/ESTs (ETSTY2, ETSTY6, 
RBMY and UBE1Y) that demonstrated significant decrease in average copy number in 
infertile/subfertile stallions, three genes (ETSTY6, ETSTY2 and RBMY) were also 
downregulated in these individuals. Notably, downregulation of ETSTY6 and RBMY was 
statistically significant (Fig. 9). Therefore, the lower transcriptional level of the three 
genes is likely caused by decreased average copy number. In contrast, there was negative 
correlation between UBE1Y copy numbers and transcription level – in infertile/subfertile 
stallions UBE1Y has less copies but its transcription is upregulated. It is possible that 
elevated transcription compensates for the loss of UBE1Y copies, or alternatively, loss of 
copies in stallions with fertility problems is associated with a regulatory mutation which 
increases the transcriptional level of this gene. 
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It is worth to mention that the stallion with sperm morphological abnormalities 
and elevated levels of TSPY transcription (abnormal 1 Table 8, discussed in Chapter III) 
showed decrease in TSPY average copy numbers. The mechanism of such negative 
correlation between TSPY transcription and copy numbers and causes of sperm 
morphological abnormalities remain currently unclear but provide material for future 
studies.  
 
Full length cDNA sequences: structure in relation to function 
Full length cDNA sequences were obtained for three multicopy, testis-specific 
genes/ESTs: TSPY and two novel Y-linked transcripts, viz., ETSTY2 and ETSTY5. 
TSPY is an evolutionarily conserved gene on the Y chromosome of all placental 
mammals, except mouse (Vogel et al. 1997a; Vogel et al. 1997b). The full-length cDNA 
sequence of equine TSPY showed the presence of a NAP domain which is conserved 
across all known mammalian TSPY proteins. Humans have three different polymorphic 
TSPY proteins and each contains a conserved NAP domain of ~160 amino acids (Lau et 
al. 2003). NAP domain binds to Beta Cyclins and core histone proteins and plays role in 
DNA replication, cell cycle regulation, transcription and chromatin remodeling (Nagata 
et al. 1995; Compagnone et al. 2000; Chai et al. 2001; Zhang et al. 2001; Canela et al. 
2003). Mutations or dysregulation in the members of NAP gene family have been 
associated with various forms of human cancers (Chai et al. 2001). In normal individuals 
TSPY directs the spermatogonial cells to enter meiosis (Schnieders et al. 1996; Lau 
1999) and might have an additional mitotic function in the proliferation of embryonic 
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gonocytes and adult spermatogonia (Honecker et al. 2004). Consequently, the improper 
proliferation of spermatogonial cells might affect sperm production and thus, male 
fertility. Results of this study show high degree of structural similarity between the full 
length cDNA sequences of human and horse TSPY genes. Despite the fact that we were 
not able to detect statistically significant differential expression of TSPY between normal 
and reproductively challenged stallions, it could be expected that TSPY plays important 
role in germ cell proliferation also in horses. Furthermore, overexpression of TSPY in 
one infertile stallion with sperm morphological defects (see above) indicates that the 
function of TSPY might be more complex than recognized today. 
Full length cDNA and the corresponding protein sequences of ETSTY2 and 
ETSTY5 are novel and equine specific and share no significant similarity with other 
known mammalian sequences. Therefore no comparative analysis of the two ESTs could 
be done. 
 
Novel ECAY sequences 
cDNA selection studies identified 10 novel horse-specific Y-linked transcripts. 
Six of these (ETSTY1-6) were expressed only in testis, one (ETY1) showed intermediate 
expression pattern, two (ETY2, ETY4) were expressed ubiquitously, whereas ETY3 did 
not show any expression in the panel of nine normal adult body tissues. ESTs ETSTY1-6 
were used for further studies as potential candidate genes for stallion fertility due to their 
multicopy nature and testis-specific expression. Four of these transcripts (ETSTY3-6) 
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demonstrated differential expression between fertile and infertile/subfertile individuals 
and are considered as strong candidate genes for stallion fertility. 
The Y-linked novel transcripts are shown to be associated with spermatogenesis 
and other male fertility related function in human and mouse. For example, human DAZ 
(Deleted in Azoospermia) is a novel Y-linked gene cluster. Complete deletion of DAZ 
causes azoospermia (Yen et al. 1997), while  three different patterns of partial DAZ 
deletions are associated with severe oligozoospermia and infertility (A et al. 2006). DAZ 
gene transcripts are shown to be localized in primary spermatocytes and DAZ gene 
activity seems to correspond to the proliferative activity of stem cells of germinal 
epithelium in patients with spermatogenic arrest (Szczerba et al. 2006). These findings 
strongly support the association of novel Y-linked genes (DAZ cluster) with 
spermatogenesis and thus, male fertility in human. Murine Sly (Sycp3-like Y-linked) is a 
novel multicopy gene on MMUY, is abundantly expressed in mouse spermatids and 
deletion of this gene may contribute to the abnormal sperm head development (Toure et 
al. 2005). Sly may also have a role in the development of acrosome and the regulation of 
gene expression in spermatids. Sly deletions lead to spermatogenic defects and male 
infertility in mouse (Reynard et al. 2009). Moreover, recent studies identified two novel 
Y genes in mouse, AK006152 and H2al2y. Both are expressed specifically in spermatids 
indicating their role in mid to late spermatid development. Overexpression of these novel 
MMUY genes can potentially cause abnormal sperm head development and hence 
contribute to male infertility (Ferguson et al. 2009). To date, three multicopy novel 
genes (FLJ36031Ya, TETY1 and TETY2) have been identified in cat Y chromosome 
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(Murphy et al. 2006). All three are expressed exclusively in cat testis and though the 
function of these genes is not yet clear, their testis-specific expression and multicopy 
nature indicates likely involvement in feline male fertility.  
Findings in human, mouse and cat strongly suggest that novel, testis-specific 
genes in the horse Y chromosome (e. g., ETSTY1-6) also carry out important male 
fertility related functions. However, molecular details and genetic mechanisms of these 
functions remain topics for future studies. Partial sequence similarity between ETSTY2, 
ETSTY3 and ETSTY6 questions the uniqueness of these sequences – do they represent 
different regions of the same gene or are they transcripts of different genes. Based on 
sequence analysis using Sequencher V1.7 software we infer that the three sequences are 
not parts of a single transcript because at higher stringency parameters (90% and 20 
nucleotides) there is no alignment between them. However, sequence similarity at lower 
stringency (<70% and 10 nucleotides) suggests that ETSTY2, ETSTY3 and ETSTY6 
might be members of the same gene family. This is in agreement with the results of STS 
content analysis showing that ETSTY2 and ETSTY3 map to the same BAC clones in the 
multiocopy region in the distal part of Contig1 (Fig. A1). However, ETSTY6 maps to 
different BAC clones and is located in the heterochromatic region which is several 
megabases proximal to the multicopy region. It is anticipated that generation of full- 
length cDNA sequences for these transcripts or complete sequencing of the horse MSY 
will resolve the relationships between the three sequences. Otherwise, the presence of 
gene families is a typical feature of the mammalian Y chromosome. For example, human 
TSPY gene family contains a cluster of genes: TSPY1, TSPY2, TSPY3 and TSPYL (TSPY- 
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Like) which are not identical but share some sequence homology with each other and 
most likely carry out similar functions. The presence of novel, species-specific and male 
fertility related gene families, like DAZ in humans (Skaletsky et al. 2003) and Sly in 
mouse (Reynard et al. 2009), seems to be a characteristic feature of Y chromosomes. 
Our findings comply with these facts and show that such novel gene families are present 
also on the horse Y chromosome. 
This study demonstrates the discovery and analysis of potential Y-linked 
candidate genes for male fertility in horses. First, transcriptional analysis of all Y-linked 
genes on a panel of body tissues identified those genes that are expressed specifically in 
testis. Next, qRT-PCR studies showed that some of these genes are differentially 
expressed in normal stallions compared to stallions with fertility problems. Gene copy 
number analysis showed that there is a correlation between gene expression level and 
copy numbers and that is associated with stallion fertility. Finally, full-length, nearly full 
length or partial cDNA sequences were obtained for several multicopy testis-specific 
transcripts and analyzed for their protein coding abilities. Taken together, besides human 
and mouse this is the first systematic search for Y-linked male fertility genes in 
mammals and the first of its kind in domestic species. 
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CHAPTER IV 
 
 
CONCLUSIONS AND FUTURE WORK 
 
 
CONCLUSIONS  
This research represents the first systematic discovery, mapping and functional 
analysis of Y chromosome genes and ESTs in the horse. Although high-, medium- or 
low-resolution Y chromosome maps are available for a number of mammalian species, 
viz., human (Skaletsky et al. 2003), mouse (Mazeyrat et al. 1998), chimpanzee (Hughes 
et al. 2005; Kuroki et al. 2006), cattle (Liu et al. 2002), pig (Quilter et al. 2002), cat 
(Murphy et al. 1999a; Murphy et al. 2006; Pearks Wilkerson et al. 2008) and dog 
(Guyon et al. 2003a; Guyon et al. 2003b), direct association between Y-linked genes and 
male fertility has been shown so far only in humans and mice (Elliott et al. 1998; Matzuk 
and Lamb 2002; Skaletsky et al. 2003; Delbridge et al. 2004; Szczerba et al. 2006; 
Carrell 2008; Matzuk and Lamb 2008). Therefore, the present study is the first where the 
expression profiles, transcription levels and copy numbers of Y-linked genes have been 
related to male fertility in a species other than human and mouse. Given that stallion 
fertility is an important concern for the horse industry, the importance of the present 
findings cannot be underestimated. Although the research has focused on only a small 
fraction of the equine genome, it is an essential contribution to our understanding about 
the genetic component of male fertility in horses. Besides, detailed knowledge about the 
organization, gene content and functional profiles of the horse Y chromosome provides 
critical comparative information about the evolution of the sex chromosomes in 
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mammals. Finally, the high-resolution contig map of equine MSY is a foundation for 
complete sequencing of the horse Y chromosome – thus adding missing data to the 
female-based horse whole-genome-sequencing project. 
 
FUTURE WORK 
The comprehensive map of horse MSY presented in this study and the detailed 
map of the pseudoautosomal region (PAR), (Raudsepp and Chowdhary 2008) provide 
valuable resource for clone-based complete sequencing of the horse Y chromosome. 
Furthermore, the 197 BAC clones and 318 linearly ordered genes and STS markers in 
the contig map will serve as important landmarks for sequence assembly. Such 
landmarks are particularly essential for assembling Y chromosome sequences which are 
known to contain gene families, repetitive sequences, segmental duplications and 
palindromes (Skaletsky et al. 2003). 
Complete sequencing of ECAY euchromatic region will aid the discovery of new 
Y-linked genes and will provide detailed information about the organization of the 
known genes. Knowledge about gene structure is necessary to identify regulatory 
elements, evaluate protein coding abilities and relate the structure to potential functions 
of these genes. Complete sequence data will also be instrumental for determining precise 
copy numbers of ECAY genes, identifying members of gene families and discovering 
copy number variations between individuals – both within normal population and 
between fertile and reproductively abnormal animals. Identification of minor sequence 
differences between individual copies of multicopy sequences will provide tools to 
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determine by PCR Y chromosome microdeletions or other rearrangements in the 
multicopy region of ECAY. 
It is equally important to continue and expand the collection of samples (tissue, 
RNA, DNA) from stallions with a broad range of subfertile/infertile phenotypes. Only 
this way it will be possible to find out, for example, whether equine TSPY is indeed 
associated with sperm structural integrity or which Y-linked genes cause azoospermia 
and how. Larger number of samples is needed also to understand the role of other Y-
linked genes - those which are not multicopy, testis-specific and novel. For example, it is 
not clear what kind of fertility related functions, if any, are carried out by X-degenerate 
genes or the genes that have been recruited to the Y chromosome from mitochondrial 
genome or autosomes. 
The collection of ECAY genes, ESTs and STSs identified in this study will be a 
small but unique addition to equine whole genome analysis tools. Genes and ESTs will 
add Y-chromosome component to the gene expression arrays. The currently available 
platforms - the Texas A&M 21,000 element oligoarray (Chowdhary unpublished) and 
the Affymetrix 12,000 element oligonucleotide GeneChip (Nixon et al. 2008) - do not 
contain any expressed sequences from the Y chromosome. Sequences of Y-linked genes 
and ESTs will also be essential for the construction of custom-made specialized 
oligoarrays to study differential expression of sex and reproduction related (SRR) genes 
in horses and identify key-role male fertility genes genome-wide. Finally, with the horse 
genome sequenced and draft assembly available, it is anticipated that like in other 
species, whole genome tiling arrays will soon be constructed also for the horse. Y 
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chromosome sequences will, thus, be an important addition to the otherwise female-
based genomic sequence data. 
ECAY multicopy genes and variations in their copy numbers between normal 
individuals and between different fertility phenotypes is of particular interest. Recent 
studies in human and mouse demonstrate that genes present in regions of copy number 
variations (CVNs) are expressed in lower and in a more variable fashion than genes 
mapped elsewhere in the genome and can have a global influence on the transcriptome 
(Henrichsen et al. 2009). It has been proposed that copy number changes might influence 
gene expression through the perturbation of transcript structure (Reymond et al. 2007). 
CNVs have also been associated with various diseases or disease susceptibility 
phenotypes (Breunis et al. 2008; Hollox et al. 2008). It will, thus, be interesting to find 
out to which extent these properties of global CVNs apply to the multicopy 
genes/sequences in the horse Y chromosome.  
Taken together, the findings of this study add new and important information to 
the current understanding of the genetic component of stallion and mammalian male 
fertility. Identification and characterization of a number of potential male fertility genes 
takes us a step closer to the ultimate goal of the genetics of stallion fertility– identify 
key-role genes, causative mutations and develop molecular diagnostic tests for early 
detection of subfertile/infertile individuals, so that owners and breeders can make 
informed decisions. 
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APPENDIX  
 
 
Table A1: Detailed information about horse MSY BAC end sequence (BES) analysis. 
 
BES GenBank 
Acc. No.  
Size, bp GC% BLAST significant 
similarity (<E-10) to 
known genes 
Microsatellites Other repeats 
002E4-SP6 CT864643 701 32.4     LINE1 
002E4-T7 CT864644 714 36.1   (AC)16, (AT)11 LTR/ERV1, simple repeat, SINE 
003.4H8-M13   880 46.1     no repeats 
003.4H8-T7   979 43.9     LINE1 
003A5-SP6 CT825159 631 39.1     SINE 
003A5-T7 CT825160 706 43.2     MER34C, LTR/ERV1 
005.2A8-M13   889 39.1     DNA/MER1_type, 
DNA/AcHobo, LINE1 
005.2A8-T7  878 45.9     LTR/ERVL 
006B10-SP6 CT827035 387 43.7     no repeats 
006B10-T7 CT826936 1031 38.3     DNA/MER2 
008.3G9-M13   632 41.8     no repeats 
008.3G9-T7   758 39.1     SINE 
011B8-SP6 CT840125 749 37.9   (CT)3 CC (CT)1 CC 
(CT)7 
Simple repeat, LTR/MaLR 
011B8-T7 CT840126 769 36.4     no repeats 
012.2E5-M13   716 31.4     DNA/MER2 
012.2E5-T7   281 42.3     SINE 
012G3-SP6 CT841047 282 38.7     simple repeat, LTR/MaLR 
012G3-T7 CT841048 456 49.8     no repeats 
013E2-SP6 CT865642 1323 39.2     LINE1 
013E2-T7 CT865502 1313 34     LINE1, LTR/ERV1 
015.2A9-M13   635 44.9     LTR/ERVL 
015.2A9-T7   535 33.3     low complexity 
015.2E9-M13   445 41.8     SINE 
015.2E9-T7   389 34.7     LINE1 
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Table A1 continued 
 
BES GenBank 
Acc. No.  
Size, bp GC% BLAST significant 
similarity (<E-10) to 
known genes 
Microsatellites Other repeats 
016.4C5-M13   182 52.7     no repeats 
016.4C5-T7   312 35.9     LINE1 
017.2C11-M13   869 37.1     LINE1 
017.2C11-T7   712 31.2     LINE1, low complexity repeat 
017D15-SP6 CT939410 636 47.5     LINE1 
017D15-T7 CT939412 742 33.8     LINE2 
018K2-SP6   865 36.3     no repeats 
018K2-T7   855 37.2     LINE1 
019D21-SP6 CT961235 882 42.1     LTR/MaLR, SINe/MIR, LINE1 
019D21-T7 CT961236 524 46     LTR/ERVL, LINE2  
020.1G12-M13   858 43.7     Low complexity repeat 
020.1G12-T7   777 45.2     no repeats 
020B4-SP6 CT938442 502 39.8     no repeats 
020B4-T7 CT938444 342 33.6     LINE1 
020L18-SP6 CT939014 756 39.6     LTR/ERV1 
020L18-T7 CT939015 567 44.4   (TG)7 CG (TG)7 LINE1, simple repeat, SINE 
022.4 E3-M13   822 47.9     LINE1 
022.4 E3-T7   706 35.8     LINE1 
022G3-SP6 CT941801, 
ET052928 
400 47.3     no repeats 
022G3-T7 CT941802, 
ET052929 
720 53.7     no repeats 
022P7-SP6 CT942195 744 52     no repeats 
022P7-T7 CT942196 468 32.9     LINE1, DNA/MER2 
024.4G8-M13   760 49.7     SINE, LINE1 
024.4G8-T7   939 37.2     no repeats 
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Table A1 continued 
 
BES GenBank 
Acc. No.  
Size, bp GC% BLAST significant 
similarity (<E-10) to 
known genes 
Microsatellites Other repeats 
024I23-SP6 CT942381 849 47.9     no repeats; but amplifies both 
male and female 
024I23-T7 CT942288 928 38.4     no repeats 
026.4A6-M13   311 35.4     LINE1 
026.4A6-T7   347 45.8     no repeats 
026B21-SP6 CT951493 714 43.4     LINE1 
026B21-T7 CT951494 783 38.7     LINE1 
027.1A2-M13   1169 40.5     LINE1 
027.1A2-T7   294 41.2     no repeats 
027A12-SP6 CT952155 772 38.7     no repeats 
027A12-T7 CT952156 761 32.5     LTR/MaLR, simple repeat 
027B13-SP6   698 42.4     LTR/MaLR 
027B13-T7 CT952199 555 38.7     no repeats 
032H24-SP6 CT957174 638 39.5     LINE2 
032H24-T7 CT957175 444 49.8     SINE/MIR 
032K15-SP6 CT957292 633 47.1     LINE2, simple repeat 
032K15-T7 CT957293 693 41     no repeats 
034 E15-SP6 CT958457 605 39.8     no repeats 
034 E15-T7 CT958458 588 44.5     no repeats 
037.4D11-M13   558 39.8     LINE1 
037.4D11-T7   637 44.4     LINE1 
037D12-SP6 CT960488 814 36.2     LINE1 
037D12-T7 CT960489 667 31.8     LINE1 
039P6-SP6   334 43.7     no repeats 
039P6-T7   619 40.7     no repeats 
041O19-SP6 CT967953 682 34.9     LINE1 
041O19-T7 CT967954 508 31.9     low complexity 
042.4B5-M13   785 48.7     LINE1 
042.4B5-T7   968 34.3     LINE1 
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Table A1 continued 
 
BES GenBank 
Acc. No.  
Size, bp GC% BLAST significant 
similarity (<E-10) to 
known genes 
Microsatellites Other repeats 
047.1H3-M13   332 36.4   (TG)14 LINE1, simple repeat 
047.1H3-T7   704 35.8     LTR/ERV1 
047.2A3-M13   701 40.8     no repeats 
047.2A3-T7   855 36.1     LTR/ERVL, SINE, LINE1, 
DNA/MER2 
047B7-SP6 CT964598 422 36.3     LINE1, DNA/hAT-Charlie  
047B7-T7 CT964599 384 39.6     LINE1 
049.2F10-M13   1016 41.6     SINE. MIR 
049.2F10-T7   1181 45     SINE 
049.3F11-M13   955 35.4     SINE, ERE1 
049.3F11-T7   884 38.8 CRISP3, 2e-06   no repeats 
049J16-SP6 CT969091 753 32     LINE1 
049J16-T7 CT969092 641 35.7     LINE1 
052H5-SP6 CT972580 684 35.1     LINE1, low complexity 
052H5-T7 CT972585 573 38.6     no repeats 
054A8-SP6 CT973016 462 42.2     LINE1 
054A8-T7 CT973017 455 44.4     no repeats 
054F13-SP6 CT973230 703 43     no repeats 
054F13-T7 CT973231 542 33.9     LTR/ ERV1 
054J7-SP6 CT973393 670 35.1     LINE1 
054J7-T7 CT973394 620 50.2     no repeats 
055N19-SP6   720 30.4     LINE1 
055N19-T7   800 36.7     LINE1 
060D8-SP6 CT976605 856 39     SINE, LINE1 
060D8-T7  CT976606 645 44.3     LTR element 168 bp in the end  
061.4H6-M13   931 41.6     simple repeats 
061.4H6-T7   940 38.4     LINE1, SINE 
061G21-SP6 CT977473 335 62.7     no repeats 
061G21-T7 CT977474 368 31     SINE 
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Table A1 continued 
 
BES GenBank 
Acc. No.  
Size, bp GC% BLAST significant 
similarity (<E-10) to 
known genes 
Microsatellites Other repeats 
061J18-SP6 CT977591 201 37.3     no repeats 
061J18-T7 CT977592 395 34.4     LINE1 
063H12-SP6 CU002478 253 45     no repeats 
063H12-T7 CU002479 803 35.7     LINE1 
063I4-SP6   353 47.9     SINE 
063I4-T7 CU002511 922 42.6     SINE 
064P16-SP6 CU003552 685 35.2     LINE1 
064P16-T7 CU003553 610 64.4     no repeats 
066M24-SP6 CU001288 412 40.3     no repeats 
066M24-T7 CU001289 511 46.8     no repeats 
067.1G8-M13   712 35 NLGN4Y 85.0% 
NLGN4X 86.6% 
(BLAT) 
  no repeats 
067.1G8-T7   716 28.9     simple repeat, low complexity, 
LINE1 
067.4G1-M13   1185 43.4     SINE, LINE1 
067.4G1-T7   Sequence not 
available 
        
069 E11-SP6 CU000182 757 50.2     LINE1 
069 E11-T7  479 47.6     no repeats 
070F17-SP6 CU138007 264 50   (CTCA)5 LTR/MaLR, simple repeat 
070F17-T7 CU138008 541 42     NCBILTR/ERV1, SINE 
072G23-SP6 CU004599 824 37.9     LINE1  
072G23-T7 CU004600 765 35.6     LINE1  
072G7-SP6 CU004572 783 36.4     LINE1 
072G7-T7 CU004573 764 39.1     no repeats 
074P12-SP6 CU006411 780 42.2     LINE1 
074P12-T7 CU006412 439 33.6     LINE1 
077M19-SP6 CU006998 596 40.3     LINE1, LTR, low complexity 
077M19-T7 CU006999 305 44.3     no repeats 
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079.4H1-M13   718 41.4     no repeats 
079.4H1-T7   621 35.6     LINE1 
080.4F7-M13   499 45.5     SINE, LINE1 
080.4F7-T7   544 41.4     no repeats 
081F24-SP6 CU011589 325 41.2     LINE1 
081F24-T7 CU011590 465 36.8     LINE1 
081F8-SP6 CU011557 804 38.1     no repeats 
081F8-T7 CU011558 648 36.7     no repeats 
083H5-SP6 CU017259 701 32.1     LINE1, low complexity 
083H5-T7 CU017260 751 32.8     LINE1, DNA/MER1, low 
complexity, simple repeat 
086.2F8-M13   1002 37.4     SINE 
086.2F8-T7   1088 39.2     SINE, DNA/MER1, LTR/MaLR 
086J1-SP6 CU022552 667 29.8     LINE1, LTR 
086J1-T7 CU022553 575 34.4     LINE1 
087.3A5-M13   867 40.9     no repeats 
087.3A5-T7   1057 37     LINE1 
089.3B11-M13   483 39.5     LTR and LINE1  
089.3B11-T7   833 39.7     DNA/MER1, DNA/AcHobo, 
LINE1 
090B11-SP6 CU015692 492 31.5     LINE1 
090B11-T7 CU015693 396 39.7     LTR/ERVL 
090G18-SP6 CU015913 737 42.2     LINE1 
090G18-T7 CU015914 691 41.8     LTR/MaLR, LINE1 
090P8-SP6 CU016271 510 45.3     SINE, LTR 
090P8-T7 CU016272 524 35.1     LINE1 
091.4G10-M13   568 40.3     LTR/ERV1 
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091.4G10-T7   782 39.3     LINE1 
095.4B8-SP6   sequence not 
available 
n/a     n/a 
095.4B8-T7   193 36.3     no repeats 
095.4F10-M13   690 47     LTR element  
095.4F10-T7   607 44     no repeats 
097D2-SP6 CU019809 854 38.9   (AT)2 C (AT)25 simple repeat, SINE, DNA/MER 
097D2-T7 CU019810 821 37.8 CRISP1 3e-75   SINE 
100.3A11-M13   644 44.3     no repeats 
100.3A11-T7   718 37.2     LINE2 
100.4F5-M13   681 41.3     LINE1 
100.4F5-T7   716 36.5     LINE2 
100H13-SP6 AJ542956 868 43.2     LTR/MaLR 
100H13-T7 AJ542957 804 34.1     LINE1 
101H8-SP6 AJ576754 1032 37.7     SINE 
101H8-T7 AJ576755 1164 39.6     LINE1 
102J15-SP6 AJ584337 837 33.2     low complexity 
102J15-T7 AJ584338 882 37.8     LINE1 
103.3A6-M13   1078 46.2     SINE, LINE1 
103.3A6-T7   sequence not 
available 
n/a     n/a 
106F1-SP6 CT007963 899 46.9     LINE1 
106F1-T7 CT008006 873 40.8     LINE1 
106J17-SP6   743 44.4 NLGN4X   0.0   no repeats 
106J17-T7   772 39.5     LINE/CR1 
107.3H9-M13   816 39.3     LINE1, SINE 
107.3H9-T7   763 52.6     LINE1 
108.4C7-M13   490 50.4     no repeats 
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108.4C7-T7   1150 44     no repeats 
110.3H12-M13   1042 37.2 EIF2S3 1e-63   LTR/MaLR, snRNA 
110.3H12-T7   1002 40     simple repeat 
111.2F5-M13   1044 41.9     LINE1, SINE 
111.2F5-T7   1182 45     LINE1 
112.1A9-M13   1443 45.6     LINE1 
112.1A9-T7   1450 49.4     simple repeat 
112C10-SP6  585 37.8     LINE1 
112C10-T7  913 38.2     LINE1 
112E12-SP6 CR955686 587 49.7     no repeats 
112E12-T7 CR957122 494 36.4     LTR/MaLR 
114E24-SP6 CT006488 636 37.4     LINE1 
114E24-T7 CT006811 720 38.1     DNA/MER1 
114I17-SP6 CT006994 431 34.6     SINE/MIR 
114I17-T7 CT007019 463 40.2     no repeats 
117.4F7-M13   928 32.5     MER2  
117.4F7-T7   757 38.6     SINE and LINE1  
118.1A9-M13   781 41.6     LINE2 
118.1A9-T7   680 28.1     LINE1 
118L7-SP6 CU025610 840 47.7     LINE1 
118L7-T7 CU025611 1111 37.8   (AC)5 AT (AC)13 simple repeat 
118N21-SP6 CU025698 396 40.4     no repeats 
118N21-T7 CU025699 745 34.5     no repeats 
119K22-SP6 CU026858 314 27.7     LINE2 
119K22-T7   426 36.6     LINE1, SINE/Alu 
120.1A5-M13   1042 34.8  AMELY   DNA/tip100 
120.1A5-T7   648 38.5     SINE, LINE1 
120A19-SP6 CU027080 220 55     LINE1  
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120A19-T7 CU027081 362 58.3     no repeats 
121G24-SP6 CU028694 622 42.8     no repeats 
121G24-T7 CU028695 523 33.3     LINE1 
121H9-SP6 CU028712 513 31.2     LINE1, SINE 
121H9-T7 CU028713 793 34.4 horse MAP3K7IP3     
8e-76; ECAX 24.1. 
Human MAP3K7IP3 
1e-66;  HSAX 30.7;  
  no repeats 
124.3G9-M13   477 33.5     DNA/MER2 
124.3G9-T7   852 39.4     LTR/MaLR 
125.3G11-M13   711 42.3     SINE, LTR, MER2 
125.3G11-T7   644 39     no repeats 
125H6-SP6 CU029932 674 26.3     LINE1 
125H6-T7   847 40.3     LINE1, SINE 
126G2-SP6 CU029327 522 39.7     no repeats 
126G2-T7  866 37.6     SINE, LTR present 
129K23-SP6 CU033122 528 53.6     no repeats 
129K23-T7 CU033123 409 46     LINE1 
131N23-SP6 CU034701 559 33.8     SINE, LINE1 
131N23-T7 CU034702 590 29     LINE1 
132K10-SP6 CU035255 560 42     DNA/MER1, SINE 
132K10-T7 CU035256 590 38.8     LTR/ERV1 
132N15-SP6 CU035402 533 41.8     no repeats 
132N15-T7 CU035403 551 43.8     no repeats 
134H14-SP6 CU036544 623 62.9     no repeats 
134H14-T7 CU036545 584 37.2     LINE1 
134I16-SP6 CU036592 688 55.2     no repeats 
134I16-T7 CU036593 667 49     no repeats 
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137I17-SP6 CU038728 423 44.9     no repeats 
137I17-T7 CU038729 484 45.7     DNA/MER2 
139C20-SP6 CU040631 686 46.8     LINE1 
139C20-T7 CU040632 746 41.8     LINE1 
140J20-SP6 CU039506 801 40.6     LINE1 
140J20-T7 CU039507 817 38.8     LINE1 
140M23-SP6 CU039648 885 36.8     LINE1 
140M23-T7 CU039649 879 30.8     LINE1 
142O2-SP6 CU044834 569 40.1     LINE1 
142O2-T7 CLY074, 
CU044835 
529 50.3     no repeats 
144B9-SP6 CU045683 711 40.4     LINE1 
144B9-T7 CU045684 508 49.4     no repeats 
145I6-SP6 CU046684 781 35.1     LINE1 
145I6-T7 CU046685 624 41.7     LINE1 
147K8-SP6 CU048189 792 39.8     LINE1 
147K8-T7 CU048190 770 36.9     LINE1 
148G3-SP6 CU048698 509 36.1     LINE1 
148G3-T7 CU048699 1218 48.7     low complexity 
149H18-SP6 CU049495 633 54.3     no repeats 
149H18-T7  CU049496 652 36.5     LINE1 
152E2-SP6   772 35.6     no repeats 
152E2-T7   429 42.2     LTR/MaLR 
152G20-SP6 CU051535 569 54     LINE1 
152G20-T7 CU051536 590 37.5     LINE1 
155B8-SP6   851 65.7     no repeats 
155B8-T7   949 37.7     LINE/RTE 
155M11-SP6 CU054469 604 41.7     LINE1 
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155M11-T7 CU054470 673 38.3     LTR/MaLR, SINE/MIR 
159E3-SP6 CU056230 551 36.5     no repeats 
159E3-T7 CU056231 555 27     SINE 
159F5-SP6 CU056277 591 27.1     no repeats 
159F5-T7 CU056278 576 32.1     DNA/MER1 
160K10-SP6 CU057249 719 28.9     low complexilty 
160K10-T7 CU057250 758 60.4     LINE2 
165 E24-SP6 CU060545 660 45.6     no repeats 
165 E24-T7 CU060546 580 37.4     LINE1 
167N20-SP6 CU062306 385 34.8     Low complexity, SINE/MIR 
167N20-T7 CU062307 630 31.7     low complexity 
168I4-SP6 CU061376 929 35.8     LINE1 
168I4-T7   1008 39.8     LTR/ERVL, LINE1 
168O8-SP6 CU061645 609 49.1     LINE1 
168O8-T7 CU061646 551 37.1     LTR/ERVL-MaLR, LINE1  
172 E14-SP6 CU079797 549 39     no repeats 
172 E14-T7 CU079798 626 35.1     LINE1, low complexity 
172D14-SP6 ET052930 354 56.2     no repeats 
172D14-T7 ET052931 539 35.1     LINE1, low complexity 
172I8-SP6   657 38.5     LINE1 
172I8-T7   839 38.9     no repeats 
179K8-SP6 CU083108 560 61.4     low complexity, LINE1, Alu 
179K8-T7 CU083388 604 48.3     LTR/ERVL, SINE 
180P20-SP6 CU084740 777 36.3     DNA/MER1, low complexity 
180P20-T7 CU084545 780 35.8     LTR/ERV1 
181B18-SP6 CU085205 506 43.7     SINE, LTR 
181B18-T7 CU085127 567 44.4     LINE1 
185M14-SP6 CU087822 684 34.9     no repeats 
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185M14-T7 CU088298 390 36.4     LINE1 
186J13-SP6   320 39     LINE1 
186J13-T7   560 36     LINE1 
188E20-SP6 CU088810 693 41.4     SINE 
188E20-T7 CU089040 1131 48.2     LINE1, low complexity 
190M2-SP6 CU091407 1150 40.4     LINE1 
190M2-T7 CU091759 1124 37.7     no repeats 
205D10-SP6 CU100955 552 41.5     LINE1, LINE2 
205D10-T7 CU100417 522 35.6 CRISP3/TPX1 6e-12   LINE1 
207D10-SP6 CU102230 660 38.2     LINE1 
207D10-T7 CU102329 649 61.8     no repeats 
207P5-SP6 CU102452 632 51.1     no repeats 
207P5-T7 CU102185 649 46.1     LTR, ERV1 
209K10-SP6 CU103461 777 34.7 KAL1 4e-112   no repeats 
209K10-T7 CU103487 761 34.4     LINE1 
215C6-SP6 CU108088 632 36.6     SINE/MIR  
215C6-T7 CU107955 605 45.1     DNA/Tip100, SINE 
244B13-SP6 CU126429 525 44.4     DNA/MER2 
244B13-T7 CU126281 306 50.3     no repeats 
263G23-SP6 CU140369 698 47.9     simple repeat 
263G23-T7 CU139968 632 46.4     no repeats 
264G20-SP6 CU141122 658 60.3     Low_complexity  
264G20-T7 CU143373 612 44.4     DNA/TcMar-Tigger 
269J9-SP6 CU143890 758 30.6     SINE/MIR  
269J9-T7 CU143890 629 39.9     LTR/ERVL, DNA/MER1 
272B4-SP6 CU147224 611 33.2     LINE1 
272B4-T7  872 32.8     LINE1 
  
180
Table A1 continued 
 
BES GenBank 
Acc. No.  
Size, bp GC% BLAST significant 
similarity (<E-10) to 
known genes 
Microsatellites Other repeats 
275P16-SP6 CU148527 799 33.4     no repeats 
275P16-T7 CU148738 760 38.9     LINE1 
278M12-SP6 CU148483 593 33.4 UTY (BLAT)   no repeats 
278M12-T7  CU148207 660 52     no repeats 
280P20-SP6 CU151385 349 55.6     LINE1 
280P20-T7 CU151203 655 33.9     LINE1 
291D19-SP6 CU152144 645 32.4     low complexity, LINE1 
291D19-T7 CU152471 656 35.7     LINE1 
309A2-SP6 CU168483 528 47     no repeats 
309A2-T7 CU168709 482 48.1     no repeats 
318M1-SP6 CU168992 584 31.8     LTR/ERV1 
318M1-T7 CU169153 558 37.3     no repeats 
324H11-SP6 CU207515 627 55.7     no repeats 
324H11-T7 CU208053 566 49.5     LINE1 
325B20-SP6 CU208562 682 45.2     DNA/hAT-Charlie, LTR/ERVL-
MaLR    
325B20-T7 CU208331 687 48.5     SINE/MIR  
329G16-SP6 CU210328 678 31.7     MER1 
329G16-T7 CU210572 670 34     MER2 
331E10-SP6 CU199001 697 40.6     LTR/MaLR 
331E10-T7 CU199033 716 38.3 CRISP3/TPX1 8E-39   LTR/ERV1, LTR/MaLR 
335P13-SP6 CU184042 708 34.6     SINE/MIR 
335P13-T7 CU184277 684 33     LINE1 
338A6-SP6 CU203349 648 27.2     no repeats 
338A6-T7 CU203043 673 30.6     no repeats 
341G20-SP6 CU204940 648 36.1     LINE1 
341G20-T7 CU204493 678 33.3     LINE1 
344A12-SP6 CU312820 767 37.3     no repeats 
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344A12-T7 CU312716 738 36.6     LINE1 
377O23-SP6 CU236334 653 36     no repeats 
377O23-T7 CU236809 581 42     LTR/ERVL 
394K12-SP6 CU246464 663 43.1     LINE1 
394K12-T7 CU246587 621 48.1     no repeats 
395L19-SP6 CU248760 594 44.9     no repeats 
395L19-T7 CU248652 526 33.5     LINE1 
406I22-SP6 CU257716 625 36.3     LINE1 
406I22-T7 CU258117 483 40.2     LINE1 
415H8 -SP6 CU264902 687 37.1     LINE 
415H8 -T7 CU264886 577 38     LINE1 
417N24-SP6 CU265590 674 35.2     SINE/MIR 
417N24-T7 CU265575 725 35.3     no repeats 
418J18-SP6 CU267189 750 46.9     no repeats 
418J18-T7 CU266817 754 47.9     LINE1 
422E23-SP6 CU271235 598 38.1     no repeats 
422E23-T7 CU271261 567 32.3 KAL1 4e-97   no repeats 
437I11-SP6  CU301860 716 34.8     SINE/MIR 
437I11-T7 CU301866 679 33.9     SINE 
450C22-SP6 CU286553 334 33.8     LINE1 
450C22-T7 CU286365 314 33.8     no repeats 
456J9-SP6 CU289788 683 41.4     LINE1, SINE 
456J9-T7 CU289914 731 38.6     LINE1 
504H13-SP6   856 31.1 ZFY 4e-29   low complexity repeats 
504H13-T7   869 33.8     LINE1 
510F11-SP6  854 32.7     no repeats 
510F11-T7  788 36.4     LINE1 
ABW-M13   193 52.3     simple repeats 
ABW-T7   209 38     no repeats 
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BBW-M13   157 43.9     no repeats 
BBW-T7   214 35.5     LINE1 
CBW-M13   177 46.3     no repeats 
CBW-T7   768 34.1     LINE1 
DBW-M13   150 52     LINE1 
DBW-T7   195 50.8     simple repeats 
EBW-M13   693 41.4     no repeats 
EBW-T7   1131 48.2     no repeats 
FBW-M13   1056 39.7     DNA/MER2 
FBW-T7   1385 42.2     LINE1, LTR/ERV1 
GBW-M13   993 39.6     LINE1, SINE 
GBW-T7   990 37.5     no repeats 
HBW-M13   247 52.2     simole repeats, LTR 
HBW-T7   232 47.8     no repeats 
JBW-M13   238 55     no repeats 
JBW-T7   660 39.3     LINE1 
LBW-M13   642 34.6     LINE1 
LBW-T7    1121 39     LTR 
MBW-M13   1146 43.5     SINE 
MBW-T7   1092 37.5     LINE1 
OBW-M13   1055 43.3     LINE1 
OBW-T7   1094 44.1     no repeats 
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STS marker Primers 5′ to 3′ Size, 
bp 
Ta °C Male or 
female 
amplification 
GenBank Accession and alias symbol 
002E4-T7 F: CCACAGCAGTGATGAGATGG 
R: TGCCAAGTTTTACCTGGTCTC 
218 58 M/wF   
003.4H8-M13 F: GATTAAGAGCCCAGGAGAGG 
R: TTGGCTGGAGACTTGGTAGG 
250 64 M   
003.4H8-T7 F: GCAACAGAAAGCACAGAGG 
R: TGCCAGGACCATCTCAGG 
174 62 M   
003A5INT1 F: TCAGTGGGTCTGTTTCATGC 
R: TTGCCTCCATGATTTTCTCC 
157 58 M/wF   
003A5INT2 F: GCTACAGCTTGGTCCTCTGC 
R: AGTGCAATACGGGAGTCAGG 
241 58 M/wF   
003A5-SP6 F: GCCCCATCCATCAGTTTTTA 
R: TGCATTTCTTCATTCCACTCC  
157 58 M CT825159 
005.2A8-M13 F: TCAGAATGGAGCTGCCTAAAA 
R: GGCCCTGGCTTTTCTTTATT 
274 58 M   
005.2A8-T7 F: GTCAATCCTGCTGCCCTTAG 
R: TGAGCAAGCAAATGGAAAGA 
247 58 M   
006B10-SP6 F: GCGAGGTGGCTTCTCTTATG 
R: TACGCAGTTGTCGAACTTGG 
199 58 M CT827035 
006B10-T7 F: CTTGCAATCACGTGGAAGAA 
R: TTGAATGCCACAGGTAAGGA 
207 TD60 M CT826936 
008.3G9-M13 F: TTGTAGGCATTGTGCCAGTT 
R: GGGCTTGTAAGAGACCCACA 
243 58 M   
008.3G9-T7 F: TGACAACATTCTGGCAGGAG 
R: TGAGCACCCAAACCATGATA 
161 58 M/wF   
011B8-SP6 F: GATGATAAGTGCTCTTCATTTGTGA 
R: TGGGAAAAGTGGTTGGAGTG 
232 58 M CT840125 
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011B8-T7 F: ACCGGCTTGAGAGAGAATGA 
R: ACCTTTGGGAAAATGCCTCT 
174 58 M CT840126 
012.2E5-M13 F: TGGGTTTCTTGGAATCCTGA 
R: CCAGTGAAGGGGGACATCA  
249 60 M BV140783, CLY041 
012.2E5-T7 F: CCCCTCTTGCTGAGTTTTTG 
R: ACAGCAAACCAAACCCTACG 
150 60 M BV140831, CLY037 
012G3-SP6 F: AGCAGCCTTCTAGCTTCGTT 
R: CTTGTGCCCTCCATTTTTGT 
204 58 M/wF  CT841047 
012G3-T7 F: CCATCCAAATCTGTCCTGCT 
R: CCCAGCAGACCTTGTTTGTT 
213 58 M/F CT841048 
013E2-T7 F: CAGACCAGAAGCTGAAGAAGAG 
R: GGGCTGCATACAAGGAAAGT 
331 65 M BV140783, CLY042 
015.2A9-M13 F: CCCATGACCTGTCCATACTG 
R: AACCAAGCCACATTTCATCG 
182 60 M BV140824, CLY028 
015.2A9-T7 F: GGAGGCCACAGAGTGTTTTT 
R: GAAAGGTTGTCTCCATCTTTCCT 
185 60 M BV140822, CLY022 
015.2E9-M13 F: GCCAGTACATGGCCAGAGTT 
R: GGAGCTCTGTGAATGGAAGC 
159 50 M   
016.4C5-M13 F: GTGGCAGTCTGGGTTACGTT 
R: AAGCAAACCAAGGAGAAGCA 
215 50 M   
017.2C11-M13 F: CCCAAAGTGGAATGTGAGAG 
R: AAATTACCACTTGTGTAAGGTGAACA 
150 58 M/F   
017.2C11-T7 F: TCATCATTCTTTGGCATTTG 
R: CCAACACTCAGGCAATTTGA 
194 58 M   
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017D15-SP6 F: GCTGCCTGAAACCTGACTTC 
R: TACTCCAAGTGCCAAGCTCA 
176 65 M BV140807, CLY083  
 
017D15-T7 F: AGTGGGTTTCAGGCAAAATG 
R: GGCACTTGTCTTCTCGGTGT 
209 65 M BV140806, CLY082 
018K2-SP6 F: GGTTTGACCCAAGCAAAGAA 
R: TGGGAAATGAAATTGCACAC 
209 58 M/F   
019D21-SP6 F: AGCTCCTCTGGGCACCTATC 
R: GGAAAAACTGCTCCATTCCTC 
111 58 M   
019D21-T7 F: TTTTCCTTGGCCTTTACTCC 
R: GCAAAGAATTTAGGCCTGGT  
217 60 M   
020.1G12-T7 F: TCTGGGTTCTGGATCTGACTG 
R: GACTCGGCCTGAAGCTAATG 
173 62 M   
020L18-SP6 F: TCAATAGCCATGGTGAGCTG 
R: TTCCAACCTCATTCCCTTTG 
166 58 M   
020L18-T7 F: GCTCCTTCTTGTGGCACAGT 
R: TCTTTGTAATCAGTAGCCCCATT 
407 58 M   
022.4 E3-M13 F: CCGATTCCAAACCATGAGAT 
R:AGGAAGTCAGCACCTTGCAT 
138 65 M BV140843, CLY066 
022G3-SP6 F: ACCTCAGTAGGGGGCTTCTC 
R: GTGGAACAGGGTAAGGCAAA 
154 58 M   
022P7-SP6 F: GCAATGGGACTGTGGAAAAT 
R:TTTTCACCTCAGCCCTCAAC 
383 151 M/F   
024.4G8-M13 F: ACAGTCTCCTGCTGGTTTCC 
R: AATTTCAGCCTCCTTTCCA 
156 60 M BV140847, CLY091 
024.4G8-T7 F: TCATCTCGTATCTCCTCATATCC 
R: TCCCTATCCTTGTTGAAAATCC 
495 60 M BV140846, CLY090  
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024I23-T7 F: ATCTGCTTCGGCCTTCTCTT 
R: GGTGTACCCTGCTTCTCGT 
101 65 M BV140808, CLY101 
026.4A6-M13 F: CTCCCCTCCTCCCACATTAT 
R: GGCAGCAGATCAACTACCTG 
153 60 M BV140825, CLY029 
026.4A6-T7 F: TCGGTGACATCAGCAAAATG 
R: TACCCCGAATCCAGATCCTC 
192 55 M BV140823, CLY026 
026B21-SP6 F: CAAGGAAGCCAGGAAGAGTG 
R: GTCTCTGGCCCATGAGTGAT 
160 60 M   
027.1A2-M13 F: AACACCCAACCACATAGAGGA 
R: GGGCCGTTGTTGAGTCTTAG 
190 60 M   
027.1A2-T7 F: AGGGAGGTCTATGGAGAAGG 
R: ATTTTTAGCTTGCCCTTTGG 
296 65 M BV140841, CLY059  
027A12-SP6 F: GCCCATGCTAAATTTGTGCT 
R: CTAATTGAGGGGCAACCAAA 
237 58 M   CT952155 
027A12-T7 F: CATTTTTGCTGTTTCCCACA 
R: CAGGAAGACAACCAGAAAAACC 
162 58 M   CT952156 
027B13-SP6 F: GAAACTGCCAGTGAGACAAGG 
R: TGTCTGGCATAGGAACTCAAG 
698 58 M/wF   
027B13-T7 F: CATGCTGTAATAAGACTGAGAAGA  
R: ACAGAGGAACCAGTTATTGCAT 
183 58 M/wF CT952199 
032H24-SP6 F: TCAAAAGGGTAAGGTGCAGAG 
R: GCCAGAAAATGGCAATAGTTT 
160 60 M   
032H24-T7 F: AAATGACAGCGTGTGGGAGT 
R: ACAGGACAGGTCCAGGTGAG 
163 60 M/F   
039P6-SP6 F: GCAAAGGCTCTGAGAGAGGA 
R: GGCCACATGTCCTGTGTGTA 
161 58 M   
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039P6-T7 F: CATTTCTGATCCCCTCTTGG 
R: GCCAAGATGCTCTTGATGGT 
155 58 M/F   
041O19-T7 F: ATTACATTTGCCCCAGACCA 
R: CTCTTGCTTCAGCGGTCTTT 
249 58 M   
042.4B5-M13 F: TTGGGGAGACTTACCCACCT  
R: AGAGGCGTTAGGGTTGGTTT 
100 60 M   
042.4B5-T7 F: TGGCTCTTTGTGTGGTGTAA 
R: TCCACAGACCCATGCAAATA 
238 60 M   
047.1H3-M13 F: GGATCCTATGTCCTAGTTTGGAA 
R: TTTTTGTTCTTACCATTCATACAACA 
113 58 M/wF   
047.1H3-T7 F: TTATGTCGACTTTGCCTGGA 
R: AGAATTCCATTAACAAGTTTTGGT 
107 58 M/F   
047.2A3-M13 F: ACCCTTGTCACCTTCCAGTG 
R: CCTGCCCCTTATTCTTGTGA 
194 58 M/wF   
047.2A3-T7 F: GCTGAGTCAACATCTCACATAGC 
R: GCCTTAAGATAACATCTGTGACCA 
127 58 M/wF   
049.2F10-M13 F: GCACCAATACGCTAGAGTCCA 
R: GCTTGGCCATGTTAAGTGCT 
176 61 M   
049.2F10-T7 F: GTTGGATCCTGCTGTGGACT 
R: ACAGCGTCCTTGATGCTTCT 
212 60 M   
049.3F11-M13 F: TCAGCAGCAGCAGTAAGTGA 
R: ACGGTCAACCCATCTGTGAT 
172 60 M   
049.3F11-T7 F: GCGAGTTCTGAGGACCAGAG 
R: GACCTGCCAACCAGTGATCT 
173 61 M  
052H5-T7 F: GAACTCGCCTGTGGTTTCA 
R: GCCTGAATAAGATGCTGTCAAG 
142 65 M BV140796, CLY071 
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054A8-T7 F: GATGACCACGGGTTCTCAGT 
R: CCGTTCTCCTTCAGTCCAAG 
181 64 M/F   
054F13-SP6 F: GCAGGGGCCTTAGTGATATG 
R: CATGTCTTGATCTGCCAGGA 
189  58 M    
054F13-T7 F: TTGGGCTCAAGAAGTGGTTT  
R: TCTGCAGGTTCTTTGGATCA 
164 58 M    
054J7-T7 F: GTGTGATCTGCTGTGCTTGG 
R: GCAGTTGCTGTGTGACTGTAGG 
163 65 M BV140803, CLY079 
055N19-INT F: TTTCAGCCATCCTTTCCAAC 
R: CGTGGATTGCTCCTTTGTTT 
231 58 M   
060D8-T7 F: GACAGGAGGCACGTAAAGGA 
R: ATCTCCCCATCCCAAACTTC 
171 61 M/F   
061.4H8-M13 F: CCACATTTTACACATGCCACA 
R: CCCAGAAAGACACCGTAACAA 
117 62 M/F   
061G21-SP6 F: CAGGGATCGCAGACTCTAGG 
R: AGAGAGGGTGCAGAGCAAAA 
227 58 M   
061G21-T7 F: TCTTCAGGAACGACAAACCA 
R: AAGGTACATTTTCCCCACTGAA 
150 58 M   
061J18-SP6 F: TTGGTAGGATTTCCCATAGGTG 
R: TGATAGGTGAACAAACTTGAGGA 
219 58 M   
063H12-SP6 F: ACCTCAGTAGGGGGCTTCTC 
R: GTGGAACAGGGTAAGGCAAA 
155 58 M   
063I4-SP6 F: CAGCTACTTGTGGTCTGGTCA 
R: GGACTGACTGTAAGAGCCCACT 
103 65 M BV140776, CLY020 
063I4-T7 F: TGTGACGGAGGCCAAAATTA 
R: ACTCCACATCAGGGTTGGTT 
110 58 M BV140774, CLY016 
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064P16-T7 F: TCAGAGATGGGCATTTTCAC 
R: CCTTATTCAAACAGCGTCCA 
212 65 M BV140805, CLY081 
066M24-SP6 F: TTGGCTGCTCTCAGAATTGA 
R: GGATTGTGCATGTCATCTCG 
169 58 M CU001288 
066M24-T7 F: ATGTGGGGACTGGTTCACAT 
R: GGGGAGCTTTCACAATCAAA 
243 58 M CU001289 
067.1G8-M13 F: AGCTTTTTGGCCTTGTTCAG 
R: TGCTTTGGGAACTGACATTTT 
206 58 M   
067.1G8-T7 F: CAAAAGCCACTGCAGGATTA 
R: CATGAATATGTGGGATTACATGG 
182 58 M/wF   
069 E11-T7 F: CAGCCCTGGCATGTCTATTT 
R: GTTGCGAAGGGCTCTACAAG 
237 60 M/F   
070F17-SP6 F: TTCCTTCAAGATCCCGTGAG 
R: CACAGTTGCTCCATTGGTCA 
217 58 M   
070F17-T7 F: GCCAAATGTGACCCAAGAGA 
R: CCAGGAAGGAGCTAACACCA 
102 62 M/F   
072G23-SP6 F: AGGTTTGGGGTTTTGTTTCC 
R: CTGATGGTCCAATGTCCTCA 
163 58 M/wF CU004599 
072G23-T7 F: TTGTTCTGCTCCTTTCAGCA 
R: CTTGCACTTACGCAGTTCCA 
162 58 M CU004600 
072G7-SP6 F: CCGTCTCAACTATATTTCAAAGTTTTT 
R: CGCAGGTCATCACTTCTCTG 
194 58 M   
072G7-T7 F: CAACGCTTTCTTCTGACTCTG 
R: TTTTCCTGCCCTGTTTATCA 
215 58 M   
077M19-T7 F: AGCCTGGGGTTGATATGG 
R: CTGTTCGAGATTCAGGTTGG 
216 65 M BV140801, CLY077 
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079.4H1-M13 F: AGTCCACACCACCACAGTGA 
R: TGATGGGAGTGGGAGTTTTC 
248 60 M   
080.4F7-M13 F: TTTAACCACTCAGCCACAAGG 
R: CTTAACCACTGTGCCACCAA 
245 60 M/F   
080.4F7-T7 F: ATCACTGTTGGTCGGCACTC 
R: TCTGCACATCAGCCTTGTTC 
187 60 M   
081F8-SP6 F: GCAAAGGCTCTGAGAGAGGA 
R: CCATGCTTCTTGACCAGACA 
182 58 M/wF CU011557 
081F8-T7 F: CAAACTACCACCTCCCAAGAA 
R: ACCAAAGGCACAAAGCAGTC 
194 58 M CU011558 
083H5-T7 F: TGCCCTTATCTACGTTTTGG 
R: TCTGCAAAGCTGGATCTCTT 
123 58 M BV140789, CLY054 
086.2F8-M13 F: GGTCCAGAATGCCTGAGTAA 
R: AGAGACCTTTTGTGGGTGGA 
396 65 M BV140826, CLY032 
086.2F8-T7 F: CTGCCTATCTCCATTCTTCATAC 
R: AGTGTTTTGGGGCAAGTGTT 
153 65 M BV140830, CLY036 
086J1-SP6 F: TCAACTTAGCGACTTCCTAGCC 
R: TTCAAAAATTCGATGTTGTCC 
351 63 M BV140795, CLY070 
086J1-T7 F: GCCAGGATCGTGAGATATGG 
R: AACGTGCACGAGATAAGATGG 
151 67 M BV140794, CLY069 
087.3A5-M13 F: CAAGGGAAATGGAGTCAAGG 
R: AAAGAAAGTGTGTGTGTGTCAGG 
201 65 M BV140828, CLY034 
089.3B11-
M13 
F: GTCTTGTCCCCATCCTTTGA 
R: TGGCCCCATCTCTTATCAAC 
158 60 M   
089.3B11-T7 F: CACAGCCTGAATGCAAAATG 
R: TATCTATGTTTTTGATGTTATTGACG 
161 60 M   
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090B11-SP6 F: TTGCTTGTGGTATTTCCTTGC 
R: CCTTTCTTCTTTCCTTACATGC 
150 65 M BV140791, CLY057 
090B11-T7 F: AGTGGTTAAGGCACAATCCA 
R: CCCCTACATCAGTTCAACTTTTT 
166 60 M BV140788, CLY052 
090G18INT F: GGAGCAGATGTCAGCATTCA 
R: GCCTTTGGTGGCTGATTTTA 
246 60 M   
090G18-T7 F: AAATCCAAACAGATATGACAAAGA 
R: GATTAAGTCTCTGCTGCCATC 
155 60 M   
091.4G10-
M13 
F: AACTCCGGTAGGAGAGGAAG 
R:AAGGAGATGGACTCTTTTATTATTCC 
152 54 M   
095.4B8-T7 F: TATAAGGGTACATGCAATTCTAACAAA 
R: CAAAGTCACGTGCTGCAGTT 
150 60 M   
095.4F10-
M13 
F: GGGACAAAACCACTGAATGC 
R: GCTGTTGCTAGGTGGGAAGA 
250 62 M   
095.4F10-T7 F: TTTTGCTTGCCACATCCATA 
R: CTCACGCAACTGAAAGTCCA 
212 60 M/F   
097D2-SP6 F: TTTGGTTTCCCACTCTCTGTG 
R: CTTCCTTTGCAGGCTAGTGA 
190 58 M BV140810, CLY103 
097D2-T7 F: GCAAGATTGGAAACATGAAGC 
R: TCACATTTCTTCTTTGCTCTATGC 
177 65 M BV140777, CLY021 
100.3A11-
M13 
F: AATTCGTCTGCCACTGGAAC 
R: AAAAAGCGACAATGGAGTCG 
217 55 M   
100.3A11-T7 F: TCCCCTGACCACTAAGGTTG 
R: CTTCACATGGCGTGAAAATG 
197 58 M   
100.4F5-M13 F: AGAGGATCCGTCACGATTTG 
R: TGGAGCCTTCTGAGGTTAGC 
162 58 M   
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100.4F5-T7 F: TGCAAAATTCAAAGGTCAGC 
R: GGCAACAGATGCCTGGTATT 
152 58 M   
100H13-SP6 F: GGTATTTGCCCAGTGACCAG 
R: TCCCTGCAGTGCATTGTAAA 
165 62 M/F AJ542956 
101H8-SP6 F: GTTGTGCCCTAAGGCAGGTA  
R: TTGGCAAACTATGCCGAGTA 
170 58 M   
102J15-SP6 F: CCACAGTGCATACAGCAACC 
R: GCTGATCTGCTTGTTTTCTGG 
190 58 M/wF   
103.3A6-M13 F: GTGGAACTGCGCACTGCTTA 
R: CAGGAACATTAGGCCTCAGC 
150 65 M BV140840, CLY058 
106F1-SP6 F: ATCTGAAGGTGGAGGTGCTG 
R: TCTGCTCTCCTGGGGTTCTA 
244 58 M   
106F1-T7 F: CTCCTGATGACCATGGGACT 
R: TGCCCTAATGTCTGGCTTTT 
153 58 M   
106J17-SP6 F: ATGCCTTCTACCACCACTGC 
R: ACCACTGCACTGAGCATGAC 
161 58 M/F   
106J17-T7 F: TGGCATCTCTCATTCACCAA 
R: TGTAAGCAACCAGTGGAACG 
158 58 M   
107.3H9-T7 F: GTCAGCACGACAGCTCACAG 
R: ACAGCAATAGTCCACCAGCA 
247 68 M 
  
108.4C7-M13 F: AGCGAGGTCTGCACTTTCC 
R: GCGGGGAGTACATCAGTTCC 
156 66 M BV140827, CLY033 
108.4C7-T7 F: CTACGTGAAGGAATGTGTCTGG 
R: GATGTTTCTAAAGTCCAGCAAGG 
150 60 M BV140832, CLY038 
110.3H12-M13 F: GGGCCAGAATATGCAAGGA 
R: GATGTGTTTGTGTGCCTCTGTT 
182 60 M BV140834, CLY047 
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110.3H12-T7 F: GCCTCAAGTAGAACCACATCC 
R: GCATCCAGAACAGCAAACC 
300 60 M BV140837, CLY050 
111.2F5-M13 F: TGGAGAATTCACTGGCTGTC 
R: AAATGAAATAGCTGCAATGAAGT 
102 60 M BV140842, CLY060  
111.2F5T7 F: GGCAGGAATCCCACACATAA 
R: CAGGAACATTAGGCCTCAGC 
116 60 M   
112.1A9-M13 F: AACAGAACCACTGCACTAAACC 
R: CAGATTCCCTTGGCTGACC  
358 60 M BV140835, CLY048 
112.1A9-T7 F: TGTCAGCTTTGCCATTGTCT 
R: TCTGCCTGAAATGAAAGGAA 
226 62 M BV140836, CLY049 
112E12-SP6 F: CTCCTTAGGGTCTGCAGTGG 
R: TTGTGGACAGGCCTGGTAAT 
216 58 M/wF CR955686 
112E12-T7 F: AGTTGGGACCCTCAACTGC 
R: AGGCATGCATCATCTCACAG 
177 58 M/F CR957122 
114E24-T7 F: GTGTGCACTAGGCACCCTCT 
R: TCAGGTGCTTGCCTCATGTA  
240 58 M CT006811 
114I17-SP6 F: CCCCATGGTGTTATTCATGT 
R: GTGGCATTTCCAAAAATCAG 
172 58 M   
114I17-T7 F: GAGCCACAGCACATTTCTCT 
R: CAGGTTATCCCGTGACAAAG 
215 58 M   
117.4F7-M13 F: TGGGTTTCTTGGAATCCTGA 
R: CCAGTGAAGGGGGACATCA 
248 55 M   
117.4F7-T7 F: ATATGCCAGACATGGCACTG 
R: GCCCTGATCTAACTACTGCCAATC 
148 60 M   
118.1A9-M13 F: TGAAAACAAAAACCGAACAGG 
R: ATGGCATGCAAACACAAAAA 
157 58 M   
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118L7-SP6 F: GGGCTACAGGAGGACATGAG 
R: GCACAAGTTTGGCCGATT 
177 60 M   
118L7-T7 F: ATCTGCTCCCCTTTGGTTTT 
R: CCCCAGATTTACTGCCTTTG 
225 55 M   
118N21-SP6 F: GAGAGGGAGAGAGGTGGACA 
R: GGGAATGTTCTATTGCTCCAA 
275 58 M/F CU025698 
118N21-T7 F: GCAAATAAAAGTGGGGGACA 
R: TCATGTGGGAACCAGAGACA 
153 58 M/F CU025699 
119K22-SP6 F: CTGGGTCTAGCCCCTTATCC 
R: ATCGAGGGCTTGAAGCTGTA 
158 50 M   
120.1A5-M13 F: ACAGTGCGTTCTGTGGTGAT 
R: AGTGAGCTGAGAATGCTTTGG 
174 60 M BV140838, CLY053 
120.1A5-T7 F: GAACCAGCACTGCTCATCAA 
R: CCTCCAGAATGTCTCCTCCA 
210 60 M BV140839, CLY055 
120A19-SP6 F: CTGGCTGGAGTGCGATCT 
R: ACAACCCGTCGGATTCTCC 
151 55 M   
120A19-T7 F: GACTAACCACGTTGGGGAGA 
R: TATACATGTGCTGGGCTTGG 
151 58 M   
121G24-SP6 F: CCTTGAGTCATTGCCCTCAT 
R: GTTGGTGAAGCACATGTTGG 
246 58 M/wF   
121H9-T7 F: TCTGAGACCTTGCGAATCCT 
R: TGAATCCTTTCCCAGTTCCA 
166 58 M   
124.3G9-T7 F: TTACCAAGTCGCTGTGGTCTT 
R: GATTCTGCATTTCTTGAGCTCTT 
151 58 M   
125.3G11-T7 F: TGTGCATGAAATCTGGACTCA 
R: TGCTGTGTAGGAGGCATTTG 
164 65 M/F   
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125H6INT F: CAAAAGGAACAACCCCACTC 
R: TTCACATGACAGATTCAGCAAA 
242 55 M   
125H6-T7 F: CCAGCACCCTACTTTGAGGA 
R: AGGGCATGGGAACTTTAACC 
204 58 M/wF   
126G2-SP6 F: TCAGGCAGGAGAGCTGATTT 
R: CAGATGGGTGTGTCCTCCTT 
249 58 M   
126G2-T7 F: GCAACTTGCACTGATTGTCC 
R: ATTTGTGTGGAGGGCAGGT 
200 58 M   
129K23-SP6 F: ACACACATACCTGGCTGTCC 
R: GGTGAGCAGATCCCACTTCC 
112 67 M BV140875, CLY076  
129K23-T7 F: GGGGAAAACTCCAAAGCAG 
R: CAGGGGAACAAAGCCAGAG 
133 65 M BV140800, CLY075  
131N23-SP6 F: GCTTGTCCTAATTTGCCTCTG 
R: CTTTGAGGACGGGTAAATTG 
152 58 M   
132K10-SP6 F: AGGGGCATCTTCACTCACTC 
R: ATGTCACAAGGTCCCTGAGC 
220 58 M   CU035255 
132N15-SP6 F: GAGCCACAGCACATTTCTCT 
R: CAGGTTATCCCGTGACAAAG 
214 58 M   
132N15-T7 F: TGTCACAGCCATCTTTCAGA 
R: GTCTGCAGGCTCTCATGATT 
186 58 M   
134H14-SP6 F: AAGGGAAAGCAGGTTCCAGT 
R: ACAAGCGGTCTGAGGACACT 
191 60 M   
134I16-SP6 F: AGTTGAAGCAAGTGTGTGTGG 
R: CGGACTACGCCAAGAAAAGG 
188 62 M   
134I16-T7 F: CCATAGAGTGAGAGCTGATTG 
R: TTGTTTTCCTTTTGGACTGG 
238 62 M   
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137I17-SP6 F: AAGGCCAAAGACATTCTCCA 
R: ACCTCCTGAGTTGGCTGAGA 
213 62 M CU038728 
139C20-SP6 F: GTGGGTCTTCTTGTGGCAGT 
R: ACAAGAGAGGGCCCTGGAC 
109 58 M   
142O2-T7 F: AATATCCACAACCCCTCTTCC 
R: CGGAGCATAGTAGCCAGACC 
155  58 M   
144B9-T7 F: TCAATGGCCCAAAGGTCTAC 
R: GGGGAGCACCAGATATGAGA 
156 58 M   
145I6-SP6 F: AGGCAAGTTGTAGGAAGAGCA 
R: TTTAAAAGGATCATTTCATTCCA 
164 58 M CU046684 
145I6-T7 F: AACGGCCCAGGCTAGAGTAT 
R: AGAGGTGGTTTGCCTTGCTA 
213 58 M CU046685 
148G3-T7 F: CAGAGGAGCGTCTTCCAGTT 
R: GGGTTTTTCCCCCAGTTTT 
159 60 M BV140785, CLY045 
149H18-SP6 F: GCGGTCTCAGTTTCTCTTCC 
R: CTGCTTCTTTCGCCTCTCC 
242 65 M BV140784, CLY043 
152E2-SP6 F: CGGTGAATTTTGAGGAAGGA 
R: TGTGCCTTTGTCAGGAATCT 
174 TD60-
50 
M/F   
152E2-T7 F: CAGCATGAGAAAGAACTATAATAGGC                                   
R: AACAAAACATGGTCGATGTAGAGA 
150 58 M   
152G20-SP6 F: GATGAGGGGCTATTCAGGTT 
R: ATCCCACACGTGAACTGTCT 
246 58 M   
152G20-T7 F: TTACTCCAGGTAACGCTTGC 
R: GAAAAGCCTGTCCTCCTCTC 
182 58 M   
155B8INT F: TAGCACCCAGGAGGTGTAGG 
R: CCTGCGACTAAATTGTTCTTCC 
165 60 M   
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155B8-T7 F: GGTACCAAAGGCACCAGAGA 
R: CCTCCTAAAGATGGCATGGA 
225   60 M   
155M11-T7 F: GGGGAGAGGATCTTCATAGGG 
R: TCCAGGCTGCCATGTTTTA 
247 50 M/wF   
159E3-SP6 F: TGAGCCCCCACAGTAATTTT 
R: TGAAGCCAGCCAGAGTTTTT 
237 58 M   
159E3-T7 F: TGGTAAGCAACTAAGATGAAAAGG 
R: CATCAACACAAAAGTTAGACAGGAA 
246 58 M   
159F5-SP6 F: ATGCGTTAGCCCACTCAAAG 
R: TTTTTGCTGTGGTCTCTGGA 
241 58 M   
159F5-T7 F: CCACAGCAATGACAAACTGC 
R: AGTGTTGGGCATCAGGTTTC 
169 58 M   
160K10-SP6 F: TCACGTCCCTCAACAAACAC 
R: GGGACACGGTAATGAGGAAA 
198 60 M   
160K10-T7 F: CAGCTCAGGGAAGAGACAGG 
R: CATTTCCACACGGAAGTCCT 
247 60 M/wF   
165 E24-SP6 F: ACCCAGCCAAAAGCAGATAC 
R: CTGAGGCCAGGTGTGGAG 
171 62 M   
167N20-SP6 F: CCATGGAAAGTGCAATGGTT 
R: GCATCTAGAAAAATGGAAGGTGA 
214 58 M/wF CU062306 
167N20-T7 F: CTCCAAACCTCCACTTCCAG 
R: GAGCTGCTGGTCGATTTTTC 
187 58 M/wF CU062307 
168I4-SP6 F: TCAGAAGGGGAAGAGAGTGG 
R: AGGCTCGGCTCGATTTTT 
138 55 M   
168I4-T7 F: CCATTTCAACTCCTGATCCA 
R: AAGGGTAGGTCAGAGAGGAAGG 
101 65 M BV140781, CLY031 
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168O8INT-2 F: AAGTTCCTGAAATCCCACTCC 
R: CATCTGAACCCCACTTCACC 
200 58 M   
168O8INT-3 F: ATACCTGGGAGAGGAATTGG 
R: CAAGGAAAGGACCGTGTAGG 
310 58 M   
172I8-T7 F: GCCCTTTCCTTCTCTCTCAC 
R: GCCACCACACGAGAATAAAC 
196 60 M   
179K8-T7 F: TCATAAGCCTCAGTGGAAGC 
R: CCCTTTTACTTCTCCCCAAA 
200 58 M   
180P20-SP6 F: CCCGTCCTTGTACTTTGGAG 
R: ATTTCACATGGCCCCTAATC 
128 60 M BV140790, CLY056 
180P20-T7 F: ATAAATGCCGGAATCCATGC 
R: CCCCATGGGAATGGTAAAGT 
181 52 M BV140787, CLY051 
181B18-SP6 F: CCCGCCAAGTCTATTTCC 
R: CAGTTAGTGGGAGGTGAGACG 
156 60 M   
185M14-SP6 F: TCAAGACTCTATCACAGCACTAAACAG 
R: AAGGGTCCACCTCAGTCACA 
100 50 M   
185M14-T7 F: AACCCATTTTCTCACAGTCTTG 
R: CAACACAAGTTGGAATGAGATG 
106 60 M BV140782, CLY039 
186J13-T7 F: AATCATAAACAGTCCATGGTCA 
R: TCAGTTCTCCCACCTGGATA 
151 58 M   
188E20-SP6 F: TCAGGTGAAGATTAAAGGAAGC 
R: GGGAATCCAACCAATAAGGAA 
250 58 M BV140780, CLY030 
188E20-T7 F: CTCAGTGTCAGCAGGTTCCA 
R: TGCAGCTCTCTATCAGAACAGG 
185 58 M BV140778, CLY023 
190M2-SP6 F: CTGATGCAGGTTTCACTGG 
R: GAGTCAGAGAGCTGGAACTGG 
109 67 M BV140775, CLY018 
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190M2-T7 F: CAGCATGGCTTCACTATTTCC 
R: TTTAGACAGGCAGAATCAGTTCC 
164 66 M BV140874, CLY015 
205D10-T7 F: GGGCTATGGCCTAGGAGAAC 
R: CTAGCAAAACATCTTGTGACAGTA 
169 62 M   
207D10-T7 F: AAGGGAAAGCAGGTTCCAGT 
R: ACAAGCGGTCTGAGGACACT 
191 58 M   
207P5-T7 F: CTGGAGTTCCATTGGGAGGT 
R: CACTCACAGGCAGCACATTT 
169 58  M/F CU102185 
209K10-SP6 F: TGGCTTCCTGCTGAAAGATT 
R: ATGGCAGCAAGTTTCTCTGG 
203 62 M   
215C6-SP6 F: AGCTTGGGTTCATGGTCAAA 
R: CCTCTCCCTATGGATCATGC 
221 58 M CU108088 
244B13-T7 F: GCTGGACAAATCGGTGTCTT  
R: CCTTGTGGACTATGCCACCT 
171  62 M CU126281 
263G23-SP6 F: GTGCCTCTGGGCATATCTTT 
R: TAATGTCAGCGGAGATGCAG 
150 58 M/F CU140369 
263G23-T7 F: GATGACCACGGGTTCTCAGT 
R: GGCCCAGGGATTAATTTTGT 
168  58 M CU139968 
269J9-SP6 F: CCGTGGCAACAAATGTTAGA 
R: CCAGAGAATGCTCCTGAACC 
191 58 M CU143890 
269J9-T7 F: CCATGGCAATATCTCCCTTT 
R: CCTGCAAATTGTGTGAAAGC 
184 58 M CU143373 
275P16-SP6 F: GGATCCTTACCACAGCCAGA 
R: CACATGAGGATATGAGGAGATACG 
249 58 M   
275P16-T7 F: CGACTCACTATAGGGGAGAGGA 
R: GGTGCTCTTCGTTACCTGGA 
157 58 M   
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Table A2 continued 
 
STS marker Primers 5′ to 3′ Size, 
bp 
Ta °C Male or 
female 
amplification 
GenBank Accession and alias symbol 
278M12-SP6 F: GTTGGCAGACGTAAGAAATGC 
R: TGAAAATGCTGGTTTTGTGG 
244 58 M   
278M12-T7 F: TATTACGGCCGTTACCAAGC 
R: GTGCCTGGATAGGCACATTT 
189 55 M   
280P20-SP6 F: CACAGTCATTTCTGGGATGC 
R: CCTGAGACTATGGGCAGTGA 
242 58 M   
291D19-T7 F: TGAGTTTGTGGTTAAAATGACAGG 
R: GGAGACAAATAGATGGACTCAGAA 
115 62 M   
318M1-T7 F: AAGTCAGGGACCAGCAAAGA 
R: TCCCTCTGAGAACCCAAATG 
193 58 M   
324H11-SP6 F: GACAGGACAGCGGAGTAAGC 
R: GTCCAGCAATGCACTCAGAA 
191 60 M   
324H11-T7 F: GCTGCCTGAAACCTGACTTC 
R: CATACACATGTCCCCTGCAA 
217 60 M   
329G16-SP6 F: CTCACCACTTGTTCTGGAAGC 
R: GGTGGAACTACTTGCTCATGG 
204 60 M   
331E10-SP6 F: TCATTAGGTCCTGGGCTCAC 
R: ATTGTTGGATGCTGGGACTC 
172 58 M/wF   
331E10-T7 F: CAGTTTCCCCACACTGAACC 
R: TCCATGGAGCATAGTGGATTC 
105 58 M/wF   
335P13-SP6 F: AAATGCCAGACACCTTCCAG 
R: TTCTCCTGTTTTTCCTTTTTCG 
210 58 M   
338A6-SP6 F: TCAACCCTGAATCCAGTCTCT 
R: TGCCTACTCTTCCCCCTAAAA 
249 62 M   
338A6-T7 F: CTGGGGATTTTGCTTGATGT 
R: CATGGGGAAATTCTATTTTAGGC 
154 58 M   
  
201
Table A2 continued 
 
STS marker Primers 5′ to 3′ Size, 
bp 
Ta °C Male or 
female 
amplification 
GenBank Accession and alias symbol 
341G20-T7 F: GCAAGGAATGATGCACAAGA 
R: ATTCCTTTGGTGTGCCTTTG 
178 58 M   
344A12-SP6 F: AACCTTGCCTACGGGCTTAT 
R: ATGTTTGTCCCCTTGTCAGG  
152 58 M CU312820 
377O23-SP6 F: GAATGCACATGTAGTGCCGTA 
R: TGACTGATGCAGCAGGAAAG 
151 58 M   
394K12-SP6 F: TTCCATATGCCAAGGAAGC 
R: TTGTCTAGGACAATGTTTTTCAGG 
151 60 M   
394K12-T7 F: GGGAATCTTGAGTCGCTTTG 
R: GCCTTACTCTGAGGCTGTGG 
249 60 M   
395L19-SP6 F:ACCCTGAATGCCAGTCTTTG 
R: CTGCCCAGTTTTCTCCTCAG 
 170  58 M 
  
417N24-SP6 F: CCCTAGGGCAGGTAAACAGA 
R: TTGGCAAACTATGCCGAGTA 
164 58 M   
417N24-T7 F: GCAATGCAAACGAGAACAGA 
R: AACAGCCAACCTCAGAGGAA 
239 58 M   
418J18-SP6 F: TCTGCTGGCACATTTGTTCT 
R: CCAAAAGTTCAGGCAGCAAT 
250 58 M   
418J18-T7 F: CTCCCCCTCCAAACTACACCA 
R: GGGAGGGAGCAAAGTTCTCT 
163 58 M   
422E23-SP6 F: GGCAGCATTTTGGTAGAAGC 
R: ATAGCGGGGTGGATGTACTG 
177 58 M   
422E23-T7 F: ACGCAAAAGGTTCATTACCG 
R: TTTCCATCTGTCATCCAATCAG 
175 55 M   
437I11-SP6 F: GCAATGCAAACGAGAACAGA 
R: AACAGCCAACCTCAGAGGAA 
239 60 M   
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Table A2 continued 
 
STS marker Primers 5′ to 3′ Size, 
bp 
Ta °C Male or 
female 
amplification 
GenBank Accession and alias symbol 
437I11-T7 F: GAGGATTTCCCTTCCCACAT 
R: TGCGTCCAATATGTCTACCC 
241 60 M   
450C22-T7 F:CCTGTTACAGCTCCGCTTTT 
R:CTGGTTGCCCAATTTGTTCT 
151 58 M  
504H13-SP6 F: CCCTTCCGCACTGTAAATGT 
R: TCCTGTTACCCACACAACCA 
163 58 M   
510F11-SP6 F: GGCAAACTATACCTAGCAC 
R: TCCGCAGTCTGATAGAGCAA 
213 58 M   
510F11-T7 F: AATCTGGGGAAGCTGTGCTA 
R: TTGATGGTGGCAGAATGAGA 
155 58 M   
ABW-M13 F: GCGAGGGGTGAGTTATTGAA 
R: TTAGCTGGCCCTTCCCTTAT 
193 60 M BV140869, CLY088  
ABW-T7 F: TATGGAACCCCTTCTGCAAG 
R: CCTGCCGACATGACAAAATA 
209 65 M BV140868, CLY087 
BBW-M13 F: CAGTCCTGTCAGTGCTCCAA 
R: CATGGCACAATGCAACTAGG 
157 60 M CLY063, CLY063 
BBW-T7 F: CCCACCTCAGGATATTGCAT 
R: GCAGTGGTGTACAAAGACAGCA 
214 65 M BV140862, CLY061 
CBW-M13 F: GAGGAGAAGTGCCTTAAATTCC 
R: CCCAGAAAATCGTTCATTCC 
177 60 M BV140870, CLY089 
DBW-M13 F: GTGCCTGGGGATTCTCAGAT 
R: 
GTATAGTTTGGAAGGTGCTAAACACAG 
150 60 M BV140866, CLY065 
DBW-T7 F: CTGCTGAGCAAGGGGTTAAG 
R: CGAGTGTTTCAGCAAACAGG 
195 65 M BV140865, CLY064 
EBW-M13 F: TTAGAATGGGCTTGGCTCCT 
R: ACAGCTTTGAGGGATGGTTC 
179 60 M BV140858, CLY025 
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Table A2 continued 
 
STS marker Primers 5′ to 3′ Size, 
bp 
Ta °C Male or 
female 
amplification 
GenBank Accession and alias symbol 
EBW-T7 F: TTGAGCCCTTGTTTCTGTCC 
R: CAGGGAAGTAGGGAGTGACC 
165 60 M BV140859, CLY027 
FBW-T7 F: AGCTGATCGAACCCATAACC 
R: CTCTCCCAATGCCCTTCC 
173 60 M BV140861, CLY044 
GBW-T7 F: ACTTTGCACTTGCCCCATAA 
R: TCCCAGCTAAAAAGGTACTCC 
120 60 M BV140860, CLY040 
HBW-M13 F: GTTGCTCTGGGTTTTCTTCC 
R: ACTCACCATCACACGACACC 
247 60 M BV140872, CLY093 
HBW-T7 F: CGTACTGCTTTTAGCTTGAGACC 
R: AAGAGGTGAGTCCGTTGACC 
236 60 M BV140871, CLY092 
JBW-M13 F: CCTCTGCTGGTCACCTTCTG 
R: TTCCACATAGAAGCCCCCTA 
242 60 M BV140873, CLY094 
MBW-M13 F: AGAAGGAGCCTGAGACAAGG 
R: CTCAACACCCAGTCTTTTTGG 
154 60 M   
OBW-M13 F: TGTGGCAGAGTGAGCTTTCC 
R: CATTCCAGTAGAGGGCTTCC 
348 60 M BV140856, CLY017 
OBW-T7 F: CCAAAACTAATGAGAGCCGTGA 
R: CACAGACTCAGGAGCAGGAA 
173 60 M BV140857, CLY019 
SH2A1 F: CGGTGTCAGGTTTTGGACTT 
R: AAGGATTCTGCTGCCCTCAT 
747 64 M BV005744 
SH3B14 F: GTGACCTCCCAGGAGCTGT 
R: TCTGCCTATGCTCTGGTGAA 
486 64 M BV005745 
SH3B19 F: AAGCCTTTCATGGAAATTGG 
R: TTACGCAGACATCCTGGACA 
255 58 M BV005720, Y3B19 
SH3B6 F: AGAGTGCGATTTGTGATGG 
R: AGAGTCAGAAGAAAGCGTTGAT 
492 64 M BV005718 
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Table A2 continued 
 
STS marker Primers 5′ to 3′ Size, 
bp 
Ta °C Male or 
female 
amplification 
GenBank Accession and alias symbol 
SH3B8 F: CCCAAGTTCCTTGCCATC 
R: AAATTGAAGAGGCCCCAAAG 
472 58 M G72337, Y3B8 
Y2B17 F: TTCAGTCCTGCTTTCTCCTCA 
R: CAGGATGTGCCATGTGATTG 
528 58 M G72335 
Y3B1 F: TGGGTTAATGGGATTTGGTG 
R: CAAGCACAGCTCTGTATCAA 
508 58 M G72336 
Y3B12 F: GGGAGGCACTGGAAAGTACA 
R: GGTGGAGGAATCAGCTGGAG 
400 58 M G72338 
YA16 F: TGACTGGAAATTGAAGATG 
R: TTGTAGCAACAAAGTAACAC 
157  58 M BV005729 
YE1 F: CTTCACTCCCGACCAAGAGA 
R: GTGTGTCGTGCCGTGTTTAC 
199 58 M BV005727 
YH12 F: CGAACAGGTGACGAAGCATC 
R: GCAGACATGCACACCAACC 
98  58 M BV005747 
YJ10 F: AGTTCCCCTGCACACCT 
R: TGCCTCCCACAGCCATAC 
215 64 M BV005728 
YM2 F: TGGTTCAGATGGTGTATTTTGTT 
R: TTTGCAGCCAGTACCTACCTT 
119 58 M BV005725 
YP9 F: AAGCACTGCCTTTTGGAATC 
R: AACCCTGGACTTTCTTTGAA 
216 60 M BV005726 
 
 
(M: male, F: female, M/F: male and female; M/wF: male and weak female)  
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Table A3: Summary information about the MSY contig map. 
 
Contigs Genes STSs Number of 
BACs 
Average BES 
size, bp 
GC% of BES Number and % of 
repetitive BES 
Heterochromatin 3 3 2 557 46.2 2 (50%) 
Single copy 2 33 28 756 42.7 8 (14.3%) Contig I 
Multicopy 13 63 52 623 42.6 41(39.2%) 
Contig II  11 87 55 777 42.1 31(28.1%) 
Contig III  2 47 27 660 38.5 9(16.7%) 
Contig IV  2 31 20 683 38.0 10 (25%) 
Contig V  3 18 13 856 31.1 8 (30.7%) 
Total/Average 36 282 197 701 40.1 109 (29.1%) 
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Figure A1: Comprehensive map of the male specific region of the horse Y chromosome. 
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a. GAPDH
 
 
Figure A2: Expression analysis of ECAY genes and reference genes in normal fertile and infertile/subfertile (abnormal) 
stallions (represented data obtained directly from qBase software) a. Expression of GAPDH (reference gene): showed uniform 
expression across fertile and subfertile group of animals. 
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b. ACTB
 
 
        
Figure A2: Expression analysis of ECAY genes and reference genes in normal fertile and infertile/subfertile (abnormal) 
stallions (represented data obtained directly from qBase software) (contd.) b. Expression of ACTB (reference gene): showed 
uniform expression across fertile and subfertile group of animals. 
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c. ETSTY1
 
 
 
Figure A2: Expression analysis of ECAY genes and reference genes in normal fertile and infertile/subfertile (abnormal) 
stallions (represented data obtained directly from qBase software) (contd.) c. Expression of ETSTY1 (multicopy, testis-
specific): showed differential expression in subfertile/infertile (abnormal) group compared to normal, fertile group of stallions. 
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d. ETSTY6
 
 
 
Figure A2: Expression analysis of ECAY genes and reference genes in normal fertile and infertile/subfertile (abnormal) 
stallions (represented data obtained directly from qBase software) (contd.) d. Expression of ETSTY6 (multicopy, tetis-specific): 
showed differential expression in subfertile/infertile (abnormal) group compared to normal, fertile group of stallions. 
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